10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2012

or

o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from                                                                 to                      

Commission File Number 001-33695

Westinghouse Solar, Inc.

(Exact name of registrant as specified in its charter)

Delaware	90-0181035
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

1475 S. Bascom Ave. Suite 101, Campbell, CA	95008
(Address of principal executive offices)	(Zip Code)

(408) 402-9400

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes x    No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x    No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  o		Accelerated filer  o
Non-accelerated filer  o	(Do not check if a smaller reporting company)	Smaller reporting company  x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o    No x

As of August 10, 2012, 19,148,083 shares of the issuer’s common stock, par value $0.001 per share, were outstanding (including non-vested restricted shares).

TABLE OF CONTENTS

PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
Condensed Consolidated Balance Sheets	2
Condensed Consolidated Statements of Comprehensive Income (Loss)	3
Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders’ Equity	4
Condensed Consolidated Statements of Cash Flows	5
Notes to Condensed Consolidated Financial Statements	7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.	21
Item 3. Quantitative and Qualitative Disclosures About Market Risk.	30
Item 4. Controls and Procedures.	30
PART II - OTHER INFORMATION
Item 1. Legal Proceedings.	31
Item 1A. Risk Factors.	31
Item 6. Exhibits.	40
SIGNATURES	41
Exhibit Index	42
EX-31 Section 302 Certification of CEO and CFO
EX-32 Section 906 Certification of CEO and CFO

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

Westinghouse Solar, Inc.

Condensed Consolidated Balance Sheets

	June 30, 2012 (unaudited)			December 31, 2011
Assets
Current assets:
Cash and cash equivalents	$	192,544		$	1,346,777
Accounts receivable, net		573,552			1,096,580
Other receivables		467,401			469,469
Inventory, net		2,319,705			4,172,809
Prepaid expenses and other current assets, net		474,423			978,709
Assets of discontinued operations		17,296			87,455
Assets held for sale – discontinued operations		15,570			18,293
Total current assets		4,060,491			8,170,092
Property and equipment, net		116,302			196,718
Other assets, net		1,546,427			955,570
Assets of discontinued operations – long-term		200,000			209,913
Total assets	$	5,923,220		$	9,532,293
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	3,100,461		$	3,865,039
Accrued liabilities		725,191			428,813
Accrued warranty		294,036			217,812
Common stock warrant liability		10,123			317,490
Credit facility		94,077			92,266
Capital lease obligations – current portion		4,731			4,699
Note payable – current portion		95,067			283,252
Liabilities of discontinued operations – short-term		1,117,999			1,308,820
Total current liabilities		5,441,685			6,518,191
Capital lease obligations, less current portion		2,362			4,713
Long-term liabilities of discontinued operations		—			10,200
Total liabilities		5,444,047			6,533,104
Commitments, contingencies and subsequent events (Notes 17 and 18)
Stockholders’ equity:
Convertible redeemable preferred stock, $0.001 par value, 1,000,000 shares authorized; 2,273 shares issued and outstanding on June 30, 2012 and December 31, 2011		751,223			751,223
Common stock, $0.001 par value; 100,000,000 shares authorized; 19,165,060 and 16,040,581 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively (Note 1)		19,165			16,041
Additional paid-in capital		75,250,830			72,683,781
Accumulated deficit		(75,542,045	)		(70,451,856	)
Total stockholders’ equity		479,173			2,999,189
Total liabilities and stockholders’ equity	$	5,923,220		$	9,532,293

The accompanying notes are an integral part of these condensed consolidated financial statements  

2

Westinghouse Solar, Inc.

Condensed Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)

	Three Months Ended  June 30,						Six Months Ended  June 30,
	2012			2011			2012			2011
Net revenue	$	1,209,211		$	2,757,729		$	3,631,551		$	4,752,091
Cost of goods sold		1,243,034			2,563,842			3,423,003			4,280,405
Gross profit		(33,823	)		193,887			208,548			471,686
Operating expenses
Sales and marketing		467,523			700,103			1,090,703			1,046,431
General and administrative		1,663,885			1,464,269			3,727,294			3,143,214
Total operating expenses		2,131,408			2,164,372			4,817,997			4,189,645
Loss from continuing operations		(2,165,231	)		(1,970,485	)		(4,609,449	)		(3,717,959	)
Other income (expense)
Interest income (expense), net		(39,006	)		(35,148	)		(34,786	)		(57,849	)
Adjustment to the fair value of common stock warrants		10,303			668,041			(426,640	)		1,130,989
Total other income (expense)		(28,703	)		632,893			(461,426	)		1,073,140
Loss before provision for income taxes and discontinued operations		(2,193,934	)		(1,337,592	)		(5,070,875	)		(2,644,819	)
Provision for income taxes		—			—			—			—
Net loss from continuing operations (Note 3)		(2,193,934	)		(1,337,592	)		(5,070,875	)		(2,644,819	)
Net income (loss) from discontinued operations, net of tax		(2,880	)		9,830			22,973			3,568
Net loss		(2,196,814	)		(1,327,762	)		(5,047,902	)		(2,641,251	)
Preferred stock dividend		(21,028	)		—			(42,287	)		—
Preferred deemed dividend		—			—			—			(975,460	)
Net loss attributable to common stockholders	$	(2,217,842	)	$	(1,327,762	)	$	(5,090,189	)	$	(3,616,711	)
Net loss attributable to common stockholders per common and common equivalent share (basic and diluted)	$	(0.12	)	$	(0.11	)	$	(0.29	)	$	(0.31	)
Weighted average shares used in computing loss per common share: (basic and diluted)		18,459,159			11,387,874			17,302,561			11,374,872

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

Westinghouse Solar, Inc.

Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders’ Equity

(Unaudited)

	Convertible Redeemable Preferred Stock				Common Stock
	Number of Shares		Amount		Number of Shares		Amount		Additional Paid-in Capital			Accumulated Deficit			Stockholders' Equity
Balance at January 1, 2012		2,273	$	751,223		16,040,581	$	16,041	$	72,683,781		$	(70,451,856	)	$	2,999,189
Issuance of common stock for supply agreement		—		—		2,080,558		2,080		1,130,790			—			1,132,871
Preferred stock dividends paid in common stock		—		—		111,537		112		42,175			(42,287	)		—
Reclassify fair value of common stock warrant liability upon exercise and modification		—		—		—		—		734,007			—			734,007
Exercise of warrants for common stock		—		—		472,222		472		282,862			—			283,334
Grants of restricted stock, net of forfeitures and repurchases for employee taxes		—		—		460,162		460		(4,948	)		—			(4,488	)
Stock-based compensation expense		—		—		—		—		440,342			—			440,342
Placement agent and registration fees and other direct costs		—		—		—		—		(58,180	)		—			(58,180	)
Net loss		—		—		—		—		—			(5,047,902	)		(5,047,902	)
Balance at June 30, 2012		2,273	$	751,223		19,165,060	$	19,165	$	75,250,830		$	(75,542,045	)	$	479,173

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

 Westinghouse Solar, Inc.

Condensed Consolidated Statements of Cash Flows

 (Unaudited)

	Six Months Ended June 30,
	2012			2011
Cash flows from operating activities
Net loss	$	(5,047,902	)	$	(2,641,251	)
Adjustments to reconcile net loss to net cash used in by operations:
Depreciation		80,416			108,691
Amortization of patents		12,402			2,927
Bad debt expense		102,000			10,000
Unrealized gain (loss) on fair value adjustment of common stock warrants		426,640			(1,130,989	)
Non-cash stock-based compensation expense		440,342			606,317
Loss on assets held for sale		—			10,840
Changes in assets and liabilities:
Accounts receivable		421,028			(335,691	)
Other receivables		2,068			8,336
Inventory		1,940,974			1,270,448
Prepaid expenses and other current assets		504,286			(2,438	)
Assets of discontinued operations – short term		70,159			566,363
Assets held for sale		2,723			20,738
Other assets		(603,259	)		(101,454	)
Assets of discontinued operations – long-term		9,913			(200,000	)
Accounts payable		280,422			697,499
Accrued liabilities and accrued warranty		372,603			(55,099	)
Liabilities of discontinued operations		(201,022	)		(279,825	)
Net cash used in operating activities		(1,186,207	)		(1,444,588	)
Cash flows from investing activities
Acquisition of property and equipment		—			(28,564	)
Proceeds from disposal of property and equipment		—			18,800
Proceeds from disposal of property and equipment from discontinued operations		—			189,019
Net cash provided by (used in) investing activities		—			179,255
Cash flows from financing activities
Repayment of notes payable		(188,185	)		(95,425	)
Borrowing on line of credit		94,077			—
Repayment on line of credit		(92,266	)		(540,250	)
Repayments on capital lease obligations		(2,319	)		(1,431	)
Repayments on capital lease obligations from discontinued operations		—			(5,662	)
Restricted cash		—			540,250
Proceeds from stock offering		—			3,600,000
Proceeds from exercise of warrants		283,334			—
Payment of placement agent and registration fees and other direct costs		(58,180	)		(521,609	)
Employee taxes paid for vesting of restricted stock		(4,487	)		(18,224	)
Net cash provided by financing activities		31,974			2,957,649
Net increase (decrease) in cash and cash equivalents		(1,154,233	)		1,692,316
Cash and cash equivalents
Beginning of period		1,346,777			596,046
End of period	$	192,544		$	2,288,362

5

Supplemental cash flows disclosures:
Cash paid during the period for interest	$	25,213	$	11,092
Supplemental disclosure of non-cash financing activity:
Fair value of warrants issued in stock offering	$	—	$	2,713,550
Conversion of common stock warrant liability upon exercise of warrants	$	252,765	$	—
Common stock warrant liability issued in connection with agency placement fee	$	—	$	89,010
Reclassification of common stock liability upon modification of warrants	$	481,242	$	—
Preferred deemed dividend	$	—	$	975,460
Preferred stock dividends paid in common stock	$	42,287	$	—
Stock issued in satisfaction of accounts payable to investor supplier	$	1,045,000	$	—
Stock issued to procure inventory	$	87,871	$	—
Property and equipment acquired through capital lease	$	—	$	11,000

The accompanying notes are an integral part of these condensed consolidated financial statements.

6

Westinghouse Solar, Inc.

Notes to Condensed Consolidated Financial Statements

June 30, 2012

(Unaudited)

1. Basis of Presentation and Description of Business

Basis of Presentation — Interim Financial Information

The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with generally accepted accounting principles for interim financial information. They should be read in conjunction with the financial statements and related notes to the financial statements of Westinghouse Solar, Inc. (“we”, “us”, “our” or the “Company”), formerly Akeena Solar, Inc., for the years ended December 31, 2011 and 2010 appearing in our Form 10-K. The June 30, 2012 unaudited interim consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements filed with our Annual Report on Form 10-K have been condensed or omitted as permitted by those rules and regulations. In the opinion of management, all adjustments, consisting of normal recurring accruals, necessary for a fair statement of the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the entire year.

Reclassifications

Reverse Stock Split

On April 6, 2011, we filed a Certificate of Amendment to our Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a reverse split of our common stock at a ratio of 1-for-4. The reverse stock split was effective at the close of business on April 13, 2011. All historical share and per share amounts have been adjusted to reflect the reverse stock split. Our par value was not changed by the reverse stock split.

Description of Business

We are a designer and manufacturer of solar power systems and solar panels with integrated microinverters (which we call AC solar panels). We design, market and sell these solar power systems to solar installers, trade workers and do-it-yourself customers through distribution partnerships, our dealer network and retail outlets. Our products are designed for use in solar power systems for residential and commercial rooftop customers. Prior to September 2010, we were also in the solar power installation business. We launched the distribution of our solar power systems in the second quarter of 2009.

On May 17, 2010, we entered into an exclusive worldwide agreement that permits us to manufacture, distribute and market our solar panels under the Westinghouse name. On July 22, 2010, we announced that we will operate under the name “Westinghouse Solar” and, effective July 23, 2010 at the opening of the market, our stock began trading under the stock symbol “WEST” on the NASDAQ Capital Market.

At the Annual Meeting of Stockholders held on March 31, 2011, our stockholders approved an amendment to our Certificate of Incorporation to formally change the name of the company from “Akeena Solar, Inc.” to “Westinghouse Solar, Inc.”. The name change became effective on April 6, 2011.

Our Corporate headquarters is located at 1475 S. Bascom Ave., Campbell, CA 95008. Our telephone number is (408) 402-9400. Additional information about Westinghouse Solar is available on our website at http://www.westinghousesolar.com. The information on our web site is not incorporated herein by reference.

On May 7, 2012, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with CBD Energy Limited, an Australian corporation (“CBD”), and CBD-WS Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of CBD (“Merger Sub”). Under the terms of the Merger Agreement, Merger Sub will be merged with and into the Company, with the Company to be the surviving corporation and a wholly-owned subsidiary of CBD (the “Merger”).

Under the Merger Agreement, our stockholders would receive shares of CBD in exchange for their shares. Our common stockholders will receive approximately 3.7 CBD common shares for each common share held and our preferred stockholders will receive CBD preferred shares which will be convertible into CBD common shares. On an as-converted basis, the holders of our common stock and holders of our Series B preferred stock would collectively hold approximately 15% of the outstanding CBD common shares, calculated as if the Merger was consummated on the signing date. The Merger will not qualify as a “tax free reorganization” for U.S. federal income tax purposes. CBD has applied for listing on the Nasdaq Stock Market, with listing to be effective on or before consummation of the Merger. Completion of the Merger is subject to customary conditions, including (i) the adoption of the Merger Agreement by the required vote of the holders of our outstanding common stock, (ii) the Securities and Exchange Commission (the “SEC”) has declared effective a Registration Statement registering the CBD common shares under the Securities Act of 1933, as amended, (iii) the approval and adoption by the holders of outstanding CBD common shares of the Merger Agreement and the issuance of additional CBD common shares as consideration in the Merger, and (iv) the approval by the Australian Securities Exchange (the “ASX”) and the holders of outstanding CBD common shares of the delisting of the CBD common shares from the ASX. In conjunction with the execution of the Merger Agreement, the holders of a majority of our outstanding Company Series B preferred stock entered into a Waiver and Agreement in substantially the form attached as Exhibit D to the Merger Agreement (and included in Exhibit 2.1 to the Current Report on Form 8-K filed with the SEC on May 9, 2012).

7

2. Significant Accounting Policies

Liquidity and Financial Position

For the six months ending June 30, 2012, and for each of the two years in the period ending December 31, 2011, we have incurred net losses and negative cash flows from operations. In addition, we expect to incur a net loss from operations for our year ending December 31, 2012. During recent years, we have undertaken several equity financing transactions to provide the capital needed to sustain and to grow our business. Based on current cash projections for 2012, which contemplate a smaller operating loss, we intend to address ongoing working capital needs through cost reduction measures recently implemented and utilization of existing inventory, along with utilizing our available credit facility and raising additional equity. In the event that revenue is lower, further staffing reductions and expense cuts could occur.

As of June 30, 2012, we had approximately $193,000 in cash on hand and $656,000 available under our credit facility. As an additional source of capital, outstanding warrants provide the possibility to receive additional proceeds upon exercise, depending on market conditions (See “Stock Warrants and Warrant Liability”). During the three months ending March 31, 2012, warrants to purchase 472,222 shares of common stock with an exercise price of $0.60 per share were exercised, resulting in approximately $283,000 in proceeds. We are seeking potential investors to obtain additional funding, and we have engaged an investment banker to facilitate these efforts.

The accompanying consolidated financial statements have been prepared assuming we will continue as a going concern. Our significant operating losses and negative cash flow from operations raise substantial doubt about our ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty and contemplate the realization of assets and the settlement of liabilities and commitments in the normal course of business. We believe our current cash balance, projected financial results and the amounts that should be available through debt and equity financing provide sufficient resources and operating flexibility through at least the next 12 months, however, there can be no assurance that we will be able to raise additional funds on commercially reasonable terms, if at all.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Revenue Recognition

Revenue from sales of products is recognized when: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) the sale price is fixed or determinable, and (4) collection of the related receivable is reasonably assured. We recognize revenue when the solar power systems are shipped to the customer.

Cash and Cash Equivalents

We consider all highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. We maintain cash and cash equivalents which consist principally of demand deposits with high credit quality financial institutions. At certain times, such amounts exceed FDIC insurance limits. We have not experienced any losses on these investments.

Accounts Receivable

Accounts receivable consist of trade receivables. We regularly evaluate the collectability of our accounts receivable. An allowance for doubtful accounts is maintained for estimated credit losses, and such losses have historically been minimal and within our expectations. We consider a number of factors when estimating credit losses, including the aging of a customer’s account, creditworthiness of specific customers, historical trends and other information.

Discontinued operations

Discontinued operations are presented and accounted for in accordance with Accounting Standards Codification (ASC) 360, “Impairment or Disposal of Long-Lived Assets,” (ASC 360). When a qualifying component of the Company is disposed of or has been classified as held for sale, the operating results of that component are removed from continuing operations for all periods presented and displayed as discontinued operations if: (a) elimination of the component’s operations and cash flows from the Company’s ongoing operations has occurred (or will occur) and (b) significant continuing involvement by the Company in the component’s operations does not exist after the disposal transaction.

On September 10, 2010, we announced that we were exiting the solar panel installation business. The exit from the installation business was essentially completed by the end of 2010, other than potential warranty payments related to past installations. (See “Manufacturer and Installation Warranties”). The exit from the installation business was therefore classified as discontinued operations for all periods presented under the requirements of ASC 360.

8

Manufacturer and Installation Warranties

The manufacturer directly warrants the solar panels and inverters for a range from 15 to 25 years. We warrant the balance of system components of our products against defects in material and workmanship for five years. We assist our customers in the event of a claim under the manufacturer warranty to replace a defective solar panel or inverter. The warranty liability for the material and the workmanship of the balance of system components of approximately $294,000 at June 30, 2012 and $218,000 at December 31, 2011, is included within “Accrued warranty” in the accompanying condensed consolidated balance sheets.

The liability for our manufacturing warranty consists of the following:

	June 30, 2012 (Unaudited)			December 31, 2011
Beginning accrued warranty balance (January 1)	$	217,812		$	51,860
Reduction for labor payments and claims made under the warranty		(1,388	)		—
Accruals related to warranties issued during the period		77,612			165,952
Ending accrued warranty balance	$	294,036		$	217,812

We previously recorded a provision for warranty liability related to our discontinued installation operations. We provided for a 5-year or a 10-year warranty on the installation of a system and all equipment and incidental supplies other than solar panels and inverters that are covered under the manufacturer warranty. The liability for the installation warranty of approximately $1.1 million at June 30, 2012 and December 31, 2011 is included within “Liabilities of Discontinued Operations” in the accompanying condensed consolidated balance sheets. Defective solar panels or inverters are covered under the manufacturer warranty. In the event that a panel or inverter needs to be replaced, we will replace the defective item within the manufacturer’s warranty period (between 5-25 years).

Patent Costs

We capitalize external legal costs and filing fees associated with obtaining or defending our patents. Upon issuance of new patents or successful defense of existing patents, we amortize these costs using the straight line method over the shorter of the legal life of the patent or its economic life. We believe the remaining useful life we assign to these patents, approximately 12.5 years as of June 30, 2012, are reasonable. As a result of the settlement of various legal disputes with Zep Solar, Inc., (Zep) (see “Commitments and Contingencies”) during the quarter ended June 30, 2012, we reclassified approximately $1.3 million in legal costs from other long-term assets to patents, both included in "other assets, net" in the accompanying balance sheets, which is being amortized over 12.5 years. We periodically review our patents to determine whether any such cost have been impaired and are no longer being used. To the extent we are no longer using certain patents, the associated costs will be written off at that time.

Common Stock Warrant Liabilities

In March 2009 and February 2011, we issued warrants to purchase shares of our common stock in connection with certain capital financing transactions. The terms of the March 2009 warrant agreements include a cash-out provision which may be triggered at the option of the warrant holders if the Company “goes private,” is acquired for all cash or upon the occurrence of certain other fundamental transactions involving the Company. Under the Financial Accounting Standards Board (“FASB”) Topic 480, Distinguishing Liabilities from Equity (“ASC 480”), financial instruments that may require the issuer to settle the obligation by transferring assets or to reduce the exercise price of its warrants to purchase shares of its common stock are classified as a liability. Therefore, we classified these warrants as liabilities and we record mark-to-market adjustments to reflect the fair value at each period-end. On March 30, 2012, the February 2011 warrants were amended to remove any future price adjustment to the exercise price. (See Note 12. “Stock Warrants” relating to the accounting treatment of the Series E and K warrants).

Significant Accounting Policies and Estimates

There have been no material developments or changes to the significant accounting policies discussed in our 2011 Annual Report on Form 10-K or accounting pronouncements issued or adopted, except as described below.

Recently Adopted Accounting Standards

In June 2011, the FASB issued ASU No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income (ASU No. 2011-05). ASU No. 2011-05 requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements, eliminating the option to present other comprehensive income in the statement of changes in equity. Under either choice, items that are reclassified from other comprehensive income to net income are required to be presented on the face of the financial statements where the components of net income and the components of other comprehensive income are presented. We adopted ASU No. 2011-05 on January 1, 2012 and the adoption of this guidance did not have a material impact on our financial position, results of operations or cash flows.

9

3. Discontinued Operations

On September 10, 2010, we announced that we were exiting the solar panel installation business and we were expanding our distribution business to include sales of our Westinghouse Solar Power Systems directly to dealers in California. The exit from the installation business was essentially completed by the end of 2010. During the six months ended June 30, 2012, we recorded a gain from discontinued operations of approximately $23,000 compared to a gain from discontinued operations of approximately $4,000 during the six months ended June 30, 2011. The assets and liabilities of discontinued operations are presented separately under the captions “Assets of discontinued operations,” “Liabilities of discontinued operations” and “Long-term liabilities of discontinued operations,” respectively, in the accompanying condensed consolidated balance sheets at June 30, 2012 and December 31, 2011, and consist of the following:

Assets of discontinued operations:	June 30, 2012 (unaudited)		December 31, 2011
Accounts receivable and other receivables	$	7,383	$	41,762
Prepaid expenses and other current assets		—		34,415
Other assets		9,913		11,278
Total current assets of discontinued operations		17,296		87,455
Security deposits on operating leases		—		9,913
Security deposit – escrow account for installation jobs		200,000		200,000
Total assets of discontinued operations	$	217,296	$	297,368

Liabilities of discontinued operations:	June 30, 2012 (unaudited)		December 31, 2011
Accrued liabilities	$	36,682	$	124,751
Accrued warranty		1,081,317		1,133,549
Deferred revenue		—		50,520
Total current liabilities		1,117,999		1,308,820
Other long-term liabilities		—		10,200
Total discontinued operations liabilities	$	1,117,999	$	1,319,020

We entered into a Supply and Warranty Agreement and Master Assignment Agreement with Real Goods Solar, Inc. (Real Goods), pursuant to which Real Goods has agreed to perform certain warranty work. The terms of the agreement provide that an escrow account be established as a source of funds from which to satisfy our obligation to pay Real Goods for its fees and reimburse it for its expenses for this warranty work. In March 2011, we entered into an Escrow Agreement with Real Goods and deposited $200,000 into an escrow account. The amount is reflected in long-term assets of discontinued operations in the balance sheet. The escrow deposit will be released to us in the amount of $40,000, or one-fifth of the remaining escrow funds, per year after each of the fifth through the ninth anniversary of the escrow agreement.

In connection with the announcement of our exit from the solar panel installation business, we reclassified certain assets as “Assets held for sale,” in the accompanying condensed consolidated balance sheets at June 30, 2012 and December 31, 2011, which consists of inventory of solar inverters of approximately $16,000 and $18,000, respectively.

4. Accounts Receivable

Accounts receivable consists of the following:

	June 30, 2012 (Unaudited)			December 31,  2011
Trade accounts	$	728,056		$	1,230,895
Less: Allowance for bad debts		(141,000	)		(39,000	)
Less: Allowance for returns		(13,504	)		(95,315	)
	$	573,552		$	1,096,580

The following table summarizes the allowance for doubtful accounts as of June 30, 2012 and December 31, 2011:

	Balance at Beginning of Period		Provisions, net		Write-Off/ Recovery		Balance at End of Period
Six months ended June 30, 2012	$	39,000	$	102,000	$	—	$	141,000
Year ended December 31, 2011	$	5,000	$	34,000	$	—	$	39,000

10

5. Inventory

Our inventory, which consists entirely of finished goods inventory, was approximately $2.3 million and $4.2 million at June 30, 2012 and December 31, 2011, respectively. As of June 30, 2012 and December 31, 2011, there was approximately $17,000 and $75,000, respectively, capitalized in inventory related to the restricted stock grant for a supply agreement with Light Way Green New Energy Co., Ltd, (Lightway) and approximately $42,000 and $12,000, respectively, related to rent, depreciation and salary costs.

6. Property and Equipment, Net

Property and equipment, net consist of the following:

	June 30, 2012 (Unaudited)			December 31,  2011
Office equipment	$	573,852		$	573,852
Leasehold improvements		148,759			148,759
Vehicles		17,992			17,992
		740,603			740,603
Less: Accumulated depreciation and amortization		(624,301	)		(543,885	)
	$	116,302		$	196,718

Depreciation expense for the three months ended June 30, 2012 and 2011 was approximately $40,000 and $44,000, respectively. For the six months ended June 30, 2012 and 2011, depreciation expense was approximately $80,000 and $109,000, respectively.

7. Accrued Liabilities

Accrued liabilities consist of the following:

	June 30, 2012 (Unaudited)		December 31,  2011
Accrued salaries, wages, benefits and bonus	$	63,494	$	92,692
Accrued accounting and legal fees		167,973		138,233
Allowance for returns		—		20,081
Customer deposit payable		44,345		13,819
Accrued tariff		66,751		—
Royalty payable		292,500		125,000
Accrued interest		36,337
Other accrued liabilities		53,791		38,988
	$	725,191	$	428,813

8. Credit Facility

On February 15, 2011, we entered into a Business Financing Agreement (the "2011 Credit Facility") with Bridge Bank, National Association (“Bridge Bank”) to finance our accounts receivables. The 2011 Credit Facility provides for a credit limit of $750,000, representing the maximum amount of advances based on up to 50% of $1.5 million of gross eligible accounts receivables. The 2011 Credit Facility may be terminated at any time by either party and may be renewed under similar terms if acceptable and agreed to by both parties. If any advance is not repaid in full within 90 days from the earlier of (a) invoice date, or (b) the date on which such advance is made, we are obligated to immediately pay the outstanding amount to Bridge Bank. Outstanding loans under the 2011 Credit Facility will accrue interest at the Bridge Bank Prime rate plus 3.0% (annualized) of the daily gross financed amount outstanding. The 2011 Credit Facility is secured by substantially all of our assets. As of June 30, 2012 and December 31, 2011, there was approximately $94,000 and $92,000, respectively, borrowed under the 2011 Credit Facility.

11

9. Stockholders’ Equity

On February 17, 2011, we entered into a securities purchase agreement with certain institutional accredited investors relating to the sale of 4,000 units at a price of $900 per unit. See Note 10 for a discussion of the sale of units.

On March 25, 2011, we entered into a Supply Agreement (the “Lightway Supply Agreement”) with Light Way Green New Energy Co., Ltd (Lightway). Lightway is a vertically integrated manufacturer of polycrystalline silicon wafers, solar cells and solar modules. Lightway is a supplier for our proprietary Westinghouse solar panels. In consideration of the new contract manufacturing arrangement, we agreed to issue to Lightway shares of our common stock with a market value of $520,000, based on the closing share price of our common stock on the date of the first shipment of products by Lightway. On July 31, 2011, in conjunction with their first shipment, we issued Lightway 361,111 unvested shares of our common stock. The shares will vest ratably on a monthly basis over a one year period beginning August 31, 2011. As of June 30, 2012, 331,019 shares have vested. The unvested shares are subject to forfeiture in the event of termination of the Lightway Supply Agreement by either party.

On August 16, 2011, we entered into a securities purchase agreement with an institutional accredited investor relating to the sale of 990,099 shares of common stock at a price of $1.01 per share, along with the sale of Series L Warrants to purchase up to 643,564 shares of common stock (65% of the number of shares of common stock initially issued) at an exercise price of $1.17 per share. The warrants were not exercisable until six months after issuance and have a term of five years from the date they are first exercisable. The aggregate purchase price for the shares and the warrants was $1,000,000. Under the securities purchase agreement, we agreed to amend the outstanding Series J Warrants, such that the exercise price of the Series J Warrants was reduced from $2.44 per share to $1.17 per share. In addition, each of the Series J Warrants, (i) is not exercisable until the six month anniversary of the closing under the August 16, 2011 securities purchase agreement, and (ii) the expiration date is extended such that the warrant is exercisable for five years from the delayed initial exercise date.

On September 28, 2011, we entered into a securities purchase agreement with an institutional accredited investor relating to the sale of 500,000 shares of common stock at a price of $0.80 per share, along with the sale of Series M Warrants to purchase up to 325,000 shares of common stock (65% of the number of shares of common stock initially issued) at an exercise price of $0.81 per share. The warrants were not exercisable for six months after issuance and have a term of 5½ years from the date they are first exercisable. The aggregate purchase price for the shares and the warrants was $500,000. Under the securities purchase agreement, we agreed to amend the outstanding Series L Warrants, such that the exercise price of the Series L Warrants is reduced from $1.17 per share to $0.81 per share. In addition, each of the Series L Warrants, (i) was not exercisable for the six month anniversary of the closing under the September 28, 2011 securities purchase agreement, and (ii) the expiration date is extended such that the warrant is exercisable for five years from the delayed initial exercise date. 

On December 30, 2011, we entered into a securities purchase agreement with CBD Energy Limited (“CBD”), an Australian corporation, relating to the sale of 1,666,667 shares of common stock at a price of $0.60 per share. The aggregate purchase price was $1,000,000.

As a result of the December 30, 2011 sale, (i) the conversion price of the Series B Preferred was reduced to $0.60 per share of common stock, and (ii) the exercise price per share of the Series K Warrants was reduced to $0.60 per share of common stock. There are currently 2,273 shares of Series B Preferred that remain outstanding. After adjustment to the conversion price, the outstanding Series B Preferred would be convertible into 3,409,029 shares of common stock. Because we have previously recognized the full amount of proceeds allocated to the preferred stock as a preferred deemed dividend, there was no further accounting implication to this adjustment.

On March 30, 2012, we entered into an amendment to the outstanding Series K warrants which removed the provision for any future price adjustment to the exercise price. See Note 12 for a discussion on the accounting treatment of these warrants.

Pursuant to the Lightway Supply Agreement, on March 30, 2012, we issued 1,900,000 shares of our common stock to Lightway. The shares were issued at $0.55 per share based on the latest closing sale price on the date of issuance. The issuance of the common stock, valued at $1,045,000, increased equity and reduced accounts payable by an equal amount. We filed a registration statement, on May 15, 2012, to register for resale the shares of common stock issued to Lightway. The registration statement was declared effective on May 25, 2012.

12

10. Convertible Redeemable Preferred Stock and Preferred Deemed Dividend

On February 17, 2011, we entered into a securities purchase agreement with certain institutional accredited investors relating to the sale of 4,000 units at a price of $900 per unit (the “Securities Purchase Agreement”). Each unit consists of (i) one share of Series B Preferred Stock (the “Series B Preferred”), with each such share of Series B Preferred initially convertible into 500 shares of common stock at an initial conversion price of $1.80 per share, subject to future adjustment for various events, and (ii) warrants to purchase 425 shares of common stock at an initial exercise price of $2.40 per share, subject to future adjustment for various events, which warrants were not exercisable for six months after issuance and have a term of five years from the date of first exercisability (the “Series K Warrants” and together with the Series B Preferred, the “Securities”). The aggregate purchase price for the Securities was $3,600,000, less $532,000 in issuance costs. As of May 10, 2012, 1,727 shares of preferred stock had been converted into 891,601 shares of common stock.

The Certificate of Designation to create the Series B Preferred includes certain negative covenants regarding indebtedness and other matters, and includes provisions under which the holders of the Series B Preferred are entitled to demand redemption for cash upon specified triggering events. The Series B Preferred bears dividends at the rate 4% per year for the first year, and 8% per year thereafter, payable in stock or in cash at our election, subject to certain restrictions.

In connection with the sale of the Securities under the Securities Purchase Agreement, we entered into a registration rights agreement with the purchasers (the “Registration Rights Agreement”). In accordance with the Registration Rights Agreement, we filed a registration statement, on March 18, 2011, to register for resale the shares of common stock issued and issuable to the purchasers upon conversion of the Series B Preferred and the shares issuable upon exercise of the Series K Warrants. The registration statement was declared effective on June 17, 2011. Under the terms of the Registration Rights Agreement, we are obligated to maintain the effectiveness of the resale registration statement until all securities registered thereunder are sold or otherwise can be sold pursuant to Rule 144, without restriction.

On the date of issuance, we recorded the value of the Series B Preferred of $1.0 million and of the warrants of $2.6 million on our balance sheet. The closing price of our common stock on the date of issuance was used to value the Series B Preferred and we used the Black-Scholes model to value the Series K Warrants. For purposes of calculating the fair value of the warrants, we used a risk free rate of return of 1.4%, an expected life of 4.1 years and a volatility percentage of 103.2%. The intrinsic value of the beneficial conversion feature is considered a preferred deemed dividend totaling $975,000 to the preferred shareholders, and was charged to additional paid-in capital on our condensed consolidated balance sheets and net loss attributable to common stockholders on our condensed consolidated statements of operations.

Effective August 23, 2011, we amended our Certificate of Designation of Preferences, Rights and Limitations of the Series B 4% Convertible Preferred Stock to amend the terms of the outstanding Series B 4% Convertible Preferred Stock. The principal changes included in the Certificate of Amendment are to: (i) add a hard floor price of $0.10 per share of common stock as a limitation to any future conversion price adjustment to the Series B Preferred Stock resulting from future sales of common stock (or common stock equivalents) or at the one year anniversary of the original issuance date (February 18, 2012) if the recent trading price (20 day VWAP) is below the then current conversion price; (ii) reclassify the consequence of certain breaches and triggering events such that the holders of the Series B Preferred Stock would not be entitled to potentially receive cash redemption in such events, but instead would have rights to receive additional shares of common stock (either in the form of increased dividend payments or upon redemption of their Series B Preferred); and (iii) take into account certain adjustment events that have occurred since the Original Filing, including the 1-for-4 reverse stock split of our common stock implemented after the close of business on April 13, 2011. The purpose for adopting the Certificate of Amendment was to implement revisions that caused the balance sheet value associated with the Series B Preferred Stock to be treated as stockholders’ equity, rather than as “mezzanine” equity, for accounting purposes.

As a result of our December 30, 2011 stock sale to CBD, the conversion price of the Series B Preferred was reduced to $0.60 per share of common stock. The maximum intrinsic value of the beneficial conversion feature was previously recorded on the date of issuance for the Series B Preferred and, consequently, no additional preferred deemed dividend was recorded as a result of the reduction in the conversion price of the Series B Preferred.

See Note 12 for a discussion of the accounting treatment of the stock warrant transactions described above.

13

11. Stock Option Plan and Stock Incentive Plan

On August 8, 2006, we adopted the Westinghouse Solar, Inc. 2006 Stock Incentive Plan (the “Stock Plan”) pursuant to which shares of common stock are available for issuance to employees, directors and consultants under the Stock Plan as restricted stock and/or options to purchase common stock. The Stock Plan allows for issuance of up to 3,000,000 shares and there were 1,843,418 shares available for issuance under the Stock Plan as of June 30, 2012.

Restricted stock and options to purchase common stock may be issued under the Stock Plan. The restriction period on restricted stock grants generally expires at a rate of 25% per year over four years, unless decided otherwise by our Compensation Committee. Options to purchase common stock generally vest and become exercisable as to one-third of the total amount of shares subject to the option on each of the first, second and third anniversaries from the date of grant. Options to purchase common stock generally have a 5-year term.

We use the Black-Scholes-Merton Options Pricing Model (Black-Scholes) to estimate fair value of our employee and our non-employee director stock-based awards. Black-Scholes requires various judgmental assumptions, including estimating stock price volatility, expected option life and forfeiture rates. If we had made different assumptions, the amount of our deferred stock-based compensation, stock-based compensation expense, gross margin, net loss and net loss per share amounts could have been significantly different. We believe that we have used reasonable methodologies, approaches and assumptions to determine the fair value of our common stock, and that our deferred stock-based compensation and related amortization were recorded properly for accounting purposes. If any of the assumptions we used change significantly, stock-based compensation expense may differ materially in the future from that recorded in the current period.

We measure compensation expense for non-employee stock-based compensation under Accounting Standards Codification (ASC) 505-50, “Equity-Based Payments to Non-Employees.” The fair value of the option issued is used to measure the transaction, as this is more reliable than the fair value of the services received. The estimated fair value is measured utilizing Black-Scholes using the value of our common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty’s performance is complete (generally the vesting date). The fair value of the equity instrument is charged directly to expense and additional paid-in capital.

We recognized stock-based compensation expense of approximately $145,000 and $189,000 during the three months ended June 30, 2012 and 2011, respectively, and approximately $440,000 and $606,000 during the six months ended June 30, 2012 and 2011, respectively, relating to compensation expense calculated based on the fair value at the time of grant for restricted stock and based on Black-Scholes for stock options granted under the Stock Plan.

The following table sets forth a summary of restricted stock activity for the six months ended June 30, 2012:

	Number of Restricted Shares			Weighted-Average Grant Date Fair Value
Outstanding and not vested beginning balance at January 1, 2012		289,795		$	1.92
Granted		551,839		$	0.48
Forfeited/cancelled		(84,150	)	$	2.22
Released/vested		(408,511	)	$	0.75
Outstanding and not vested at June 30, 2012		348,973		$	0.95

Restricted stock is valued at the grant date fair value of the common stock and expensed over the requisite service period or vesting period. We estimate forfeitures when recognizing stock-based compensation expense for restricted stock, and the estimate of forfeitures is adjusted over the requisite service period should actual forfeitures differ from such estimates. At June 30, 2012 and December 31, 2011, there was approximately $277,000 and $465,000, respectively, of unrecognized stock-based compensation expense associated with the granted but unvested restricted stock. Stock-based compensation expense relating to these restricted shares is being recognized over a weighted-average period of 1.4 years. The total fair value of shares vested during the six months ended June 30, 2012 and 2011, was approximately $196,000 and $110,000, respectively. Tax benefits resulting from tax deductions in excess of the compensation cost recognized (excess tax benefits) are classified as financing cash flows on our consolidated statements of cash flows. During the three and six months ended June 30, 2012 and 2011, there were no excess tax benefits relating to restricted stock and therefore there is no impact on the accompanying consolidated statements of cash flows.

14

The following table sets forth a summary of stock option activity for the six months ended June 30, 2012:

	Number of Shares Subject to Option			Weighted-Average Exercise Price
Outstanding at January 1, 2012		1,077,744		$	5.47
Granted		25,000		$	0.40
Forfeited/cancelled/expired		(397,875	)	$	7.82
Exercised		—		$	—
Outstanding at June 30, 2012		704,869		$	3.97
Exercisable at June 30, 2012		412,122		$	5.01

Stock options are valued at the estimated fair value grant date or the measurement date and expensed over the requisite service period or vesting period. The weighted-average volatility was based upon the historical volatility of our common stock price. The fair value of stock option grants during the three and six months ended June 30, 2012 and 2011 was estimated using the Black-Scholes option-pricing model with the following assumptions:

	Three Months Ended June 30,					Six Months Ended June 30,
	2012			2011		2012			2011
Weighted-average volatility		105.5			—		105.5			103.1	%
Expected dividends		0.0	%		—		0.0	%		0.0	%
Expected life	2.6 years				—	2.6 years			3.0 years
Weighted-average risk-free interest rate		0.4	%		—		0.4	%		1.2	%

The weighted-average fair value per share of the stock options as determined on the date of grant was $0.24 for the stock options to purchase 25,000 shares of common stock granted during the six months ended June 30, 2012. The weighted-average remaining contractual term for the stock options outstanding (vested and expected to vest) and exercisable as of June 30, 2012 and December 31, 2011, was 3.1 years and 3.2 years, respectively. The total estimated fair value of stock options vested during the three and six months ended June 30, 2012 was approximately $8,000 and $333,000, respectively.The aggregate intrinsic value of stock options outstanding as of June 30, 2012 was zero.

We estimate forfeitures when recognizing stock-based compensation expense for stock options and the estimate of forfeitures is adjusted over the requisite service period should actual forfeitures differ from such estimates. At June 30, 2012 and December 31, 2011, there was approximately $110,000 and $520,000, respectively, of unrecognized stock-based compensation expense associated with stock options granted. Stock-based compensation expense relating to these stock options is being recognized over a weighted-average period of approximately 11 months. Tax benefits resulting from tax deductions in excess of the compensation cost recognized (excess tax benefits) is classified as financing cash flows on our consolidated statements of cash flows. During the three and six months ended June 30, 2012, there were no excess tax benefits relating to stock options and therefore there is no impact on the accompanying consolidated statements of cash flows.

12. Stock Warrants and Warrant Liability

During March 2009, in connection with an equity financing, we issued Series E Warrants to purchase 334,822 shares of common stock at an exercise price of $5.36 per share. The fair value of the warrants was estimated using Black-Scholes with the following weighted average assumptions: risk-free interest rate of 2.69%, an expected life of five years; an expected volatility factor of 112% and a dividend yield of 0.0%. The value assigned to these warrants was approximately $1.0 million, of which $1.0 million was reflected as common stock warrant liability with an offset to additional paid-in capital as of the offering close date. As of June 30, 2012, the fair value of the warrants was estimated using Black-Scholes with the following weighted average assumptions: risk-free interest rate of 0.2%, an expected life of 1.7 years; an expected volatility factor of 120.5% and a dividend yield of 0.0%. The fair value of the warrants decreased to $10,000 as of June 30, 2012 and we recognized a $10,000 unfavorable non-cash adjustment from the change in fair value of these warrants for the three months ended June 30, 2012.

On June 1, 2009, we entered into an amendment agreement (the “Amendment Agreement”) with investors who had previously acquired Series G Warrants. Pursuant to the Amendment Agreement, the investors purchased 156,250 shares of our common stock through the exercise of a portion of their Series G Warrants, with gross proceeds to us of $700,000. In conjunction with that exercise, we issued new Series H Warrants to purchase up to an aggregate of 156,250 shares of Common Stock at a strike price of $5.36 per share. The Series H Warrants became exercisable on December 1, 2009 and had a term of nine months from the day they first become exercisable. In conjunction with the May 17, 2010 transaction discussed below, the expiration date for the Series H Warrants was extended.

15

On May 17, 2010, we entered into a Securities Purchase Agreement and issued Series I Warrants to purchase 339,677 shares of common stock at an exercise price of $4.40 per share (the “Series I Warrants”). The fair value of the warrants was estimated using Black-Scholes with the following weighted-average assumptions:  risk-free interest rate of 1.28%, an expected life of 4.1 years; an expected volatility factor of 107% and a dividend yield of 0.0%. The estimated value of these warrants was approximately $950,000. Under the May 17, 2010 Securities Purchase Agreement, we also agreed to extend the term of the remainder of our outstanding Series H Warrants until December 1, 2011. The estimated value assigned to the extension of these warrants was approximately $210,000.

On October 7, 2010, we entered into a securities purchase agreement and issued Series J Warrants to purchase 400,001 shares of common stock at an exercise price of $2.44 per share. The fair value of the warrants was estimated using Black-Scholes with the following weighted-average assumptions:  risk-free interest rate of 0.54%, an expected life of 4.1 years; an expected volatility factor of 103.7% and a dividend yield of 0.0%. The estimated value of these warrants was approximately $694,000, which was allocated to additional paid in capital. Under the securities purchase agreement, we also agreed to amend the outstanding Series I Warrants, such that the exercise price of the Series I Warrants was reduced to $2.44 per share. In addition, with respect to 45% of the shares of common stock subject to each of the Series I Warrants, (i) each warrant was not exercisable until the six month anniversary of the closing under the securities Purchase agreement, and (ii) the expiration date was extended such that the warrant is exercisable for five years from the delayed initial exercise date. The outstanding Series I Warrants were originally issued on May 17, 2010, and represent the right to purchase up to an aggregate of 339,677 shares of our common stock. The estimated value assigned to the reduction in exercise price and extension of these warrants was approximately $97,000. As the terms of the Series I Warrants are classified as equity, as opposed to liability, there was no accounting impact as a result of the amendment to the Series I Warrant agreement.

On February 17, 2011, we entered into a securities purchase agreement and issued Series K Warrants to purchase up to 1,700,002 shares of common stock at an exercise price of $2.40 per share, which warrants are not exercisable until six months after issuance and have a term of five and one-half years. The fair value of the warrants was estimated using Black-Scholes with the following weighted-average assumptions:  risk-free interest rate of 1.4%, an expected life of 4.1 years; an expected volatility factor of 103.2% and a dividend yield of 0.0%. The estimated value of these warrants was approximately $2.6 million, of which $2.6 million was reflected as common stock warrant liability with an offset to preferred stock as of the offering close date. As a result of the August 16, 2011 security sale, the exercise price of the Series K warrants was reduced from $2.40 to $1.01; as a result of the September 28, 2011 security sale, the exercise price of the Series K warrants was further reduced from $1.01 to $0.80. The estimated value assigned to the reduction in exercise price was $270,000 and $50,000, respectively, on August 16, 2011 and September 28, 2011, and we recognized a non-cash charge from the change in the fair value of the warrants. During the six months ended June 30, 2012, 472,222 Series K Warrants were exercised at a price of $0.60 and total proceeds of approximately $283,000. As a result of the exercise, we recognized approximately $253,000 in the change in the estimated value assigned to the warrants as an increase to equity and a decrease to the warrant liability. On March 30, 2012, we entered into an Amendment to Securities Purchase Agreement with the holders of the remaining Series K warrants (Series K Amendment) reducing the exercise price to $0.40 and removing provisions for any future price adjustment to the exercise price. On March 30, 2012, the fair value of the warrants was estimated using Black-Scholes with the following weighted average assumptions: risk-free interest rate of 0.5%, an expected life of 3.0 years; an expected volatility factor of 109.3% and a dividend yield of 0.0%. The fair value of the warrants increased to approximately $481,000 as of March 30, 2012 and we recognized a $425,000 unfavorable non-cash adjustment from the change in fair value of these warrants for the three months ended March 31, 2012. On March 30, 2012, as a result of the Series K Amendment, the fair value of the warrants of approximately $481,000 was reclassified from warrant liability to equity.

In connection with the February 17, 2011 securities purchase agreement, we issued as a placement agent fee to our financial advisory firm warrants to purchase 60,000 shares of common stock at an exercise price of $2.44 per share, with a term of five years. The fair value of the warrants was estimated using Black-Scholes with the following weighted-average assumptions:  risk-free interest rate of 1.4%, an expected life of 3.8 years; an expected volatility factor of 103.2% and a dividend yield of 0.0%. The estimated value of these warrants was approximately $89,000 which was reflected as a reduction in the net proceeds of the preferred stock with an offset to additional paid in capital as of the offering close date.

On August 16, 2011, we entered into a securities purchase agreement and issued Series L Warrants to purchase up to 643,564 shares of common stock at an exercise price of $1.17 per share, which warrants were not exercisable until six months after issuance and have a term of five and one-half years. The fair value of the warrants was estimated using Black-Scholes with the following weighted-average assumptions:  risk-free interest rate of 0.3%, an expected life of 4.1 years; an expected volatility factor of 109.5% and a dividend yield of 0.0%. The estimated value of these warrants was approximately $554,000. In connection with the August 16, 2011 securities purchase agreement, we agreed to extend the term of the remainder of our outstanding Series J Warrants until March 28, 2017. The estimated value assigned to the reduction in exercise price and extension of these warrants was approximately $86,000. As the terms of the Series J Warrants are classified as equity, as opposed to liability, there was no accounting impact as a result of the amendment to the Series J Warrant agreement.

On September 28, 2011, we entered into a securities purchase agreement and issued Series M Warrants to purchase up to 325,000 shares of common stock at an exercise price of $0.81 per share, which warrants are not exercisable until six months after issuance and have a term of 5½ years. The fair value of the warrants was estimated using Black-Scholes with the following weighted-average assumptions:  risk-free interest rate of 0.4%, an expected life of 4.1 years; an expected volatility factor of 109.1% and a dividend yield of 0.0%. The estimated value of these warrants was approximately $193,000. In connection with the September 28, 2011 securities purchase agreement, we agreed to extend the term of the remainder of our outstanding Series L Warrants until March 28, 2017. The estimated value assigned to the reduction in exercise price and extension of these warrants was approximately $31,000. As the terms of the Series L Warrants are classified as equity, as opposed to liability, there was no accounting impact as a result of the amendment to the Series L Warrant agreement.

The following table summarizes the Warrant activity for the six months ending June 30, 2012:

	Warrants for Number of Shares			Weighted-Average Exercise Price
Outstanding at January 1, 2012		4,106,016		$	3.57
Issued		—		$	—
Exercised		(472,222	)	$	0.60
Cancelled/expired		—		$	—
Outstanding at June 30, 2012		3,633,794		$	3.89

16

13. Earnings Per Share

On January 1, 2009, we adopted ASC 260 (formerly Financial Accounting Standards Board Staff Position (FSP) Emerging Issues Task Force (EITF) 03-6-1) (ASC 260), Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities (the “Staff Position”), which states that unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and shall be included in the computation of net income (loss) per share pursuant to the two-class method described in ASC 260 (formerly Statement of  Financial Accounting Standards (SFAS) No. 128), Earnings Per Share.

In accordance with the Staff Position, basic net income (loss) per share is computed by dividing net income (loss), excluding net income (loss) attributable to participating securities, by the weighted average number of shares outstanding less the weighted average unvested restricted shares outstanding. Diluted net income (loss) per share is computed by dividing net income (loss), excluding net income (loss) attributable to participating securities, by the denominator for basic net income (loss) per share and any dilutive effects of stock options, restricted stock, convertible notes and warrants.

On April 6, 2011, we filed a Certificate of Amendment to our Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a reverse split of our common stock at a ratio of 1-for-4. The reverse stock split became effective at the close of business on April 13, 2011. All historical share and per share amounts have been adjusted to reflect this reverse stock split. The par value of our common stock did not change. The following table sets forth the computation of basic and diluted net loss per share (unaudited):

	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
Basic:
Numerator:
Net loss	$	(2,196,814	)	$	(1,327,762	)	$	(5,047,902	)	$	(2,641,251	)
Less: Net loss allocated to participating securities		56,260			24,695			115,380			41,312
Net loss attributable to stockholders		(2,140,554	)		(1,303,067	)		(4,932,522	)		(2,599,939	)
Preferred stock dividend		(21,028	)		—			(42,287	)		—
Preferred deemed dividend		—			—			—			(975,460	)
	$	(2,161,582	)	$	(1,303,067	)	$	(4,974,809	)	$	(3,575,399	)
Denominator:
Weighted-average shares outstanding		18,944,321			11,603,691			17,707,296			11,555,616
Weighted-average unvested restricted shares outstanding		(485,162	)		(215,817	)		(404,735	)		(180,744	)
Denominator for basic net loss per share		18,459,159			11,387,874			17,302,561			11,374,872
Basic net loss per share attributable to common stockholders	$	(0.12	)	$	(0.11	)	$	(0.29	)	$	(0.31	)
Diluted:
Numerator:
Net loss	$	(2,196,814	)	$	(1,327,762	)	$	(5,047,902	)	$	(2,641,251	)
Less: Net loss allocated to participating securities		56,260			24,695			115,380			41,312
Net loss attributable to stockholders		(2,140,554	)		(1,303,067	)		(4,932,522	)		(2,599,939	)
Preferred stock dividend		(21,028	)		—			(42,287	)		—
Preferred deemed dividend		—			—			—			(975,460	)
	$	(2,161,582	)	$	(1,303,067	)	$	(4,974,809	)	$	(3,575,399	)
Denominator:
Denominator for basic calculation		18,459,159			11,387,874			17,302,561			11,374,872
Weighted-average effect of dilutive stock options		—			—			—			—
Denominator for diluted net loss per share		18,459,159			11,387,784			11,302,561			11,374,872
Diluted net loss per share attributable to common stockholders	$	(0.12	)	$	(0.11	)	$	(0.29	)	$	(0.31	)

The following table sets forth potential shares of common stock at the end of each period presented that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive:

	June 30, 2012		December 31, 2011
Stock options outstanding		704,869		1,077,744
Unvested restricted stock		348,973		289,795
Warrants to purchase common stock		3,633,794		4,106,016
Preferred stock convertible into common stock		3,409,029		3,409,029

17

14. Concentration of Risk

Financial instruments that potentially subject us to credit risk are comprised of cash and cash equivalents, which are maintained at high quality financial institutions. At December 31, 2011, there was approximately $1.1 million in excess of the Federal Deposit Insurance Corporation (FDIC) limit of $250,000. At June 30, 2012, we did not have any deposits in excess of the FDIC limit.

The relative magnitude and the mix of revenue from our largest customers have varied significantly quarter to quarter. During the three and six months ended June 30, 2012 and 2011, three customers have accounted for significant revenues, varying by period, to our company: Lennar Corporation (Lennar), a leading national homebuilder, Lennox International Inc. (Lennox), a global leader in the heating and air conditioning markets, and Lowe’s Companies, Inc. (Lowe’s), a leading residential solar energy installation company/integrator. For the three and six months ended June 30, 2012 and 2011, the percentages of sales to Lennar, Lennox and Lowe’s are as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
Lennar Corporation		—			21.2	%		12.6	%		14.6	%
Lennox International Inc.		26.0	%		25.2	%		39.2	%		32.3	%
Lowe’s Companies, Inc.		13.7	%		1.8	%		8.0	%		1.6	%

We had no receivable balance from Lennar as of June 30, 2012 or December 31, 2011. Lennox accounted for 23.5% and 23.1% of our gross accounts receivable as of June 30, 2012, and December 31, 2011, respectively. Lowe’s accounted for 10.5% and 13.9% of our gross accounts receivable as of June 30, 2012, and December 31, 2011, respectively.

Over time, as we work to add additional distributors to our network and to grow our distribution business, we anticipate the relative significance to our revenue of any particular customer will decline.

We maintain reserves for potential credit losses and such losses, in the aggregate, have generally not exceeded management’s estimates. Our top three vendors accounted for approximately 46.2% and 58.0% of materials purchased during the six months ended June 30, 2012 and 2011, respectively. At June 30, 2012, accounts payable included amounts owed to these top three vendors of approximately $1.1 million. At December 31, 2011, accounts payable included amounts owed to the top three vendors of approximately $3.3 million.

Historically, we obtained virtually all of our solar panels from Suntech. On March 25, 2011, we entered into a volume supply agreement for a new generation of our solar panel products with Light Way Green New Energy Co., Ltd (Lightway), and in August 2011, we began purchasing solar panels from Lightway. Both Suntech and Lightway manufacture panels for us that are built to our unique specifications. We currently purchase all of the microinverters used in our AC solar panels from Enphase. Although we had an adequate amount of inventory on hand as of June 30, 2012, and although we believe we could find alternative suppliers for solar panels manufactured to our specifications, and alternative suppliers for microinverters, on comparable terms, the sudden loss of any of our current primary component supply relationships could be disruptive to our operations. In recent months, because of our cash position and liquidity constraints, we have been late in making payments to both of our panel suppliers. On March 30, 2012, pursuant to our Supply Agreement with Lightway, we issued 1,900,000 shares of our common stock to Lightway in partial payment of our past due account payable to them. The shares were valued at $1,045,000. On May 1, 2012, Suntech America filed a lawsuit against us for breach of contract, alleging that it delivered products to us and has not received full payment. We currently do not have any unshipped orders for solar panel product pending with Suntech. We have pending and planned orders for additional shipments of product from Lightway. Unless we are able to satisfy our panel suppliers that we will make timely payment for future product orders, our suppliers may delay further shipments to us, which could result in decreased sales and revenue for us, and adversely affect our customer relationships and result in cancelled orders.

18

15. Fair Value Measurement

We use a fair-value approach to value certain assets and liabilities. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. We use a fair value hierarchy, which distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs). The hierarchy consists of three levels:

• Level one — Quoted market prices in active markets for identical assets or liabilities;

• Level two — Inputs other than level one inputs that are either directly or indirectly observable; and

• Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

Determining which category an asset or liability falls within the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter. Assets and liabilities measured at fair value on a recurring basis are summarized as follows (unaudited):

Liabilities	Level 1		Level 2		Level 3		June 30, 2012
Fair value of common stock warrant liability	$	—	$	—	$	10,123	$	10,123
Accrued rent related to office closures		—		—		35,182		35,182
Total	$	—	$	—	$	45,305	$	45,305

A discussion of the valuation techniques used to measure fair value for the common stock warrants is in Note 13. The accrued rent relates to a non-cash charge for the closure of our Anaheim and San Diego, California locations, calculated by discounting the future lease payments to their present value using a risk-free discount rate from 0.0% to 1.2%. The accrued rent is included within liabilities of discontinued operations and long-term liabilities of discontinued operations in our consolidated balance sheets.

The following table shows the changes in Level 3 liabilities measured at fair value on a recurring basis for the six months ended June 30, 2012:

	Other Liabilities*			Common Stock Warrant Liability			Total Level 3
Beginning balance – January 1, 2012	$	79,888		$	317,490		$	397,378
Total realized and unrealized gains or losses		222			426,640			426,862
Repayments		(44,928	)		—			(44,928	)
Net transfers in and/or (out) of level 3		—			(734,007	)		(734,007	)
Ending balance – June 30, 2012	$	35,182		$	10,123		$	45,305

*           Represents the estimated fair value of the office closures included in accrued and other long-term liabilities.

16. Income Taxes

Deferred income taxes arise from timing differences resulting from income and expense items reported for financial account and tax purposes in different periods. A deferred tax asset valuation allowance is recorded when it is more likely than not that deferred tax assets will not be realized. During the three and six months ended June 30, 2012, there was no income tax expense or benefit for federal and state income taxes in the accompanying condensed consolidated statements of operations due to our net loss and a valuation allowance on the resulting deferred tax asset. Our deferred tax asset has a 100% valuation allowance.

19

17. Commitments and Contingencies

Litigation

We have been involved in various patent litigation with Zep Solar, Inc. (“Zep”) and other parties, including (1) an action we filed on October 22, 2009 against Zep and several other defendants in the United States District Court for the Northern District of California, San Francisco Division for infringement of U.S. Patent No. 7,406,800 (the “’800 District Court Action”), (2) an action Zep and Trina Solar filed on August 2, 2011 against us in the United States District Court for the Northern District of California, San Francisco Division for declaratory judgment of non-infringement of U.S. Patent No. 7,987,641 issued to our subsidiary Andalay Solar on August 2, 2011 (the “’641 District Court Action”), (3) an action we filed with the United States International Trade Commission (“ITC”) on October 4, 2011 accusing Zep and Canadian Solar of infringing the ’800 patent and the ’641 patent (the “ITC Action”), and (4) an action Zep filed against us and other defendants in the United States District Court for the Northern District of California, San Francisco Division alleging that the our products infringe U.S. Patent No. 7,952,537 (the “’537 District Court Action”).

On May 25, 2012, we and Zep entered into a final and comprehensive settlement of these legal disputes. In June 2012, the three actions pending in the United States District Court for the Northern District of California and the ITC Action were all dismissed and the cases were terminated. The specific terms of the global settlement are confidential.  The settlement extends to all customers, suppliers, licensees and business partners of both Zep and us who were named in one or more of the proceedings.

On May 1, 2012, Suntech America, Inc., a Delaware corporation (Suntech America), filed a complaint for breach of contract, goods sold and delivered, account stated and open account against us in the Superior Court of the State of California, County of San Francisco. Suntech America alleged that it delivered products to us and did not receive full payment by us. On July 31, 2012, we and Suntech entered into a settlement of this dispute. As of June 30, 2012, we have included in our Condensed Consolidated Balance Sheets, under accounts payable, a balance due to Suntech America of $989,771.

On June 7, 2012, Barry Cinnamon, the former chief executive officer of the Company, filed a complaint with the U.S. Department of Labor, Occupational Safety and Health Administration, at its office in San Francisco California, alleging that Mr. Cinnamon’s termination of employment on May 8, 2012 constituted a violation of the whistleblower protections of the Sarbanes-Oxley Act of 2002.  In his complaint, Mr. Cinnamon requests that the Secretary of Labor institute an investigation of alleged retaliation against Mr. Cinnamon by us and our board of directors. The complaint also indicates that Mr. Cinnamon has a variety of state law claims, which he intends to pursue in court. We have not been notified that any other proceedings have been filed by Mr. Cinnamon as of August 10, 2012.  We have responded to the initial complaint, disagreeing with Mr. Cinnamon’s characterization of events.  We believe that the complaint and claims by Mr. Cinnamon are without merit, and we intend to defend ourselves in any proceedings brought by Mr. Cinnamon.

We are also involved in other litigation from time to time in the ordinary course of business. In the opinion of management, the outcome of such proceedings will not materially affect our financial position, results of operations or cash flows.

20

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

All references to the “Company,” “we,” “our,” and “us” refer to Westinghouse Solar, Inc. and its subsidiaries (“Westinghouse Solar”).

The following discussion highlights what we believe are the principal factors that have affected our financial condition and results of operations as well as our liquidity and capital resources for the periods described. This discussion should be read in conjunction with our financial statements and related notes appearing elsewhere in this Quarterly Report and in our Annual Report on Form 10-K. This discussion contains “forward-looking statements,” including but not limited to expectations regarding revenue growth, net sales, gross profit, operating expenses and performance objectives, and statements using the terms “believes,” “expects,” “will,” “could,” “plans,” “anticipates,” “estimates,” “predicts,” “intends,” “potential,” “continue,” “should,” “may,” or the negative of these terms or similar expressions. These forward-looking statements are subject to risks and uncertainties that may cause our actual results to differ materially from those expressed or implied by these forward-looking statements. Such risks and uncertainties include, without limitation, the risks described below in Item 1A. of Part II of this Quarterly Report. Further information on potential risk factors that could affect our future business and financial results and financial condition can be found in our periodic filings with the Securities and Exchange Commission (the “SEC”). We undertake no obligation to update any of these forward-looking statements.

Company Overview

We are a designer and manufacturer of solar power systems and solar panels with integrated microinverters (which we call AC solar panels). We design, market and sell these solar power systems to solar installers, trade workers and do-it-yourself customers in the United States and Canada through distribution partnerships, our dealer network and retail outlets. Our products are designed for use in solar power systems for residential and commercial rooftop customers. Prior to September 2010, we were also in the solar power installation business.

In September 2007, we introduced our new “plug and play” solar panel technology (under the brand name “Andalay”), which we believe significantly reduces the installation time and costs, and provides superior reliability and aesthetics, when compared to other solar panel mounting products and technology. Our panel technology offers the following features: (i) mounts closer to the roof with less space in between panels; (ii) all black appearance with no unsightly racks underneath or beside panels; (iii) built-in wiring connections; (iv) approximately 70% fewer roof-assembled parts and approximately 50% less roof-top labor required; (v) approximately 25% fewer roof attachment points; (vi) complete compliance with the National Electric Code and UL wiring and grounding requirements. We have three U.S. patents (Patent No. 7,406,800, Patent No. 7,832,157 and Patent No. 7,866,098) that cover key aspects of our solar panel technology, as well as U.S. Trademark No. 3481373 for registration of the mark “Andalay.” In addition to these U.S. patents, we received three foreign patents in 2010: Australian Patent No. 2,005,248,343; Indian Patent No. 243,626; and Mexican Patent No. 274,182. A Korean Patent No. 751,614 was issued in 2007. Currently, we have seven issued patents and eighteen other pending U.S. and foreign patent applications that cover the Andalay technology working their way through the USPTO and foreign patent offices.

In February 2009, we announced a strategic relationship with Enphase, a leading manufacturer of microinverters, to develop and market solar panel systems with ordinary AC house current output instead of high voltage DC output. We introduced Andalay AC panel products and began offering them to our customers in the second quarter of 2009. Andalay AC panels cost less to install, are safer, and generally provide higher energy output than ordinary DC panels. Andalay AC panels deliver 5-25% more energy compared to ordinary panels, produce safe household AC power, and have built-in panel level monitoring, racking, wiring, grounding and microinverters. With 80% fewer parts and 5 – 25% better performance than ordinary DC panels, we believe Andalay AC panels are an ideal solution for solar installers, trade workers and do-it-yourself customers.

On May 17, 2010, we entered into an exclusive worldwide license agreement that permits us to distribute and market our solar panels under the Westinghouse name. On July 22, 2010, we announced that we will operate under the name “Westinghouse Solar” and, effective July 23, 2010 at the opening of the market, our stock began trading under the stock symbol “WEST” on the NASDAQ Capital Market, and we are listed as Westinghouse Solar, Inc.

As a result of our announced exit from the solar panel installation business, our installation business has been reclassified in our financial statements as discontinued operations. The exit from the installation business was essentially completed by the end of the fourth quarter of 2010.

At the Annual Meeting of Stockholders held on March 31, 2011, our stockholders approved an amendment to our Certificate of Incorporation to formally change our name from “Akeena Solar, Inc.” to “Westinghouse Solar, Inc.”. The name change became effective on April 6, 2011. Also on April 6, 2011, we filed a Certificate of Amendment to our Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a reverse split of our common stock at a ratio of 1-for-4. The reverse stock split became effective at the close of business on April 13, 2011.

On May 7, 2012, we entered into a Merger Agreement with CBD. Under the terms of the Merger Agreement, a subsidiary of CBD will be merged with and into the Company, with the Company to be the surviving corporation and a wholly-owned subsidiary of CBD. Completion of the Merger is subject to customary conditions, including shareholder approvals by the Company and CBD.

21

Concentration of Risk in Customer and Supplier Relationships

The relative magnitude and the mix of revenue from our largest customers have varied significantly quarter to quarter. During the three and six months ended June 30, 2012 and 2011, three customers have accounted for significant revenues, varying by period, to our company: Lennar Corporation (Lennar), a leading national homebuilder, Lennox International Inc. (Lennox), a global leader in the heating and air conditioning markets, and Lowe’s Companies, Inc. (Lowe’s), a leading residential solar energy installation company/integrator. For the three and six months ended June 30, 2012 and 2011, the percentages of sales to Lennar, Lennox and Lowe’s are as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
Lennar Corporation		—			21.2	%		12.6	%		14.6	%
Lennox International Inc.		26.0	%		25.2	%		39.2	%		32.3	%
Lowe’s Companies, Inc.		13.7	%		1.8	%		8.0	%		1.6	%

We had no receivable balance from Lennar as of June 30, 2012 or December 31, 2011. Lennox accounted for 23.5% and 23.1% of our gross accounts receivable as of June 30, 2012, and December 31, 2011, respectively. Lowe’s accounted for 10.5% and 13.9% of our gross accounts receivable as of June 30, 2012, and December 31, 2011, respectively.

Over time, as we work to add additional distributors to our network and to grow our distribution business, we anticipate the relative significance to our revenue of any particular customer will decline.

We maintain reserves for potential credit losses and such losses, in the aggregate, have generally not exceeded management’s estimates. Our top three vendors accounted for approximately 46.2% and 58.0% of materials purchased during the six months ended June 30, 2012 and 2011, respectively. At June 30, 2012, accounts payable included amounts owed to these top three vendors of approximately $1.1 million. At December 31, 2011, accounts payable included amounts owed to the top three vendors of approximately $3.3 million.

Historically, we obtained virtually all of our solar panels from Suntech. On March 25, 2011, we entered into a volume supply agreement for a new generation of our solar panel products with Light Way Green New Energy Co., Ltd (Lightway), and in August 2011, we began purchasing solar panels from Lightway. Both Suntech and Lightway manufacture panels for us that are built to our unique specifications. We currently purchase all of the microinverters used in our AC solar panels from Enphase. Although we had an adequate amount of inventory on hand as of June 30, 2012, and although we believe we could find alternative suppliers for solar panels manufactured to our specifications, and alternative suppliers for microinverters, on comparable terms, the sudden loss of any of our current primary component supply relationships could be disruptive to our operations. In recent months, because of our cash position and liquidity constraints, we have been late in making payments to both of our panel suppliers. On March 30, 2012, pursuant to our Supply Agreement with Lightway, we issued 1,900,000 shares of our common stock to Lightway in partial payment of our past due account payable to them. The shares were valued at $1,045,000. On May 1, 2012, Suntech America filed a lawsuit against us for breach of contract, alleging that it delivered products to us and has not received full payment. We currently do not have any unshipped orders for solar panel product pending with Suntech. We have pending and planned orders for additional shipments of product from Lightway. Unless we are able to satisfy our panel suppliers that we will make timely payment for future product orders, our suppliers may delay further shipments to us, which could result in decreased sales and revenue for us, and adversely affect our customer relationships and result in cancelled orders.

22

Three Months Ended June 30, 2012 as Compared to Three Months Ended June 30, 2011

Results of Operations

The following table sets forth, for the periods indicated, certain information related to our operations, expressed in dollars and as a percentage of net sales:

	Three Months Ended June 30,
	2012					2011
Net revenue	$	1,209,211		100.0	%	$	2,757,729		100.0	%
Cost of goods sold		1,243,034		102.8	%		2,563,842		93.0	%
Gross profit		(33,823	)	(2.8	)%		193,887		7.0	%
Operating expenses
Sales and marketing		467,523		38.7	%		700,103		25.4	%
General and administrative		1,663,885		137.6	%		1,464,269		53.1	%
Total operating expenses		2,131,408		176.3	%		2,164,372		78.5	%
Loss from continuing operations		(2,165,231	)	(179.1	)%		(1,970,485	)	(71.5	)%
Other income (expense)
Interest income (expense), net		(39,006	)	(3.2	)%		(35,148	)	(1.3	)%
Adjustment to the fair value of common stock warrants		10,303		0.9	%		668,041		24.2	%
Total other income (expense)		(28,703	)	(2.4	)%		632,893		22.9	%
Loss before provision for income taxes and discontinued operations		(2,193,934	)	(181.4	)%		(1,337,592	)	(48.5	)%
Provision for income taxes		—		0.0	%		—		0.0	%
Net loss from continuing operations (Note 3)		(2,193,934	)	(181.4	)%		(1,337,592	)	(48.5	)%
Gain (loss) from discontinued operations, net of tax		(2,880	)	(0.2	)%		9,830		0.4	%
Net loss		(2,196,814	)	(181.7	)%		(1,327,762	)	(48.1	)%
Preferred stock dividend		(21,028	)	(1.7	)%		—		0.0	%
Preferred deemed dividend		—		0.0	%		—		0.0	%
Net loss attributable to common stockholders	$	(2,217,842	)	(183.4	)%	$	(1,327,762	)	(48.1	)%
Net loss per common and common equivalent share (basic and diluted)	$	(0.12	)			$	(0.11	)
Weighted average shares used in computing loss per common share: (basic and diluted)		18,459,159					11,387,854

Discontinued operations

As a result of the exit from the installation business on September 7, 2010, and in accordance with generally accepted accounting principles, the installation business operation has been reclassified to discontinued operations in our Consolidated Balance Sheets and our Consolidated Statements of Operations. The installation business segment had historically been our core business and represented most of our revenue.

Net revenue

We generate revenue from the sale of solar power systems. In the three months ended June 30, 2012, we generated $1.2 million of revenue, a decrease of $1.5 million, or 56.2%, compared to $2.8 million of revenue in the three months ended June 30, 2011. The decrease in revenue was due to a decrease in sales to strategic partners, lower average selling prices and the overall soft solar market conditions following punitive tariff announcements in the U.S. related to solar modules manufactured in China.

23

Cost of goods sold

Cost of goods sold as a percent of revenue during the three months ended June 30, 2012, was 102.8% of net revenue, compared to 93.0% during the three months ended June 30, 2011. Gross loss for the three months ended June 30, 2012 was $34,000, or 2.8% of revenue, compared to gross profit of $194,000 or 7.0% of revenue for the same period in 2011. The decrease in gross margin in the three months ended June 30, 2012 compared to the three months ended June 30, 2011, was due to year-to-date impact of imposed tariffs on Chinese modules and lower average selling prices, partially offset by a decline in panel and component costs. Excluding the tariff expense of $86,000, gross profit would have been $52,000 or 4.3% of revenue.

Sales and marketing expenses

Sales and marketing expenses for the three months ended June 30, 2012 were $468,000, or 38.7% of net revenue as compared to $700,000, or 25.4% of net revenue during the same period of the prior year. The decrease in sales and marketing expense for the three months ended June 30, 2012, reflects lower advertising and trade shows of $141,000, travel costs of $41,000, payroll and commissions of $30,000 and timing of the Westinghouse licensing fees of $49,000.

General and administrative expenses

General and administrative expenses for the three months ended June 30, 2012 were $1.7 million, or 137.6% of net revenue as compared to $1.5 million, or 53.1% of net revenue during the same period of the prior year. The increase in general and administrative expense for the three months ended June 30, 2012 was due primarily to increases in legal fees of $311,000 and professional fees of $234,000, related to the pending CBD merger transaction and recently settled patent litigation, partially offset by lower payroll costs of $258,000.

Interest, net

During the three months ended June 30, 2012, net interest expense was approximately $39,000 compared with net interest expense of $35,000 for the same period in 2011.

Adjustment to the fair value of common stock warrants

During the three months ended June 30, 2012, we recorded mark-to-market adjustments to reflect the fair value of outstanding common stock warrants accounted for as a liability, resulting in an unrealized gain of $10,000 in our condensed consolidated statements of operations. The fair value of the warrants is lower now primarily due to a decrease in the price of our common stock and a shorter life for the remainder of our outstanding warrants. During the three months ended June 30, 2011, we recorded mark-to-market adjustments resulting in a $668,000 unrealized gain in our condensed consolidated statements of operations.

Income taxes

During the three months ended June 30, 2012 and June 30, 2011, there was no income tax expense or benefit for federal and state income taxes reflected in our condensed consolidated statements of operations due to our net loss and a valuation allowance on the resulting deferred tax asset.

Net loss from continuing operations

Net loss from continuing operations for the quarter ended June 30, 2012 was $2.2 million, or $0.12 per share, compared to a net loss from continuing operations of $1.3 million, or $0.11 per share, for the quarter ended June 30, 2011. For the quarter ended June 30, 2012, the net loss includes a favorable non-cash adjustment to the fair value of common stock warrants of $10,000 compared with a favorable non-cash adjustment to the fair value of the common stock warrants of $668,000 for the quarter ended June 30, 2011. Excluding the impact of the common stock warrant adjustments in both periods, net loss from continuing operations for the quarter ended June 30, 2012 was $2.2 million, or $0.12 per share, compared to a net loss of $2.0 million, or $0.17 per share, for the same quarter of 2011.

Gain (loss) from discontinued operations

During the quarter ended June 30, 2012, we recorded a $3,000 net loss from the discontinuance of our installation business segment, compared with a gain of $10,000 during the same period in 2011.

24

Six Months Ended June 30, 2012 as Compared to Six Months Ended June 30, 2011

Results of Operations

The following table sets forth, for the periods indicated, certain information related to our operations, expressed in dollars and as a percentage of net sales:

	Six Months Ended June 30,
	2012					2011
Net revenue	$	3,631,551		100.0	%	$	4,752,091		100.0	%
Cost of goods sold		3,423,003		94.3	%		4,280,405		90.1	%
Gross profit		208,548		5.7	%		471,686		9.9	%
Operating expenses
Sales and marketing		1,090,703		30.0	%		1,046,431		22.0	%
General and administrative		3,727,294		102.6	%		3,143,214		66.1	%
Total operating expenses		4,817,997		132.7	%		4,189,645		88.2	%
Loss from continuing operations		(4,609,449	)	(126.9	)%		(3,717,959	)	(78.2	)%
Other income (expense)
Interest income (expense), net		(34,786	)	(1.0	)%		(57,849	)	(1.2	)%
Adjustment to the fair value of common stock warrants		(426,640	)	(11.7	)%		1,130,989		23.8	%
Total other income (expense)		(461,426	)	(12.7	)%		1,073,140		22.6	%
Loss before provision for income taxes and discontinued operations		(5,070,875	)	(139.6	)%		(2,644,819	)	(55.7	)%
Provision for income taxes		—		0.0	%		—		0.0	%
Net loss from continuing operations (Note 3)		(5,070,875	)	(139.6	)%		(2,644,819	)	(55.7	)%
Gain (loss) from discontinued operations, net of tax		22,973		0.6	%		3,568		0.1	%
Net loss		(5,047,902	)	(139.0	)%		(2,641,251	)	(55.6	)%
Preferred stock dividend		(42,287	)	(1.2	)%		—		0.0	%
Preferred deemed dividend		—		0.0	%		(975,460	)	(20.5	)%
Net loss attributable to common stockholders	$	(5,090,189	)	(140.2	)%	$	(3,616,711	)	(76.1	)%
Net loss per common and common equivalent share (basic and diluted)	$	(0.29	)			$	(0.23	)
Weighted average shares used in computing loss per common share: (basic and diluted)		17,302,561					11,374,872

Net revenue

In the six months ended June 30, 2012, we generated $3.6 million of revenue, a decrease of $1.2 million, or 23.6%, compared to $4.8 million of revenue in the six months ended June 30, 2011. The decrease in revenue was due to a decrease in unit volume of product sales to our dealer network and strategic partners, lower average selling prices and the overall soft solar market conditions following punitive tariff announcements in the U.S. related to solar modules manufactured in China.

Cost of goods sold

Cost of goods sold as a percent of revenue during the six months ended June 30, 2012, was 94.3% of net revenue, compared to 90.1% during the six months ended June 30, 2011. Gross profit for the three months ended June 30, 2012 was $209,000, or 5,7% of revenue, compared to gross profit of $472,000 or 9.9% of revenue for the same period in 2011. The decrease in gross margin in the six months ended June 30, 2012 compared to the six months ended June 30, 2011, was due to year-to-date impact of imposed tariffs on Chinese modules and lower average selling prices, partially offset by a decline in panel and component costs. Excluding the tariff expense of $86,000, gross profit would have been $295,000 or 8.1% of revenue.

25

Sales and marketing expenses

Sales and marketing expenses for the six months ended June 30, 2012 were $1.1 million, or 30.0% of net revenue as compared to $1.0 million, or 22.0% of net revenue during the same period of the prior year. The increase in sales and marketing expense for the six months ended June 30, 2012, is primarily due to an increase in Westinghouse licensing fees of $125,000, offset by lower expenditures for advertising and trade shows of $80,000, travel of $37,000 and payroll and commission costs of $9,000.

General and administrative expenses

General and administrative expenses for the six months ended June 30, 2012 were $3.7 million, or 102.6% of net revenue as compared to $3.1 million, or 66.1% of net revenue during the same period of the prior year. The increase in general and administrative expense for the six months ended June 30, 2012 was due primarily to increases in legal fees of $813,000 and professional fees of $299,000, related to the pending CBD merger transaction and recently settled patent litigation, and due to higher insurance costs of $59,000 and tax consulting costs of $26,000, partially offset by lower payroll costs of $372,000.

Interest, net

During the six months ended June 30, 2012, net interest expense was approximately $35,000 compared with net interest expense of $58,000 for the same period in 2011.

Adjustment to the fair value of common stock warrants

During the six months ended June 30, 2012, we recorded mark-to-market adjustments to reflect the fair value of outstanding common stock warrants accounted for as a liability, resulting in an unrealized loss of $427,000 in our condensed consolidated statements of operations. The fair value of the warrants is lower now primarily due to a decrease in the price of our common stock and a shorter life for the remainder of our outstanding warrants. During the six months ended June 30, 2011, we recorded mark-to-market adjustments resulting in a $1.1 million unrealized gain in our condensed consolidated statements of operations.

Income taxes

During the six months ended June 30, 2012 and June 30, 2011, there was no income tax expense or benefit for federal and state income taxes reflected in our condensed consolidated statements of operations due to our net loss and a valuation allowance on the resulting deferred tax asset.

Net loss from continuing operations

Net loss from continuing operations for the six months ended June 30, 2012 was $5.1 million, or $0.29 per share, compared to a net loss from continuing operations of $2.6 million, or $0.23 per share, for the six months ended June 30, 2011. For the six months ended June 30, 2012, the net loss includes an unfavorable non-cash adjustment to the fair value of common stock warrants of $427,000 compared with a favorable non-cash adjustment to the fair value of the common stock warrants of $1.1 million for the six months ended June 30, 2011. Excluding the impact of the common stock warrant adjustments in both periods, net loss from continuing operations for the six months ended June 30, 2012 was $4.6 million, or $0.26 per share, compared to a net loss of $3.8 million, or $0.41 per share, for the same period in 2011.

Gain (loss) from discontinued operations

During the six months ended June 30, 2012, we recorded a $23,000 net gain from the discontinuance of our installation business segment, compared with a gain of $4,000 during the same period in 2011.

26

Liquidity and Capital Resources

The current economic downturn presents us with challenges in meeting the working capital needs of our business. Our primary requirements for working capital are to fund purchases for solar panels and microinverters, and to cover our payroll and lease expenses.For the six months ended June 30, 2012 and for each of the two years in the period ending December 31, 2011, we had incurred net losses and negative cash flows from operations. In addition, we expect to incur a net loss from operations for the year ending December 31, 2012. During recent years, we have undertaken several equity financing transactions to provide the capital needed to sustain and to grow our business. Based on current cash projections for 2012, which contemplate a smaller operating loss, we intend to address ongoing working capital needs through cost reduction measures recently implemented and utilization of existing inventory, along with utilizing our available credit facility and raising additional equity. In the event that revenue is lower, further staffing reductions and expense cuts could occur. Our revenue levels remain difficult to predict, and we anticipate that we will continue to sustain losses in the near term, and we cannot assure investors that we will be successful in reaching break-even.

As of June 30, 2012, we had approximately $193,000 in cash on hand and $656,000 available under our credit facility. As an additional source of capital, outstanding warrants provide the possibility for us to receive additional proceeds upon exercise, depending on market conditions. Also under the Merger Agreement we entered into with CBD, we are required to raise sufficient equity capital, with the cooperation and support of CBD to meet our liquidity and working capital requirements. In addition, prior to closing of the merger, CBD has agreed to provide capital funding support to us if necessary, and subject to conditions and limitations as provided in the Merger Agreement. We are seeking potential investors to obtain additional funding, and have engaged an investment banker to facilitate these efforts.

The accompanying consolidated financial statements have been prepared assuming we will continue as a going concern. Our significant operating losses and negative cash flow from operations raise substantial uncertainty about our ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty, and contemplate the realization of assets and the settlement of liabilities and commitments in the normal course of business. We believe our current cash balance, projected financial results from our operations, and the amounts that should be available to us through debt and equity financing provide sufficient resources and operating flexibility to fund our anticipated cash needs, through at least the next 12 months; however, there can be no assurance that we will be able to raise additional funds on commercially reasonable terms, if at all. The current economic downturn adds uncertainty to our anticipated revenue levels and to the timing of cash receipts, which are needed to support our operations. It also worsens the market conditions for seeking equity and debt financing. We currently anticipate that we will retain all of our earnings, if any, for development of our business and do not anticipate paying any cash dividends on common stock in the foreseeable future.

Our Line of Credit

On February 15, 2011, we entered into the 2011 Credit Facility with Bridge Bank to finance our accounts receivables. The 2011 Credit Facility provides for a credit limit of $750,000, representing the maximum amount of advances based on up to 50% of $1.5 million of gross eligible accounts receivables. The 2011 Credit Facility may be terminated at any time by either party and may be renewed under similar terms if acceptable and agreed to by the parties. If any advance is not repaid in full within 90 days from the earlier of (a) invoice date, or (b) the date on which such advance is made, we are obligated to immediately pay the outstanding amount to Bridge Bank. Outstanding loans under the 2011 Credit Facility will accrue interest at the Bridge Bank Prime rate plus 3.0% (annualized) of the daily gross financed amount outstanding. The 2011 Credit Facility is secured by substantially all of our assets. As of June 30, 2012, there was $94,000 borrowed under the 2011 Credit Facility.

Equity Financing Activity

On February 17, 2011, we entered into a securities purchase agreement with certain institutional accredited investors relating to the sale of 4,000 units at a price of $900 per unit. Each unit consists of (i) one share of Series B Preferred Stock, with each such share of Series B Preferred Stock initially convertible into 500 shares of common stock at an initial conversion price of $1.80 per share, subject to future adjustment for various events, and (ii) warrants to purchase 425 shares of common stock at an initial exercise price of $2.40 per share, subject to future adjustment for various events, which warrants are not exercisable until six months after issuance and have a term of five years from the date of first exercisability. The aggregate purchase price for the Securities was $3,600,000. As of May 10, 2012, 1,727 shares of preferred stock had been converted into 891,601 shares of common stock.

On August 16, 2011, we entered into a securities purchase agreement with an institutional accredited investor relating to the sale of 990,099 shares of common stock at a price of $1.01 per share, along with the sale of Series L Warrants to purchase up to 643,564 shares of common stock (65% of the number of shares of common stock initially issued) at an exercise price of $1.17 per share. The warrants are not exercisable until six months after issuance and have a term of five years from the date they are first exercisable. The aggregate purchase price for the shares and the warrants was $1,000,000. Under the securities purchase agreement, we agreed to amend the outstanding Series J Warrants, such that the exercise price of the Series J Warrants is reduced from $2.44 per share to $1.17 per share. In addition, each of the Series J Warrants, (i) is not exercisable until the six month anniversary of the closing under the August 16, 2011 securities purchase agreement, and (ii) the expiration date is extended such that the warrant is exercisable for five years from the delayed initial exercise date. The outstanding Series J Warrants were originally issued on October 7, 2010, and represent the right to purchase up to an aggregate of 400,001 shares of common stock.

27

As a result of the August 16, 2011 securities sale, (i) the conversion price of the Series B Preferred was reduced from $1.80 per share of common stock to $1.01 per share of common stock, and (ii) the exercise price of the Series K Warrants was reduced from $2.40 to $1.01 per share. The Series K Warrants were originally issued on February 22, 2011 and represent the right to purchase up to an aggregate of 1,700,002 shares of common stock.

On September 28, 2011, we entered into a securities purchase agreement with an institutional accredited investor relating to the sale of 500,000 shares of common stock at a price of $0.80 per share, along with the sale of Series M Warrants to purchase up to 325,000 shares of common stock (65% of the number of shares of common stock initially issued) at an exercise price of $0.81 per share. The warrants are not exercisable until six months after issuance and have a term of five years from the date they are first exercisable. The aggregate purchase price for the shares and the warrants was $500,000. Under the securities purchase agreement, we agreed to amend the outstanding Series L Warrants, such that the exercise price of the Series L Warrants is reduced from $1.17 per share to $0.81 per share. In addition, each of the Series L Warrants, (i) is not exercisable until the six month anniversary of the closing under the September 28, 2011 securities purchase agreement, and (ii) the expiration date is extended such that the warrant is exercisable for five years from the delayed initial exercise date. The outstanding Series L Warrants were originally issued on August 16, 2011, and represent the right to purchase up to an aggregate of 643,564 shares of common stock.

On December 30, 2011, we entered into a securities purchase agreement with CBD Energy Limited (“CBD”), an Australian corporation, relating to the sale of 1,666,667 shares of common stock at a price of $0.60 per share. The aggregate purchase price was $1,000,000. See previous discussion in Liquidity and Capital resources on proposed merger with CBD.

As a result of the December 30, 2011 security sale, the conversion price of the Series B Preferred was further reduced from $0.80 per share of common stock to $0.60 per share of common stock, and (ii) the exercise price of the Series K Warrants was further reduced from $0.80 to $0.60 per share. As of June 30, 2012, there were 2,273 shares of Series B Preferred outstanding. After adjustment to the conversion price as a result of the December 30, 2011 securities purchase agreement, the outstanding Series B Preferred is convertible into 3,409,029 shares of common stock.

On March 30, 2012, we entered into an amendment with the outstanding Series K warrants (Series K Amendment) removing the provision for any future price adjustment to the exercise price. On March 30, 2012, the fair value of the warrants was estimated using Black-Scholes with the following weighted average assumptions: risk-free interest rate of 0.5%, an expected life of 3.0 years; an expected volatility factor of 109.3% and a dividend yield of 0.0%. The fair value of the warrants decreased to $481,000 as of March 30, 2012 and we recognized a $425,000 unfavorable non-cash adjustment from the change in fair value of these warrants during the six months ended June 30, 2012. As a result of the March 30, 2012 Series K Amendment the fair value of the warrants of $481,000 was reclassified from warrant liability to equity.

On March 30, 2012, pursuant to a March 25, 2011 supply agreement with Light Way Green New Energy Co., Ltd (Lightway), we issued 1,900,000 share of our common stock to Lightway. The shares were issued at $0.55 per share based on the latest closing sale price on the date of issuance.

Cash flow analysis

Our primary capital requirement is to fund purchases of solar panels and inverters. Significant sources of liquidity are cash on hand, cash flows from operating activities, working capital and proceeds from equity financings. As of June 30, 2012, we had approximately $193,000 in cash and cash equivalents. As of June 30, 2012 we also had approximately $656,000 in additional borrowing capacity available under our 2011 Credit Facility with Bridge Bank.

Cash used in operating activities was approximately $1.2 million for the six months ended June 30, 2012. Excluding non-cash items of $427,000 of unrealized loss on the fair value adjustment of common stock warrants and stock-based compensation expense of $440,000, cash used in operating activities was primarily due to a $603,000 increase in other assets and a $280,000 decrease in accounts payable, offset by a $1.9 million decrease in inventory, a $504,000 decrease in prepaid expenses and other current assets and a $421,000 decrease in accounts receivable. The increases and decreases in assets and liabilities were primarily due to the timing of payments and receipts. Cash used in operating activities was approximately $1.4 million for the six months ended June 30, 2011. Excluding non-cash items of $1.1 million of unrealized gain on the fair value adjustment of common stock warrants and stock-based compensation expense of $606,000, cash used in operating activities was primarily from a $336,000 increase in accounts receivable and a $280,000 decrease in liabilities of discontinued operations, more than offset by a $1.3 million decrease in inventory, an increase of $697,000 in accounts payable and a decrease of $366,000 in assets of discontinued operations. The increases and decreases in assets and liabilities were primarily due to the timing of payments and receipts.

During the six months ended June 30, 2012, there was no cash provided by or used in investing activities. Cash provided by investing activities was $179,000 for the six months ended June 30, 2011, primarily due to $189,000 in proceeds from disposal of property and equipment from discontinued operations, partially offset by $29,000 in acquisitions of property and equipment.

Cash provided by financing activities was approximately $32,000 for the six months ended June 30, 2012. During the six months ended June 30, 2012, we received proceeds of $283,000 from the exercise of warrants and $94,000 from borrowing on our line of 2011 Credit Facility, partially offset by the repayment of notes payable and $92,000 on our line of credit. Cash provided by financing activities was approximately $3.0 million for the six months ended June 30, 2011. During the six months ended June 30, 2011, we received proceeds of $3.1 million from the issuance of common stock, net of $522,000 in fees.

28

Application of Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires estimates and assumptions that affect the reporting of assets, liabilities, sales and expenses, and the disclosure of contingent assets and liabilities. Note 2 to our consolidated financial statements for the years ending December 31, 2011 and 2010 as filed in our Annual Report on Form 10-K provides a summary of our significant accounting policies, which are all in accordance with generally accepted accounting policies in the United States. Certain of our accounting policies are critical to understanding our consolidated financial statements, because their application requires management to make assumptions about future results and depends to a large extent on management’s judgment, because past results have fluctuated and are expected to continue to do so in the future.

The application of the accounting policies described in the following paragraphs is highly dependent on critical estimates and assumptions that are inherently uncertain and highly susceptible to change. For all these policies, we caution that future events rarely develop exactly as estimated, and the best estimates routinely require adjustment. On an ongoing basis, we evaluate our estimates and assumptions, including those discussed below.

Revenue recognition. Revenue from sales of products is recognized when: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) the sale price is fixed or determinable, and (4) collection of the related receivable is reasonably assured. We recognize revenue when the solar power systems are shipped to the customer.

Inventory. Inventory is stated at the lower of cost (on an average basis) or market value. We determine cost based on our weighted-average purchase price and include both the costs of acquisition and the shipping costs in our inventory. We regularly review the cost of inventory against its estimated market value and record a lower of cost or market write-down to cost of goods sold, if any inventory has a cost in excess of estimated market value. Our inventory generally has a long life cycle and obsolescence has not historically been a significant factor in its valuation.

Long-lived assets. We periodically review our property and equipment and identifiable intangible assets for possible impairment whenever facts and circumstances indicate that the carrying amount may not be fully recoverable. Assumptions and estimates used in the evaluation of impairment may affect the carrying value of long-lived assets, which could result in impairment charges in future periods. Significant assumptions and estimates include the projected cash flows based upon estimated revenue and expense growth rates and the discount rate applied to expected cash flows. In addition, our depreciation and amortization policies reflect judgments on the estimated useful lives of assets.

Patent Costs.  We capitalize external legal costs and filing fees associated with obtaining or defending our patents. Upon issuance of new patents or successful defense of existing patents, we amortize these costs using the straight line method over the shorter of the legal life of the patent or its economic life. We believe the remaining useful life we assign to these patents, approximately 12.5 years as of June 30, 2012, are reasonable. We periodically review our patents to determine whether any such cost have been impaired and are no longer being used. To the extent we are no longer using certain patents, the associated costs will be written off at that time.

Stock-based compensation. We use the Black-Scholes-Merton Options Pricing Model (Black-Scholes) to estimate fair value of our employee and our non-employee director stock-based awards. Black-Scholes requires various judgmental assumptions, including estimating stock price volatility, expected option life and forfeiture rates. We measure compensation expense for non-employee stock-based compensation under ASC 505-50, “Equity-Based Payments to Non-Employees.” The fair value of the option issued is used to measure the transaction, as this is more reliable than the fair value of the services received. The estimated fair value is measured utilizing Black-Scholes using the value of our common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty’s performance is complete.

Warranty provision. The manufacturer directly warrants the solar panels and inverters for a range from 15 to 25 years. We warrant the balance of system components of our products against defects in material and workmanship for five years. We assist our customers in the event of a claim under the manufacturer warranty to replace a defective solar panel or inverter.

Common Stock Warrant Liabilities.  In March 2009 and February 2011 we issued warrants to purchase shares of our common stock in connection with certain capital financing transactions. The terms of the warrant agreements related to these two offerings contained a cash-out provision which may be triggered at the option of the warrant holders if the Company “goes private,” is acquired for all cash or upon the occurrence of certain other fundamental transactions involving the Company. In addition, the terms of the warrant agreement related to the February 2011 offering contain a provision that may require us to reduce the exercise price of the warrants to purchase shares of our common stock upon the occurrence of certain lower-priced future offerings of our equity securities. Under the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity (“ASC 480”), financial instruments that may require the issuer to settle the obligation by transferring assets or to reduce the exercise price of its warrants to purchase shares of its common stock are classified as a liability. Therefore, we have classified the warrants as liabilities and will record mark-to-market adjustments to reflect the fair value at each period end.

Significant Accounting Policies and Estimates

There have been no material changes or developments to the significant accounting policies discussed in our 2011 Annual Report on Form 10-K or accounting pronouncements issued or adopted, except as described below.

Recently Adopted Accounting Standards

In June 2011, the FASB issued ASU No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income (ASU No. 2011-05). ASU No. 2011-05 requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements, eliminating the option to present other comprehensive income in the statement of changes in equity. Under either choice, items that are reclassified from other comprehensive income to net income are required to be presented on the face of the financial statements where the components of net income and the components of other comprehensive income are presented. We adopted ASU No. 2011-05 on January 1, 2012 and the adoption of this guidance did not have a material impact on our financial position, results of operations or cash flows.

Seasonality

Our quarterly operating results may vary significantly from quarter to quarter as a result of seasonal changes in weather as well as changes in state or federal subsidies.

29

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk represents the risk of changes in the value of market risk sensitive instruments caused by fluctuations in interest rates, foreign exchange rates and commodity prices. Changes in these factors could cause fluctuations in our results of operations and cash flows.

Interest Rate Risk

As of June 30, 2012, there was $94,000 borrowed under our Bridge Bank 2011 Credit Facility. Interest under the 2011 Credit Facility accrues at the rate of the Bridge Bank Prime rate plus a margin of 3.0%.

Foreign Currency Exchange Risk

We do not have any foreign currency exchange risk as purchases of our solar panels from manufacturers outside the United States and sales of our solar panels to Canada are denominated in U.S. currency.

Item 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer/Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2012. Based upon that evaluation, our Chief Executive Officer/Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of the end of the period covered by this report. In designing and evaluating our disclosure controls and procedures, we and our management recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and that our management necessarily is required to apply its judgment in evaluating and implementing possible controls and procedures. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events.

The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Quarterly Evaluation of Changes in Internal Control Over Financial Reporting

Our management, with the participation of our Chief Executive Officer/Chief Financial Officer, also conducted an evaluation of our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) to determine whether any change occurred during the second quarter of 2012 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. Based on that evaluation, our management concluded that there was no such change during the fiscal quarter ended June 30, 2012.

30

PART II

OTHER INFORMATION

Item 1. Legal Proceedings

Litigation

We have been involved in various patent litigation with Zep Solar, Inc. (“Zep”) and other parties, including (1) an action we filed on October 22, 2009 against Zep and several other defendants in the United States District Court for the Northern District of California, San Francisco Division for infringement of U.S. Patent No. 7,406,800 (the “’800 District Court Action”), (2) an action Zep and Trina Solar filed on August 2, 2011 against us in the United States District Court for the Northern District of California, San Francisco Division for declaratory judgment of non-infringement of U.S. Patent No. 7,987,641 issued to our subsidiary Andalay Solar on August 2, 2011 (the “’641 District Court Action”), (3) an action we filed with the United States International Trade Commission (“ITC”) on October 4, 2011 accusing Zep and Canadian Solar of infringing the ’800 patent and the ’641 patent (the “ITC Action”), and (4) an action Zep filed against us and other defendants in the United States District Court for the Northern District of California, San Francisco Division alleging that the our products infringe U.S. Patent No. 7,952,537 (the “’537 District Court Action”).

On May 25, 2012, we and Zep entered into a final and comprehensive settlement of their legal disputes, resulting in the expected dismissal of the ITC Action and all three actions pending in the United States District Court for the Northern District of California.  The specific terms of the global settlement are confidential.  The settlement extends to all customers, suppliers, licensees and business partners of both Zep and us who were named in one or more of the proceedings.

On May 1, 2012, Suntech America, Inc., a Delaware corporation (Suntech America), filed a complaint for breach of contract, goods sold and delivered, account stated and open account against us in the Superior Court of the State of California, County of San Francisco. Suntech America alleged that it delivered products to us and did not receive full payment by us. On July 31, 2012, we and Suntech entered into a settlement of this dispute. As of June 30, 2012, we have included in our Condensed Consolidated Balance Sheets, under accounts payable, a balance due to Suntech America of $989,771.

On June 7, 2012, Barry Cinnamon, the former chief executive officer of the Company, filed a complaint with the U.S. Department of Labor, Occupational Safety and Health Administration, at its office in San Francisco California, alleging that Mr. Cinnamon’s termination of employment on May 8, 2012 constituted a violation of the whistleblower protections of the Sarbanes-Oxley Act of 2002.  In his complaint, Mr. Cinnamon requests that the Secretary of Labor institute an investigation of alleged retaliation against Mr. Cinnamon by us and our board of directors. The complaint also indicates that Mr. Cinnamon has a variety of state law claims, which he intends to pursue in court.  We have not been notified that any other proceedings have been filed by Mr. Cinnamon as of August 10, 2012.  We have responded to the initial complaint, disagreeing with Mr. Cinnamon’s characterization of events.  We believe that the complaint and claims by Mr. Cinnamon are without merit, and we intend to defend ourselves in any proceedings brought by Mr. Cinnamon.

We are also involved in other litigation from time to time in the ordinary course of business. In the opinion of management, the outcome of such proceedings will not materially affect our financial position, results of operations or cash flows.

Item 1A. Risk Factors

Our Quarterly Report on Form 10-Q, and information we provide in our press releases, telephonic reports and other investor communications, may contain forward-looking statements with respect to anticipated future events and our projected financial performance, operations and competitive position that are subject to risks and uncertainties that could cause our actual results to differ materially from those forward-looking statements and our expectations. Future economic and industry trends that could potentially affect revenue, profitability, and growth remain difficult to predict. The factors underlying our forecasts and forward-looking statements are dynamic and subject to change. As a result, any forecasts or forward-looking statements speak only as of the date they are given and do not necessarily reflect our outlook at any other point in time.

Risks Relating to Our Business

We will need additional capital in the future to fund our business, and financing may not be available.

Our currently available capital resources and cash flows from operations may be insufficient to meet our working capital and capital expenditure requirements. Our cash requirements will depend on numerous factors, including the rate of growth of our sales, the timing and levels of products purchased, pricing, payment terms and credit limits from manufacturers, the availability and terms of asset-based credit facilities, the timing and level of our accounts receivable collections, and our ability to manage our business profitability.

We expect to need to raise additional funds through public or private debt or equity financings or enter into new asset-based or other credit facilities, but such financings may dilute our stockholders. We cannot assure you that any additional financing that we may need will be available on terms favorable to us, or at all. In addition, on May 9, 2012 we announced the execution of an agreement and plan of merger with CBD Energy Limited, a corporation organized under the laws of Australia (“CBD”) by means of a merger in which CBD would become our parent company. This event may diminish our independent access to additional financing. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of business opportunities, develop new products or otherwise respond to competitive pressures. In any such case, our business, operating results or financial condition could be materially adversely affected.

31

The U.S. Government imposed tariffs on solar panels manufactured in China causing the prices we pay for solar panels to increase. This could cause customer demand for our products to decrease.

A group of solar panel manufacturers with domestic U.S. production facilities requested the U.S. Government to impose tariffs on the import of solar panels manufactured in China, based on allegations of unfair competition and of subsidization of prices for Chinese-made solar panels by the Chinese Government. In March 2012, the United States Commerce Department issued a preliminary decision imposing tariffs between 2.9% and 4.73%. On May 2012, a further decision by the Commerce Department was issued providing for a provisional tariff averaging 31% on 61 Chinese manufacturers caused by “dumping” solar panels into the U.S. market at prices below their actual cost. It is uncertain whether the tariff rates will be increased following the foregoing decisions by the Commerce Department, but tariff rates as high as 100% have been suggested. Given the large current market share of solar panels manufactured in China, the imposition of these tariffs will have far reaching, industry-wide effects, and will likely be disruptive to many established supply relationships. In fact, the imposition of these tariffs will likely cause prices for solar power systems in the United States to increase, possibly significantly, and result in reduced market demand for the purchase of solar power systems.

Our current solar panel suppliers, Suntech and Lightway, both manufacture panels for us in China. As a result, the solar panel tariffs were imposed in two parts: (i) a countervailing duty imposed of 2.9% for Suntech modules and 3.59% for Lightway modules received subsequent to December 23, 2011 and (ii) an anti-dumping duty imposed of 31.22% for Suntech modules and 31.18% for Lightway modules received subsequent to May 17, 2012.  We expect that the increase in our product prices will harm our competitive position in selling our products, and could adversely affect our results of operations.

We have experienced significant customer concentration in recent periods, and our revenue levels could be adversely affected if any significant customer fails to purchase products from us at anticipated levels.

The relative magnitude and the mix of revenue from our largest customers have varied significantly quarter to quarter, but have been concentrated on a small number of large customers. During the six months ended June 20, 2012, two customers have accounted for a significant portion of our revenues:, Lennox International Inc. (Lennox), a global leader in the heating and air conditioning markets and Lennar Corporation (Lennar), a leading national homebuilder. As of August 10, 2012, Lennar had ordered solar power systems from us for installation on 234 new homes, which was below the 600 home order commitment volume. The volume of orders from key customers is difficult to predict. Fluctuations in order levels from significant customers could cause our revenue levels to correspondingly fluctuate, and the failure by any significant customer to maintain anticipated order levels could cause our revenue to fall short of expectations and adversely affect our results of operations.

We may fail to realize some or all of the anticipated benefits of our shift to a design and manufacturing business model in California and throughout North America, which may adversely affect the value of our common stock.

The success of our exit from the solar system installation business in California in September 2010, and our shift to focus exclusively on a design and manufacturing business model will depend, in large part, on our ability to successfully expand our distribution channels to include authorized dealers in California, as well as elsewhere in North America, and to accelerate the growth of our design and manufacturing business. California is the largest state in the country for solar products, accounting for approximately 50 percent of the U.S. market, and we are only beginning to develop distribution channel partners in California.

If we are not able to achieve the expansion of our design and manufacturing business and meet our revenue growth and cost reduction objectives within the anticipated time frame, or at all, the anticipated benefits and cost savings of our change in strategic focus and our restructuring may not be realized or may take longer to realize than expected, and the value of our common stock may be adversely affected.

Specifically, risks in the operations of our business in order to realize the anticipated benefits of the change to a design and manufacturing business model include, among other things:

·   failure to arrange for cost competitive manufacturing of our proprietary solar panels;

·   failure to find and develop distribution relationships with new channel partners, particularly in the California market;

·   failure to successfully manage existing distribution relationships;

·   the loss of key employees critical to the ongoing operation of our business;

·   failure to effectively coordinate sales and marketing efforts to communicate the capabilities of our company;

·   unpredictability and delays in the timing of projected distribution orders, and resulting accumulation of excess product inventory;

·   failure to focus and develop our distribution product and service offerings quickly and effectively;

·   failure to successfully develop new products and services on a timely basis that address the market opportunities; and

·   unexpected revenue attrition or delays.

In addition, the shift in our business model may result in additional or unforeseen expenses, and the anticipated cost reduction benefits may not be realized.

32

We are dependent upon our key suppliers for the components used in our systems and we must arrange for cost competitive manufacturing of our proprietary solar panels in order to grow our business; our suppliers are dependent upon the continued availability and pricing of silicon and other raw materials used in solar modules.

Historically, we obtained virtually all of our solar panels from Suntech. On March 25, 2011, we entered into a volume supply agreement for a new generation of our solar panel products with Lightway, and in August 2011, we began purchasing solar panels from Lightway. Both Suntech and Lightway manufacture panels for us that are built to our unique specifications. We currently purchase all of the microinverters used in our AC solar panels from Enphase. Although we had an adequate amount of inventory on hand as of June 30, 2012, and although we believe we could find alternative suppliers for solar panels manufactured to our specifications, and alternative suppliers for microinverters, on comparable terms, the sudden loss of any of our current primary component supply relationships could cause a delay in manufacturing and be disruptive to our operations.

It is critical to the growth of our revenue that our products be high quality while offered at competitive pricing. We believe that we will need to reduce the unit production cost of our products over time to obtain and maintain our ability to offer competitively priced products. Our ability to achieve cost reductions will depend on our ability to maintain favorable supplier contracts and to increase sales volumes so we can achieve economies of scale. We cannot provide assurance that we will be able to achieve any such production cost reductions. If we fail to negotiate better terms and maintain our relationships with our current suppliers or develop new supplier relationships, we may not achieve production cost reductions necessary to competitively price our products, which could adversely affect or limit our sales and growth.

We are currently subject to market prices for the components that we purchase, which are subject to fluctuation. We cannot ensure that the prices charged by our suppliers will not increase because of changes in market conditions or other factors beyond our control. An increase in the price of components used in our systems could result in an increase in costs to our customers and could have a material adverse effect on our revenues and demand for our products.

Our suppliers are dependent upon the availability and pricing of silicon, one of the main materials used in manufacturing solar panels. In the past, the world market for solar panels experienced a shortage of supply due to insufficient availability of silicon. This shortage caused the prices for solar modules to increase.

Interruptions in our ability to procure needed components for our systems, whether due to discontinuance by our suppliers, delays or failures in delivery, shortages caused by inadequate production capacity or unavailability, financial failure, manufacturing quality, or for other reasons, would adversely affect or limit our sales and growth. There is no assurance that we will continue to find qualified manufacturers on acceptable terms and, if we do, there can be no assurance that product quality will continue to be acceptable, which could lead to a loss of sales and revenues.

We are dependent upon our solar panel suppliers for regular shipments of products; however we have not been timely in payment to them in recent periods, which may result in delays or disruption in our supply of products.

Historically, we obtained virtually all of our solar panels from Suntech. On March 25, 2011, we entered into a volume supply agreement for a new generation of our solar panel products with Lightway, and in August 2011, we began purchasing solar panels from Lightway. Both Suntech and Lightway manufacture panels for us that are built to our unique specifications. Although we had an adequate amount of inventory on hand as of June 30, 2012, and although we believe we could find alternative suppliers for solar panels manufactured to our specifications, the disruption or loss of our current primary component supply relationships would be disruptive to our operations.  In recent months, because of our cash position and liquidity constraints, we have been late in making payments to both of our panel suppliers. On March 30, 2012, pursuant to our Supply Agreement with Lightway, we issued 1,900,000 shares of our common stock to Lightway in partial payment of our past due account payable to them. The shares were valued at $1,045,000. On May 1, 2012, Suntech America filed a lawsuit against us for breach of contract, alleging that it delivered products to us and has not received full payment, and seeking payment of approximately $990,000. On July 31, 2012, we and Suntech entered into a settlement of this dispute. We currently do not have any unshipped orders for solar panel product pending with Suntech. We have pending and planned orders for additional shipments of product from Lightway. Unless we are able to satisfy our panel suppliers that we will make timely payment for future product orders, our suppliers may delay further shipments to us, which could result in decreased sales and revenue for us, and adversely affect our customer relationships and result in canalled orders.

We are exposed to risks associated with the weak global economy, which increase the uncertainty of project financing for solar installations and the risk of non-payment from customers.

The continuing tight credit markets and weak global economy are contributing to an ongoing slowdown in the solar industry, which may worsen if these economic conditions are prolonged or deteriorate further. The market for installation of solar power systems depends largely on commercial and consumer capital spending. Economic uncertainty exacerbates negative trends in these areas of spending, and may cause customers to push out, cancel, or refrain from placing orders, which may reduce our net sales. Difficulties in obtaining capital and adverse market conditions may also lead to the inability of some customers to obtain affordable financing, including traditional project financing and tax-incentive based financing and home equity based financing, resulting in lower sales to potential customers with liquidity issues, and may lead to an increase of incidents where our customers are unwilling or unable to pay for systems they purchase, and additional bad debt expense for us. Further, these conditions and uncertainty about future economic conditions make it challenging for us to obtain equity and debt financing to meet our working capital requirements to support our business, forecast our operating results, make business decisions, and identify the risks that may affect our business, financial condition and results of operations. If we are unable to timely and appropriately adapt to changes resulting from the difficult macroeconomic environment, our business, financial condition or results of operations may be materially and adversely affected.

33

Our technology may encounter unexpected problems or may not be protectable, which could adversely affect our business and results of operations.

Our technology is relatively new and has not been tested in installation settings for a sufficient period of time to prove its long-term effectiveness and benefits. Problems may occur with products or their underlying components that are unexpected and could have a material adverse effect on our business or results of operations. We have been issued several U.S. and foreign patents that cover our Andalay solar panel technology. We have several other pending patent applications covering Andalay technology. Ultimately, we may not be able to realize the benefits from any patent that is issued.

Because our industry is highly competitive and has low barriers to entry, we may lose market share to larger companies that are better equipped to weather a decline in market conditions due to increased competition.

Our industry is highly competitive and fragmented, is subject to rapid change and has low barriers to entry. Competition in the solar power services industry may increase in the future, partly due to low barriers to entry, as well as from other alternative energy sources now in existence or developed in the future. Increased competition could result in price reductions, reduced margins or loss of market share and greater competition for qualified technical personnel. There can be no assurance that we will be able to compete successfully against current and future competitors. If we are unable to compete effectively, or if competition results in a deterioration of market conditions, our business and results of operations would be adversely affected.

Our profitability depends, in part, on our success and brand recognition and we could lose our competitive advantage if we are not able to protect our trademarks and patents against infringement, and any related litigation could be time-consuming and costly.

We believe that the “Westinghouse” name has significant value and recognition in the North American market, and that our “Andalay” brand has gained substantial recognition by customers in certain geographic areas. We have registered the “Andalay” trademark with the United States Patent and Trademark Office. Use of our trademarks or similar trademarks by competitors in geographic areas in which we have not yet operated could adversely affect our ability to use or gain protection for our brand in those markets, which could weaken our brand and harm our business and competitive position. In addition, any litigation relating to protecting our trademarks and patents against infringement could be time consuming and costly.

We may have warranty obligations to Real Goods Solar, Inc. that could adversely affect our results of operations.

In connection with our exit from the solar system installation business in California, Real Goods Solar, Inc. (Real Goods) agreed to undertake primary, “first responder” responsibility for future warranty service obligations relating to the approximately 800 installations for SunRun that we have previously completed (the “WS Installations”). We retain secondary warranty responsibility on the WS Installations, in the event that Real Goods fails to perform the warranty. We will reimburse Real Goods for actual warranty service work completed by Real Goods related to these “first responder” installations. Other than solar panels and inverters that are covered under the manufacturer warranty, we provided our customers for WS Installations a 5-year or a 10-year warranty. We have accrued, and included within “Liabilities of Discontinued Operations” in our consolidated balance sheets for June 30, 2012 and December 31, 2011, a liability of approximately $1.1 million, to cover these warranty obligations. That amount is intended to cover both the WS Installations and certain installation projects assigned to Real Goods. The terms of the Warranty Agreements provided that we establish an escrow account as a source of funds from which to satisfy our obligation to pay Real Goods for its fees and reimburse it for its expenses for warranty work performed by it pursuant to the Warranty Agreements which are not paid to Real Goods from the company directly. In March 2011, we entered into an Escrow Agreement with Real Goods and deposited $200,000 into an escrow fund. The amount is reflected in long-term assets of discontinued operations in our consolidated balance sheets. The escrow deposit will be released to us in the amount of $40,000, or one-fifth of the remaining escrow funds, per year after each of the fifth through the ninth anniversary of the escrow agreement. If Real Goods fails to perform under the assigned warranty coverage, or the actual warranty expenses exceed the amounts we have accrued, we could incur significant unexpected additional expenses, which would adversely affect our results of operations.

34

Impairment charges could reduce our results of operations.

In accordance with the provisions of Financial Accounting Standards Board (FASB) Accounting Standard Codification (ASC) 350, Goodwill and Other Intangible Assets (ASC 350), we test intangible assets with indefinite useful lives for impairment on an annual basis, and on an interim basis if an event occurs that might reduce the fair value of the reporting unit below its carrying value. We also assess the fair value of our inventory and other tangible assets as of the end of each reporting period. As a result of our exit from the installation business, we impaired approximately $2.0 million for inventory, equipment and other assets no longer needed in our business. We may determine that further asset impairment charges are needed in the future. Although any such impairment charge would be a non-cash expense, further impairment of our tangible or intangible assets could materially increase our expenses and reduce our results of operations.

Our success depends on our key personnel, including our executive officers, and the loss of key personnel or the transition of key personnel, including our Chief Executive Officer, could disrupt our business.

Our success greatly depends on the continued contributions of our senior management and other key sales, marketing and operations personnel. These employees may voluntarily terminate their employment at any time. We may not be able to successfully retain existing personnel or identify, hire and integrate new personnel; and we do not have key person insurance policies in place for these employees. On May 7, 2012, Margaret Randazzo, our Chief Financial Officer, was named our interim Chief Executive Officer, and while we intend to make this transition as smooth as possible, this leadership change may result in disruptions to our business or operations. On May 7, 2012, our founder and former CEO, Barry Cinnamon, left the Company, and his departure may negatively affect our future business and relationships with our suppliers, customers, investors and others.

If we are unable to attract, train and retain highly qualified personnel, the quality of our services may decline and we may not successfully execute our internal growth strategies

Our success depends in large part upon our ability to continue to attract, train, motivate and retain highly skilled and experienced employees, including technical personnel. Qualified technical employees periodically are in great demand and may be unavailable in the time frame required to satisfy our customers’ requirements. While we currently have available technical expertise sufficient for the requirements of our business, expansion of our business could require us to employ additional highly skilled technical personnel. We expect competition for such personnel to increase as the market for solar power systems expands.

There can be no assurance that we will be able to attract and retain sufficient numbers of highly skilled technical employees in the future. The loss of personnel or our inability to hire or retain sufficient personnel at competitive rates of compensation could impair our ability to secure and complete customer engagements and could harm our business

Unexpected warranty expenses or service claims could reduce our profits.

We maintain a warranty reserve on our balance sheet for potential warranty or service claims that could occur in the future. This reserve is adjusted based on our ongoing operating experience with equipment and installations. It is possible, perhaps due to bad supplier material or defective installations, that we would have actual expenses substantially in excess of the reserves we maintain. Our failure to accurately predict future warranty claims could result in unexpected profit volatility

35

Risks Relating to Our Industry

We have experienced technological changes in our industry. New technologies may prove inappropriate and result in liability to us or may not gain market acceptance by our customers.

The solar power industry (and the alternative energy industry, in general) is subject to technological change. Our future success will depend on our ability to appropriately respond to changing technologies and changes in function of products and quality. If we adopt products and technologies that are not attractive to consumers, we may not be successful in capturing or retaining a significant share of our market. In addition, some new technologies are relatively untested and unperfected and may not perform as expected or as desired, in which event our adoption of such products or technologies may cause us to lose money.

A drop in the retail price of conventional energy or non-solar alternative energy sources may negatively impact our profitability.

We believe that an end customer’s decision to purchase or install solar power capabilities is primarily driven by the cost and return on investment resulting from solar power systems. Fluctuations in economic and market conditions that affect the prices of conventional and non-solar alternative energy sources, such as decreases in the prices of oil and other fossil fuels, could cause the demand for solar power systems to decline, which would have a negative impact on our profitability. Changes in utility electric rates or net metering policies could also have a negative effect on our business

Existing regulations, and changes to such regulations, may present technical, regulatory and economic barriers to the purchase and use of solar power products, which may significantly reduce demand for our products and services.

New government regulations or utility policies pertaining to solar power systems are unpredictable and may result in significant additional expenses or delays and, as a result, could cause a significant reduction in demand for solar energy systems and our services. For example, there currently exist metering caps in certain jurisdictions which effectively limit the aggregate amount of power that may be sold by solar power generators into the power grid.

Our business depends on the availability of rebates, tax credits and other financial incentives; reduction, elimination or uncertainty of which would reduce the demand for our products and services.

Many states offer incentives to offset the cost of solar power systems. These systems can take many forms, including direct rebates, state tax credits, system performance payments and Renewable Energy Credits (RECs). Moreover, the federal government currently offers a 30% tax credit for the installation of solar power systems. Businesses may also elect to accelerate the depreciation on their system over five years. Uncertainty about the introduction of, reduction in or elimination of such incentives or delays or interruptions in the implementation of favorable federal or state laws could substantially increase the cost of our systems to our customers, resulting in significant reductions in demand for our services, which would negatively impact our sales.

If solar power technology is not suitable for widespread adoption or sufficient demand for solar power products does not develop or takes longer to develop than we anticipate, our sales would decline and we would be unable to achieve or sustain profitability.

The market for solar power products is emerging and rapidly evolving, and its future success is uncertain. Many factors will influence the widespread adoption of solar power technology and demand for solar power products, including:

·   cost effectiveness of solar power technologies as compared with conventional and non-solar alternative energy technologies;

·   performance and reliability of solar power products as compared with conventional and non-solar alternative energy products;

·   capital expenditures by customers that tend to decrease if the U.S. economy slows; and

·   availability of government subsidies and incentives.

If solar power technology proves unsuitable for widespread commercial deployment or if demand for solar power products fails to develop sufficiently, we would be unable to generate enough revenue to achieve and sustain profitability. In addition, demand for solar power products in the markets and geographic regions we target may not develop or may develop more slowly than we anticipate.

36

Risks Relating to our Common Stock

If our shareholder’s equity remains below $2.5 million or if the trading price of our common stock remains below $1 per share or we fail to satisfy any other listing criteria, our common stock could be delisted from the NASDAQ Capital Market.

We must meet NASDAQ’s continuing listing requirements in order for our common stock to remain listed on the NASDAQ Capital Market. The listing criteria we must meet include, but are not limited to, a minimum bid price for our common stock of $1.00 per share and a minimum shareholders’ equity of $2.5 million.

On April 4, 2012, we received notice from the Listing Qualifications Department of The NASDAQ Stock Market stating that we had not regained compliance with the minimum bid price requirement for continued listing, as set forth in Listing Rule 5550(a)(2), and that as a result our common stock was subject to delisting from The NASDAQ Capital Market. We requested a hearing before a NASDAQ Hearings Panel (the “Panel”) to review the listing determination and to request that the Panel grant us additional time to regain compliance. The hearing was held on May 24, 2012.

On June 19, 2012, we received a letter from The NASDAQ Stock Market notifying us that the Panel granted our request for continued listing of our common stock on the NASDAQ Stock Market, subject to certain conditions including the closing of the merger transaction with CBD on or before October 1, 2012. Should events occur or information come to light that call into question whether the proposed merger will close by that date or whether CBD will qualify for listing on the NASDAQ Stock Market, we are to inform the Panel, which may determine at that time to delist our shares if we are not fully in compliance with the requirements for listing. We are required to provide prompt notification to NASDAQ of any significant events during the exception period, including any events that may call into question our historical financial information or that may impact our ability to maintain compliance with any NASDAQ listing requirement or exception deadline. Prior to the completion of the merger transaction, we and CBD must hold meetings of our respective stockholders, and to solicit the vote of our stockholders, we and CBD must file with the SEC a registration statement/proxy statement with respect to the proposed transaction and the CBD common shares that are issuable to our stockholders in the proposed merger.  We do not control the timing of the filing, or of the potential review by the SEC.  As an alternative to completion of the merger transaction with CBD prior to October 1, 2012, we may seek to obtain additional stockholder equity and to implement a reverse stock split, however we have no assurance that such measures will be successful or will result in our continued listing on Nasdaq.  October 1, 2012 is the last day of the maximum exception period that the Panel could authorize for us to regain compliance with the listing criteria.

A delisting from the NASDAQ Capital Market would make the trading market for our common stock less liquid, and would also make us ineligible to use Form S-3 to register the sale of shares of our common stock or to register the resale of our securities held by certain of our security holders with the SEC, thereby making it more difficult and expensive for us to register our common stock or other securities and raise additional capital.

Our stockholders may be diluted by the conversion of our Series B Preferred Stock and the exercise of warrants; in the event we have a “change of control” or if we fail to comply with the terms of the Series B Preferred Stock, we may be in default and face demands for redemption and significant penalties.

On February 17, 2011, we entered into a Securities Purchase Agreement with accredited investors, pursuant to which we sold to such investors our Series B 4% Convertible Preferred (“Series B Preferred”), which was initially convertible into an aggregate of 2,000,000 of our common stock at an initial conversion price of $1.80 per share, and our Series K Warrants that are exercisable for an aggregate of 1,700,002 shares of our common stock, initially at an exercise price of $2.40 per share. The conversion price of the Series B Preferred is subject to adjustment downward in the event that we sell common stock (or securities convertible into or exercisable for shares of common stock) at an effective price below the conversion price of the Series B Preferred. If the price adjustment provisions are triggered, then the number of shares of common stock issuable upon conversion of the Series B Preferred may be subject to increase. When the investors convert or exercise these securities, our stockholders may experience dilution in the net tangible book value of their common stock. In addition, the sale or availability for sale of the underlying shares in the marketplace could depress our stock price. We have registered for resale all of the underlying shares of common stock relating to the Series B Preferred and our outstanding warrants. As a result, the investors could resell the underlying shares immediately upon issuance, which may result in significant downward pressure on the market price of our stock.

In addition, the terms of our Series B Preferred include various agreements and negative covenants on our part. In the event we fail to comply with those provisions, or if a “change of control” of the Company occurs, it could constitute a “triggering event” (as defined in the Certificate of Designation which designates the rights of the Series B Preferred), and the holders of our Series B Preferred could then demand that all of the outstanding shares of Series B Preferred be redeemed for cash (in certain circumstances within our control), or under certain circumstances, for shares of our common stock. Any such demand for redemption in cash could have a material adverse affect on our financial position and liquidity, and any demand for redemption in stock could have a material dilutive effect for our stockholders. In addition, in such event the dividend rate on our outstanding Series B Preferred is subject to increase to 18% per annum thereafter.

37

Future sales of common stock by our existing stockholders may cause our stock price to fall.

The market price of our common stock could decline as a result of sales by our existing stockholders of shares of common stock in the market, or the perception that these sales could occur. These sales might also make it more difficult for us to sell equity securities at a time and price that we deem appropriate. As of August 10, 2012, we had 19,148,083 shares of common stock outstanding (which includes 270,475 unvested shares of restricted stock granted to our Board of Directors and our employees), 2,273 shares of Series B Preferred Stock that are convertible into 3,409,029 shares of common stock and we had warrants to purchase 3,633,794 shares of common stock and options to purchase 704,869 shares of common stock outstanding.

All of the shares of common stock issuable upon exercise of our outstanding vested options will be freely tradable without restriction under the federal securities laws unless purchased by our affiliates. The shares of common stock issuable upon exercise of our outstanding warrants are generally covered (or will be covered) by effective registration statements which permit the underlying shares issuable upon their exercise to be freely tradable in the public market.

Our stock price may be volatile, which could result in substantial losses for investors.

The market price of our common stock is likely to be highly volatile and could fluctuate widely in response to various factors, many of which are beyond our control, including the following:

·   technological innovations or new products and services by us or our competitors;

·   announcements or press releases relating to the energy sector or to our business or prospects;

·   additions or departures of key personnel;

·   regulatory, legislative or other developments affecting us or the solar power industry generally;

·   our ability to execute our business plan;

·   operating results that fall below expectations;

·   volume and timing of customer orders;

·   industry developments;

·   economic and other external factors; and

·   period-to-period fluctuations in our financial results.

·   future developments relating to our announcement of a business combination with CBD.

In addition, the securities markets have from time to time experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies. These market fluctuations may also significantly affect the market price of our common stock.

Risks Relating to Our Company

If the Merger contemplated by the Merger Agreement with CBD does not occur or is delayed, it could have a material adverse effect on our business, results of operations, and financial condition.

On May 7, 2012, we entered into a Merger Agreement with CBD. We cannot predict whether and when the closing conditions for the Merger as set forth in the Merger Agreement will be satisfied, and the contemplated Merger transaction may be delayed or even abandoned before completion if certain events occur. The Merger Agreement may be terminated by us, on the one hand, or CBD, on the other hand, under certain circumstances, and termination of the Merger Agreement may in certain circumstances require us to pay a termination fee to CBD equal to the greater of (i) $500,000 and (ii) the amount of expenses that CBD has incurred in connection with the Merger, including legal and financial advisor fees.  In addition, the failure by our stockholders to approve and adopt the Merger Agreement at our future meeting of stockholders may require us to pay CBD the same termination fee. If the closing conditions set forth in the Merger Agreement are not satisfied or waived, or if the transactions are not completed for any other reason, (i) the market price of our common stock could significantly decline; (ii) we will remain liable for the significant expenses that we have incurred related to the transaction, including legal and financial advisor fees, and may be required to pay the foregoing termination fees; (iii) we may experience substantial disruption in our sales, operating activities, customers, suppliers, and other third-party relationships, any of which could materially and adversely affect us and our business, operating results, and financial condition; and (iv) we may have difficulty attracting and retaining key personnel.

Until the closing of the Merger, the focus of our management team and employees may be diverted, and that there may be a negative reaction to the Merger on the part of our customers, employees, suppliers, or other third-party relationships. The Merger Agreement also contains certain limitations regarding our business operations prior to completion of the Merger.

38

Upon closing of the proposed Merger with CBD, we may fail to realize some or all of the anticipated benefits of the Merger, which may adversely affect the value of the common stock of the combined company.

The success of the Merger will depend, in part, on the combined company’s ability to realize the anticipated benefits and cost savings from combining our historical business with that of CBD. However, to realize these anticipated benefits and cost savings, both companies must successfully combine those businesses. If we are not able to achieve these objectives within the anticipated time frame, or at all, the anticipated benefits and cost savings of the Merger may not be realized or may take longer to realize than expected, and the value of the merger consideration to be received by our stockholders may be adversely affected.

Specifically, risks in integrating our operations into CBD’s operations in order to realize the anticipated benefits of the Merger include, among other things:

·   the loss of key employees critical to the ongoing operation of the business;

·   failure to effectively coordinate sales and marketing efforts to communicate the capabilities of the combined company;

·   failure to combine product and service offerings quickly and effectively;

·   failure to successfully develop new products and services on a timely basis that address the market opportunities of the combined company;

·   unexpected revenue attrition;

·   failure to successfully integrate and harmonize financial reporting and information technology systems of CBD and us; and

·   failure to develop and maintain an effective internal control environment as required under the Sarbanes-Oxley Act of 2002 (CBD is an Australian  public corporation not subject, at the moment, to the Sarbanes-Oxley Act of 2002).

We are subject to the reporting requirements of the federal securities laws, which impose additional burdens on us.

We are a public reporting company and, accordingly, subject to the information and reporting requirements of the Exchange Act and other federal securities laws, including compliance with the Sarbanes-Oxley Act of 2002. As a public company, these rules and regulations result in increased compliance costs and make certain activities more time consuming and costly.

Our Certificate of Incorporation authorizes our board to create new series of preferred stock without further approval by our stockholders, which could adversely affect the rights of the holders of our common stock.

Our Board of Directors has the authority to fix and determine the relative rights and preferences of preferred stock. Our Board of Directors also has the authority to issue preferred stock without further stockholder approval. As a result, our Board of Directors could authorize the issuance of new series of preferred stock that would grant to holders the preferred right to our assets upon liquidation, the right to receive dividend payments before dividends are distributed to the holders of common stock and the right to the redemption of the shares, together with a premium, prior to the redemption of our common stock. In addition, our Board of Directors could authorize the issuance of new series of preferred stock that has greater voting power than our common stock or that is convertible into our common stock, which could decrease the relative voting power of our common stock or result in dilution to our existing stockholders.

39

Item 6. EXHIBITS.

Exhibit  Number			Description
	2.1		Agreement and Plan of Merger, dated as of May 7, 2012, by and among Westinghouse Solar, Inc. CBD Energy Limited and CBD-WS Merger Sub, Inc. (incorporated herein by reference to Exhibit 2.1 to our Current Report on Form 8-K, filed on May 9, 2012).
	3.1		Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to our Current Report on Form 8-K, filed on August 7, 2006).
	3.2		By-laws (incorporated by reference to Exhibit 3.2 to our Current Report on Form 8-K, filed on August 7, 2006).
	3.3		Certificate of Amendment to Certificate of Incorporation as filed with the Delaware Secretary of State on August 11, 2006 (incorporated herein by reference to Exhibit 3.3 of our Current Report on Form 8-K, filed on August 14, 2006).
	3.4		Certificate of Amendment to Certificate of Incorporation as filed with the Delaware Secretary of State on May 7, 2010 (incorporated herein by reference to Exhibit 3.4 of our Quarterly Report on Form 10-Q, filed on July 30, 2010).
	3.5		Certificate of Amendment to Certificate of Incorporation as filed with the Delaware Secretary of State on April 6, 2011 (incorporated herein by reference to Exhibit 3.5 of our Form 10-Q, filed on May 10, 2011).
	3.6		Certificate of Designation of Preferences, Rights and Limitations with respect to Series B 4% Convertible Preferred Stock (“the “Certificate of Designation”), as filed on February 17, 2011 (incorporated herein by reference to Exhibit 4.2 to our Current Report on Form 8-K, filed on August 17, 2011).
	3.7		Certificate of Amendment to the Certificate of Designation of (incorporated herein by reference to Exhibit 3(i) to our Current Report on Form 8-K, filed on August 24, 2011).
	10.1	*‡	Employment Agreement, dated as of May 7, 2012, between the Company and Margaret R. Randazzo.
	31	*	Section 302 Certification of Principal Executive and Financial Officer
	32	*	Section 906 Certification of Principal Executive and Financial Officer
101.INS		*	XBRL Taxonomy Extension Instance Document †
101.SCH		*	XBRL Taxonomy Extension Schema Linkbase Document †
101.CAL		*	XBRL Taxonomy Extension Calculation Linkbase Document †
101.DEF		*	XBRL Taxonomy Extension Definition Linkbase Document †
101.LAB		*	XBRL Taxonomy Extension Labels Linkbase Document †
101.PRE		*	XBRL Taxonomy Extension Presentation Linkbase Document †
		*	filed herewith
		‡	Management contract or compensatory plan or arrangement.
		†	Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

40

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated:  August 14, 2012	/s/ Margaret R. Randazzo
	Margaret R. Randazzo
	Chief Executive Officer and Chief Financial Officer
	(Principal Executive Officer, Principal Financial Officer and
	Principal Accounting Officer)

41

Exhibit Index

Exhibit  Number			Description
	2.1		Agreement and Plan of Merger, dated as of May 7, 2012, by and among Westinghouse Solar, Inc. CBD Energy Limited and CBD-WS Merger Sub, Inc. (incorporated herein by reference to Exhibit 2.1 to our Current Report on Form 8-K, filed on May 9, 2012).
	3.1		Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to our Current Report on Form 8-K, filed on August 7, 2006).
	3.2		By-laws (incorporated by reference to Exhibit 3.2 to our Current Report on Form 8-K, filed on August 7, 2006).
	3.3		Certificate of Amendment to Certificate of Incorporation as filed with the Delaware Secretary of State on August 11, 2006 (incorporated herein by reference to Exhibit 3.3 of our Current Report on Form 8-K, filed on August 14, 2006).
	3.4		Certificate of Amendment to Certificate of Incorporation as filed with the Delaware Secretary of State on May 7, 2010 (incorporated herein by reference to Exhibit 3.4 of our Quarterly Report on Form 10-Q, filed on July 30, 2010).
	3.5		Certificate of Amendment to Certificate of Incorporation as filed with the Delaware Secretary of State on April 6, 2011 (incorporated herein by reference to Exhibit 3.5 of our Form 10-Q, filed on May 10, 2011).
	3.6		Certificate of Designation of Preferences, Rights and Limitations with respect to Series B 4% Convertible Preferred Stock (“the “Certificate of Designation”), as filed on February 17, 2011 (incorporated herein by reference to Exhibit 4.2 to our Current Report on Form 8-K, filed on August 17, 2011).
	3.7		Certificate of Amendment to the Certificate of Designation of (incorporated herein by reference to Exhibit 3(i) to our Current Report on Form 8-K, filed on August 24, 2011).
	10.1	*‡	Employment Agreement, dated as of May 7, 2012, between the Company and Margaret R. Randazzo.
	31	*	Section 302 Certification of Principal Executive and Financial Officer
	32	*	Section 906 Certification of Principal Executive and Financial Officer
101.INS		*	XBRL Taxonomy Extension Instance Document †
101.SCH		*	XBRL Taxonomy Extension Schema Linkbase Document †
101.CAL		*	XBRL Taxonomy Extension Calculation Linkbase Document †
101.DEF		*	XBRL Taxonomy Extension Definition Linkbase Document †
101.LAB		*	XBRL Taxonomy Extension Labels Linkbase Document †
101.PRE		*	XBRL Taxonomy Extension Presentation Linkbase Document †
		*	filed herewith
		‡	Management contract or compensatory plan or arrangement.
		†	Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

42

EX-10.1

Exhibit 10.1

Employment Agreement

This Employment Agreement is entered into between:

Westinghouse Solar, Inc.

1475 Bascom Ave., Suite 101

Campbell, CA  95008

(“the Company”)

and

Margaret Randazzo

1230 McKendrie St.

San Jose, CA 95126 (the “EXECUTIVE")

1  Date of employment

1.1  Effective May 7, 2012 (“Effective Date”), EXECUTIVE is employed as Interim Chief Executive Officer in the Company (“ICEO”).  This employment agreement (“Agreement”) replaces all previous agreements concerning the EXECUTIVE’s employment with the Company or with any of its affiliates and/or predecessors, in any capacity, except, for the avoidance of doubt, all Company proprietary rights agreements signed by EXECUTIVE shall remain in full force and effect.

2  The initial duties of the EXECUTIVE

2.1  For so long as EXECUTIVE holds the position of ICEO, EXECUTIVE is, in cooperation with the other members of the Executive Management, responsible for the daily management of the Company subject to instructions and guidelines of the Board of Directors (“Board’) of the Company.

2.2  The Board of Directors (“Board’) of the Company determines the directions applicable to the activities of the Company at any time.  It is the responsibility of the EXECUTIVE towards the Board that the activities of the Company are carried out in accordance with such directions, the Agreement and Plan of Merger (“Merger Agreement”) between the Company, CBD Energy Limited (“CBD”) and CBD-WS Merger Sub, Inc., the Company’s Certificate of Incorporation and Bylaws, and current legislation and law.

2.3  All questions of extraordinary character or major importance to the Company shall be submitted by the EXECUTIVE to the Board and the CBD Liaison (as defined in the Merger Agreement).

2.4  The EXECUTIVE is entitled to sign on behalf of the Company in matters concerning the day-to-day operations of the Company, subject to the restrictions in this Employment Agreement and otherwise in accordance with the Company’s Certificate of Incorporation and Bylaws, the Merger Agreement, and authorities delegated by the Board.

2.5  EXECUTIVE  shall hold the position of ICEO and perform the duties of such office from the Effective Date until the consummation of the Merger Agreement, or such later date as is determined by mutual agreement of EXECUTIVE and the senior executive officer (“Managing Director”) of CBD. However, if the Merger is not consummated and closed pursuant to the terms of the Merger Agreement by a date no later than December 31, 2012, the Board of Directors of the Company shall have the discretion to determine the terms and conditions of EXECUTIVE’s employment.

3  Follow-on duties of EXECUTIVE

3.1  Provided the Merger is consummated, as such term is defined in the Merger Agreement, and all of the transactions contemplated by the Merger Agreement are closed, then upon appointment by the Managing Director of CBD of a replacement Chief Executive Officer for the Company, EXECUTIVE shall be appointed to a senior executive position in the Company or within CBD or another of its subsidiaries as shall be assigned by the Managing Director of CBD and reasonably acceptable to EXECUTIVE (the “Successor Position”).  For the avoidance of doubt, all provisions of this Agreement that refer to actions or events in the Successor Position are contingent upon the consummation and closing of the Merger pursuant to the terms of the Merger Agreement. If EXECUTIVE is employed in a Successor Position with CBD or any subsidiary or affiliate of CBD other than the Company, such employer is referred to herein as the Successor Employer.  The Company and the Successor Employer are each sometimes referred to an “Employer” and collectively as “Employers”.   In the event of employment of EXECUTIVE in a Successor Position, this Employment Agreement shall continue to apply in connection with EXECUTIVE’s employment therein.

3.2  The duties of EXECUTIVE in the Successor Position shall be specified at and reasonably agreeable to EXECUTIVE at the time of the appointment.

3.3  Thereafter, at the discretion of the Managing Director of CBD, EXECUTIVE may be assigned to further Successor Positions, and this Agreement shall continue to apply in connection with EXECUTIVE’s employment therein.

4  Additional duties during the employment

4.1  The EXECUTIVE is obliged to use the EXECUTIVE’s full working capacity and best efforts in the service of Employer. In performing her duties under this Agreement, EXECUTIVE must comply with all applicable laws and Company policies, avoid conflicts of interest and in making decisions on behalf of the Company, must do that which is in the best interests of the Company. The ICEO position is exempt from state and federal wage and hour laws applicable to non-exempt employees.  There is no limit to the number of working hours, and the EXECUTIVE is not entitled to overtime pay, standby allowance, or paid time off in lieu of overtime.

4.2  The EXECUTIVE must not, without the prior written consent of the Board or, following appointment to a Successor Position, the Managing Director of CBD, engage in any other employment or engagement, whether remunerated or not, that is inconsistent with EXECUTIVE’S duties and obligations under this Agreeement..

4.3  During the employment, the EXECUTIVE must not have any interests in any other business activity, directly or indirectly, that are inconsistent with EXECUTIVE’S duties and obligations under this Agreeement, without the prior written consent of the Board or, following appointment to a Successor Position, the Managing Director of CBD.   However, the EXECUTIVE is entitled to make, and need not disclose to Employer, normal capital investments in assets, which are usually the subject of such investment, and which do not include personal working efforts of any kind and/or decisive influence.

4.4  EXECUTIVE may have opportunities from time to time to fulfill directorships and honorary offices and may do so subject to the consent of Employer, which consent shall not be unreasonably withheld.

4.5  For purposes of Section 4.2 and 4.3 herof, determination of whether EXECUTIVE’s employment, engagement or interests in a business activity are inconsistent with EXECUTIVE’s duties and obligations under this Agreement shall be at the sole discretion of the Board or, following appointment to a Successor Position, the Managing Director of CBD.

5  Place of work

5.1  The EXECUTIVE’s normal place of work will be the address of the Company, which address may change from time to time but shall be reasonably proximate to the Northern California Bay Area (“Home Region”).  However, the EXECUTIVE may be required to work from time to time at the premises of customers, business partners, CBD and its subsidiaries etc. The employment also involves travelling in the United States and abroad.

6  Remuneration

6.1  The EXECUTIVE’s annual gross salary is $225,000 (“Base Salary”).  While EXECUTIVE is serving as ICEO, she shall be paid incrementally in arrears in accordance with the Company’s standard payroll practices for exempt executive employees.  Following consummation of the Merger (as defined below), EXECUTIVE’s annual gross salary shall be adjusted to a level consistent with similar positions of responsibility and authority as determined from time to time by the Compensation Committee of CBD and confirmed in writing as a modification to this  Employment Agreement, signed by EXECUTIVE and by an authorized agent of CBD, provided however, that such annual gross salary shall not be less than the Base Salary during the term of this Agreement.  In the event of EXECUTIVE’s appointment to a Successor Position, EXECUTIVE shall be paid in a manner consistent with the standard payroll practices for exempt executive employees of the Successor Employer, provided that payment shall be no less than 1/12 of the annual salary, paid monthly in arrears and paid no later than the last business day of each month by live check or, if the EXECUTIVE so directs, by direct deposit to an account designated by the EXECUTIVE.

6.2  In addition to the compensation referenced in paragraph 6.1, the EXECUTIVE shall be eligible for bonus compensation to be set at the sole discretion of the Company’s compensation committee for the period when EXECUTIVE is serving as ICEO.  Thereafter, if EXECUTIVE is serving in a Successor Position, such bonus compensation shall be set at the sole discretion of the Managing Director of CBD.  In each instance, the target bonus amounts and performance criteria shall be set and communicated in writing to EXECUTIVE within 30 days following the appointment of EXECUTIVE and thereafter at the beginning of the fiscal year.  The Board has determined that in lieu of other annual bonus amounts established for EXECUTIVE, a target bonus amount for the services of EXECUTIVE in the position of ICEO through the end of such term, or the year ending December 31, 2012 if later, is up to $100,000, of which 50% shall be payable in stock of the Company or Successor Employer issued at the VWAP (Volume Weighted Average Price) for the 10 trading days preceding the consummation of the transaction and 50% of which shall be payable in cash in the last payroll distribution of December 2012.  The actual amount of the 2012 ICEO bonus compensation shall be based on meeting the specific objectives set forth on Schedule A; such objectives shall be mutually agreed upon by the parties and Schedule A completed within 30 days of the execution of this Agreement.

6.3  Annual bonus targets for Successor Positions shall be not less than 45% of the EXECUTIVE’S Base Salary.

7  Entertainment and travel expenses

7.1  The EXECUTIVE’s costs in connection with travel and entertainment in the interest of Employer will be refunded by the Employer subject to receipts in accordance with the guidelines and policies in force from time to time in the Company or Successor Employer.

8  Vacations and Public Holidays

8.1  The EXECUTIVE shall receive paid vacation and paid holidays, to accrue and be taken in accordance with the standard policies and practices of the Company or the Successor Employer.  The EXECUTIVE is entitled to four (4) weeks’ (twenty (20) business days’) vacation with pay per calendar year.  The EXECUTIVE is entitled to payout of any unused accrued paid vacation balance at the time of termination of employment under this Employment Agreement.

8.2  While serving as ICEO, EXECUTIVE shall coordinate the scheduling of paid vacation with the Board and the CBD Liaison.  In any Successor Position, vacation scheduling should be coordinated with the Managing Director of CBD or his delegatee.

8.3  The EXECUTIVE is entitled paid Company holidays in accordance with the policies of the Company or Successor Employer, as applicable.  The EXECUTIVE will not be entitled to additional compensation for holidays upon termination of employment.

9  Health Insurance; Life Insurance; Other Benefits

9.1  While serving as ICEO, the EXECUTIVE shall be entitled to participate in Company-sponsored health insurance plan(s) in accordance with the Company’s standard policies and procedures, which are subject to change in the Company’s sole discretion.

9.2  While serving as ICEO, EXECUTIVE shall be entitled to participate in Company-sponsored life insurance plan(s) in accordance with the Company’s standard policies and procedures, which are subject to change in the Company’s sole discretion.  The EXECUTIVE agrees fully to cooperate with the Company in connection with any application for life insurance that the Company may wish to pursue in order to obtain life insurance relating to the EXECUTIVE, including, but not limited to, submission to a medical examination as reasonably may be required by the prospective insurer(s).

9.3  While serving as ICEO, the EXECUTIVE shall be entitled to receive other Company-sponsored benefits as other full-time Company employees may receive, as may be announced by the Company from time to time, in its sole discretion, and on terms that are subject to change in the Company’s sole discretion.

9.4  While serving in a Successor Position, EXECUTIVE will be entitled to the benefits set forth in Sections 9.1, 9.2 and 9.3 hereof in accordance with the standard practices and policies of the Successor Employer; provided however, that such benefits are no less than provided by the Company while EXECUTIVE served as ICEO.

9.5  The Company acknowledges that EXECUTIVE has been and shall continue as a participant in the Westinghouse Solar, Inc. 2006 Stock Incentive Plan and prior awards under the Westinghouse Solar, Inc. 2006 Stock Incentive Plan shall not be affected by this Agreement.  On the Effective Date of the Merger, EXECUTIVE shall receive a restricted stock grant of CBD Stock having a market value on the date of consummation of the Merger of $150,000, which grant shall vest 1/3 at the end of calendar years 2012, 2013 and 2014 if Executive remains employed by CBD or an affiliate of CBD.   This stock award shall be subject to the terms and conditions of any stock equity compensation plan adopted by CBD or subject to the terms and conditions placed on the stock award by CBD’s board of directors or granting body.

9.6  EXECUTIVE shall be eligible to receive stock, option and other incentive awards for CBD executive management as may be granted by the CBD Compensation Committee, at its discretion, from time to time.  These awards, if granted, shall be subject to the terms and conditions set by the CBD Compensation Committee and the applicable incentive plans.

9.7  EXECUTIVE shall be entitled to participate in any Company sponsored 401(k) Plan, subject to the terms and conditions of the applicable Plan.

10  Illness/Disability

10.1  Subject to applicable law, Employer may terminate this Employment Agreement due to undue hardship to the Employer, subject to one month’s written notice effective from the end of a month, if, due to illness or disability, the EXECUTIVE has been unable to perform the obligations as ICEO during a consecutive period of two months or in total three months within a period of 12 months.  In such event, the EXECUTIVE shall receive, as severance compensation, the salary provided for in this Agreement through a date that is 24 months after the Effective Date of this Agreement, provided that on or before the 30th day following the termination of employment, the EXECUTIVE has signed a Severance Agreement and Release substantially in the form attached hereto as Schedule D, or in a form as otherwise reasonably may be presented by the Company or Successor Employer and it has become effective.

10.2  While serving as ICEO, the EXECUTIVE will receive paid sick leave in accordance with the Company’s standard practices and procedures.  Thereafter, while serving in a Successor Position, EXECUTIVE will receive paid sick leave in accordance with the standard practices and policies of the Successor Employer, provided that such benefits shall be no less than those of the Company while EXECUTIVE was serving as ICEO.  Paid sick leave does not accrue as a vested right, and any accrued but unused balance will not be paid out upon termination of the employment.

11  Confidentiality, duty of loyalty, protection of trade secrets and other information, and return of materials

11.1  The EXECUTIVE has a duty of confidentiality with respect to everything that the EXECUTIVE may learn in connection with the performance of the EXECUTIVE’s duties, including, but not limited to, the confidential and proprietary trade secret information, financial information, business information, customer lists, customer information, inventions, and intellectual property of Employer. The duty of confidentiality shall apply and continue to apply after termination of the employment.

11.2  During the period of employment – including during any notice period – the EXECUTIVE is obliged to observe a duty of loyalty towards the Company and any Successor Employer.

11.3  Failure to observe the EXECUTIVE’s duty of confidentiality and loyalty may have consequences for the EXECUTIVE’s employment, including discipline up to and including termination without notice, for cause.

11.4  Upon the actual termination of the employment – irrespective of cause – the EXECUTIVE must return to Employer all materials and assets in the EXECUTIVE’s possession which relate to the employer’s activities. No lien may be exercised on any materials belonging to any Employer.

11.5  The EXECUTIVE may not, during the period of employment, access, use, exploit, and/or disclose the Employer’s confidential and proprietary trade secret information, financial information, business information, employee lists, customer lists, customer information, inventions, and/or intellectual property, for any reason other than in furtherance of the Employer’s interests. The EXECUTIVE may not, after the period of employment, access, use, exploit, and/or disclose the Employer’s confidential and proprietary trade secret information, financial information, business information, employee lists, customer lists, customer information, inventions, and/or intellectual property, for any reason. The purpose of this provision is to protect, to the maximum extent provided by law, the Employer’s rights and interests in its proprietary and confidential trade secret information. Any breach of the provisions of this clause 11.5 is cause for the Employer’s termination of this Employment Agreement without notice, and also may be subject to injunction as may be available subject to clause 19. In the event of a breach of this Section 11.5, Employer may from apply other statutory or common law relief, including injunction as may be available subject to clause 19.

12  Non-competition clause

12.1  During the employment, the EXECUTIVE is not entitled to commence any activities or, directly or indirectly, be engaged in any activities (as owner, director, employee, agent, consultant or the like) which, directly or indirectly, compete with the activities of the Employer or any group-affiliated companies.

12.2  No separate compensation is paid for undertaking this non-competition clause.

12.3  The non-competition clause will apply globally.

12.4  Any breach of the non-competition clause is cause for the Employer’s termination of this Employment Agreement without notice, and also may be subject to injunction as may be available subject to clause 19. Payment by the EXECUTIVE of damages will not cause the non-competition clause to terminate and will not exclude the Employer from applying other statutory or common law relief, including injunction as may be available subject to clause 19.

13  Non-solicitation (non-poaching) clause

13.1  During the employment and for a period of 12 months after termination of the employment calculated from the last day the EXECUTIVE receives salary, the EXECUTIVE is not entitled, directly or indirectly, to

• Solicit any Colleague to breach any terms of any employment agreement the Colleague may have with the Employer
• Solicit any Colleague to become employed with or affiliated to a company, in which the EXECUTIVE, directly or indirectly, through employment, ownership, directorship or in any other way can exercise any influence on that company’s employment of employees, including as adviser, or
• in any other way solicit a Colleague to resign from the employment in the Employer.

13.2  A “Colleague” is understood to be an employee or manager employed by the Employer or any affiliate thereof.

13.3  Any breach of the non-solicitation (non-poaching) clause may be subject to injunction as may be available subject to clause 19. Payment by the EXECUTIVE of damages will not cause the non-solicitation (non-poaching) clause to terminate and will not exclude the Company from applying other statutory and/or common law relief, including injunction as may be available subject to clause 19.

14  Intellectual property rights

14.1  Without paying separate remuneration, the Employer has the exclusive right to ownership and/or exploitation of any and all intellectual property rights in inventions, productions, production methods, know how, designs, patterns, patents, trademarks or other marks, proprietary rights and other intellectual property rights or assets which the EXECUTIVE may, during his/her employment, develop or contribute to the development of, and the title and any other ownership and/or exploitation right belongs to the Employer without separate remuneration.

14.2  The EXECUTIVE should immediately inform the Employer if the rights referred to in clause 14.1 are or may be expected to be developed completely or partially by the EXECUTIVE.

14.3  The EXECUTIVE is obliged to sign declarations and permits and carry out all other actions required for the purpose of transfer, assignment, registration or procurement of any such intellectual property rights in the name of the Employer.

14.4  In connection with his/her employment with the Employer, the EXECUTIVE agrees to execute a PROPRIETARY INFORMATION, WORKS-FOR-HIRE, AND OTHER INVENTIONS AGREEMENT (“Inventions Agreement”), a form of which is attached hereto as Schedule C.  The Inventions Agreement shall, to the fullest extent possible, be read in harmony with this Employment Agreement and any Inventions Agreement previously signed by EXECUTIVE in connection with her employment with the Company or any of its predecessors, and if there is any conflict between or among the Agreements referenced in this clause 14.4, the last signed Inventions Agreement will control as to the terms and conditions contained therein

15  Information security

15.1  The EXECUTIVE is obliged in every respect to observe the general and specific directions on information security, including directions concerning use of e-mail and the internet which at any time may appear from the Employer’s directions on information security, employee handbook or personal instructions. Failure to observe these directions may have consequences for the EXECUTIVE’s employment, including, but not limited to, discipline up to and including termination of this Employment Agreement without notice, for cause.

15.2  EXECUTIVE hereby acknowledges that she has no right or expectation of privacy in her use of any and all Employer software, hardware, communications systems (including, but not limited to, telephone, email, or internet) or any other Employer property, and that the EXECUTIVE’s use of any such software, hardware, communications systems, or any other Employer property may be subject to unannounced and undisclosed monitoring, review, and/or supervision, at any time.

16  Termination

16.1  The EXECUTIVE’s employment is at will and may be terminated by either the EXECUTIVE or the Employer, without notice or cause.  In the event of termination by the Employer without cause (as “cause” is set forth in this Employment Agreement), or in the event that the Successor Position is not reasonably acceptable to EXECUTIVE following a 14-day period commencing the day after EXECUTIVE notifies the Employer, in writing, that the Successor Position is not reasonably acceptable, to allow (a) good faith efforts by EXECUTIVE and Employer to negotiate the terms and conditions of any Successor Position, which negotiated terms and conditions EXECUTIVE shall not unreasonably refuse, and/or (b) Employer’s opportunity, at Employer’s option, to modify the existing Employment to meet EXECUTIVE’s reasonable requirements, then the EXECUTIVE shall receive, all wages and accrued but unpaid vacation and bonus compensation (set forth in 6.2 and 9.5) through the date of termination (Final Wages”) on the termination date, provided that to the extent any bonus compensation that is earned as of the date of termination is payable at a later date consistent with Employer’s customary compensation policies and practices, then such bonus compensation will be paid at the later date as provided by such customary compensation policies and practices.  In addition, as severance compensation, EXECUTIVE shall receive a continuance of the Base Salary (not bonus compensation) provided for in this Agreement, payable according to the Employer’s  regular payroll schedule, policies, and practices, through a date that is 24 months after the Effective Date of this Agreement, provided that on or before the 30th day following the date of EXECUTIVE’S termination of employment, the EXECUTIVE has signed a Severance Agreement and Release substantially in the form attached hereto as Schedule D, or in a form as otherwise reasonably may be presented by the Employer, and it has become effective.  If a Successor Position is that of CEO, COO, CFO or similar senior executive position for the Company or another division of CBD and EXECUTIVE can perform such role without the necessity of relocating from the Home Region, it shall be deemed reasonably acceptable for purposes of this Section 16.1.

16.2  In the event of termination of the EXECUTIVE’s employment for cause (as “cause” is set forth in this Agreement) or in the event of the EXECUTIVE’s voluntary resignation from employment from the Employer, no severance compensation shall be payable to the EXECUTIVE.

16.3  In the event of Serious Misconduct by the EXECUTIVE as defined in Schedule B and determined by the Employer in its sole discretion to have occurred, the EXECUTIVE may be summarily terminated, for cause, and without warning or advance notice.

16.4  If the Employer or the EXECUTIVE commits a material breach of the obligations of this Employment Agreement, the other party is entitled to terminate the Agreement without notice.  If the Employer terminates the EXECUTIVE’s employment under this Agreement pursuant to this paragraph 16.4, such termination shall constitute termination for cause.

17  Miscellaneous

17.1  The EXECUTIVE shall inform the Employer of the EXECUTIVE’s current private address.

17.2  Rules, Policies and Procedures:  Subject to giving the EXECUTIVE prior notice, the Employer shall be entitled to introduce, vary or cancel company rules, policies and procedures at its discretion. All such rules, policies and procedures shall bind the EXECUTIVE who shall fully observe and comply with the same at all times during the employment.

17.3  Legal Advice: The EXECUTIVE acknowledges that she was given a reasonable opportunity to seek independent legal advice before entering into this Agreement.

17.4  Notices: Any notice to be given under this Agreement to the EXECUTIVE may be served by being handed to her personally or by being sent by courier to her at her usual or last known address; and any notice to be given to the Employer may be served by being left at or by being sent by courier to its office address noted herein.

17.5  Entire Agreement: This Employment Agreement constitutes the entire agreement and understanding between the Parties and supersedes any prior arrangements, understandings or agreements (whether oral or written) between them relating to the subject-matter of this Employment Agreement.

17.6  No Waiver: No failure or delay by either party in exercising any right or remedy provided by law under or pursuant to this Employment Agreement shall impair such right or remedy or operate or be construed as a waiver or variation of it or preclude its exercise at any subsequent time and no single or partial exercise of any such right or remedy shall preclude any other or further exercise of it or the exercise of any other right or remedy.

17.7  Modification: No modification of this Employment Agreement shall be valid unless it is in writing and signed by or on behalf of each of the Parties or as otherwise provided in this Employment Agreement.  ”Modification” shall include any amendment, variation, supplement, deletion, termination or replacement however effected.

17.8  Counterparts:  This Employment Agreement may be executed in any number of counterparts (including facsimile copies) all of which, when taken together, shall constitute one and the same instrument. A party may enter into this Employment Agreement by executing any counterpart.

17.9  Survival: If one or more of the provisions of this Employment Agreement is deemed to be invalid or unenforceable, the remaining provisions of this Employment Agreement will not be affected and will continue in full force and effect.

17.10  Collective Agreements: There are no collective agreements that directly affect the terms and conditions of the employment of the EXECUTIVE under this Employment Agreement.

18  Choice of law and venue

This Employment Agreement is governed by, and to be interpreted under, the laws of the State of California, and that, subject to any procedural rules as may apply pursuant to clause 19 hereof, any dispute arising in relation to the Employment Agreement should be settled at the venue (city, county, state and country) of the Company.

19  Mandatory Arbitration

19.1  The Parties agree that they shall submit any and all employment-related disputes between them, including, but not limited to, disputes relating to the interpretation of this Agreement, to binding arbitration, on the following terms:

(a) Arbitration.  In consideration of the EXECUTIVE’s employment with the Employer, the Employer’s mutual promise hereby to arbitrate all employment-related disputes, and the EXECUTIVE’s receipt of the compensation and other benefits paid to the EXECUTIVE by the Employer, at present and in the future, the EXECUTIVE agrees that any and all controversies, claims, or disputes with anyone (including the Employer and any employee, officer, director, shareholder or benefit plan of the Employer in their capacity as such or otherwise) arising out of, relating to, or resulting from employment with the Employer or the termination of employment with the Employer, including any breach of this agreement, shall be subject to binding arbitration under the arbitration rules set forth in the California Code Of Civil Procedure section 1280 through 1294.2, including sections 1281.8 and 1283.05 (the “Rules”) and pursuant to California law.  Disputes which the Parties mutually agree to arbitrate, and thereby agree to waive any right to a trial by jury, include any statutory claims under state or federal law, including, but not limited to, claims under Title VII of the Civil Rights Act of 1964, the Americans With Disabilities Act of 1990, the Age Discrimination In Employment Act of 1967, the Older Workers Benefit Protection Act, the California Fair Employment And Housing Act, the California Labor Code, claims of harassment, discrimination or wrongful termination, any statutory claims, and any claims under the Proprietary Information, Works-for-Hire, and Other Inventions Agreement in the form attached hereto as Schedule C., which the EXECUTIVE herein agrees to execute as a condition of his/her employment. The EXECUTIVE further understands that this agreement to arbitrate also applies to any disputes that the Employer may have with the EXECUTIVE, including under any of the foregoing authorities and agreement.

(b) Procedure.  The Parties agree that any arbitration will be administered by the American Arbitration Association (“AAA”) and that the neutral arbitrator will be selected in a manner consistent with its national rules for the resolution of employment disputes.  A true and correct copy of the AAA’s Employment Arbitration Rules is attached hereto as Schedule E.  A current version of the Rules may be accessed at http://www.adr.org/sp.asp?id=32904.  The Parties agree that the arbitrator shall have the power to issue any ruling that a court could issue, including, without limitation, deciding any motions brought by any party to the arbitration (including motions for summary judgment and/or adjudication and motions to dismiss and demurrers) prior to any arbitration hearing.  The Parties also agree that the arbitrator shall have the power to award any remedies, including attorneys’ fees and costs, that a court could award, as are available under applicable law.  The Parties agree that the Employer will pay for any administrative or hearing fees charged by the arbitrator or AAA, except that the EXECUTIVE shall pay the first $200.00 (two hundred United States Dollars) of any filing fees associated with any arbitration that the EXECUTIVE initiates.  The Parties agree that the arbitrator shall administer and conduct any arbitration in a manner consistent with the Rules and that to the extent that the AAA’s national rules for the resolution of employment disputes conflict with the Rules, the Rules shall take precedence.  The Parties agree that the decision of the arbitrator shall be in writing.

(c) Remedy.  Except as provided by the Rules and this Agreement, arbitration shall be the sole, exclusive and final remedy for any dispute between the Parties. Accordingly, except as provided for by the Rules and this Agreement, neither of the Parties will be permitted to pursue court action regarding claims that are subject to arbitration.  Notwithstanding, the arbitrator will not have the authority to disregard or refuse to enforce any lawful company policy, and the arbitrator shall not order or require the company to adopt a policy not otherwise required by law that the company has not adopted.

(d) Administrative Relief. The EXECUTIVE understands that this agreement does not prohibit him/her from pursuing an administrative claim with a local, state or federal administrative body such as the Department of Fair Employment and Housing, the Equal Employment Opportunity Commission or the Workers’ Compensation Board.  This agreement does, however, preclude the EXECUTIVE from pursuing court action regarding any such claim (except as may be provided by the Rules).

(e) Voluntary Nature of Agreement.  The EXECUTIVE acknowledges and agrees that she is executing this agreement voluntarily and without any duress or undue influence by the Company or anyone else.  The EXECUTIVE further acknowledges and agrees that she has carefully read this Agreement and that she has asked any questions needed for her to understand the terms, consequences and binding effect of this agreement and fully understand it, including that the EXECUTIVE is waiving her right to a jury trial.  Finally, the EXECUTIVE agrees that she has been provided an opportunity to seek the advice of an attorney of her choice before signing this Agreement, and that the EXECUTIVE has had the opportunity to ask questions regarding and negotiate the contents of this Mandatory Arbitration provision, including negotiating, on an arms-length basis, the issue of inclusion of this Mandatory Arbitration provision in this Employment Agreement.

This Employment Agreement is signed in three identical copies, of which each party receives one.

On behalf of the Company:

Date:  May 7, 2012

/s/ Ed Roffman

Ed Roffman

Title: Authorized Singatory

Executive:

Date:  May 7, 2012

/s/ Margaret Randazzo

Margaret Randazzo

Conditional and Limited Acknowledgement and Agreement

Conditioned upon (a) the full execution of this Agreement by Company and EXECUTIVE, and (b) the consummation of the Merger (as such term is defined in the Merger Agreement referenced in this Employment Agreement) and closing of all transactions contemplated in the Merger Agreement, CBD Energy Limited (“CBD”) acknowledges and agrees to the provisions set forth in Clauses 9.5 and 9.6, above.  If the Merger is not consummated and closed (pursuant to the terms of the Merger Agreement) and/or the Merger Agreement is terminated for any reason, this Conditional and Limited Acknowledgement and Agreement shall be invalid, void, and of no force or effect.

CBD’s execution hereof does not constitute an offer or guarantee of employment, nor an agreement to employ, EXECUTIVE, nor does it extend to EXECUTIVE any rights or benefits as against CBD other than those that are set forth in Clauses 9.5 and 9.6, above.

On behalf of CBD:

Date: May ___ ,2012

_______________________________

Name:

Title:

SCHEDULE A – 2012 ICEO PERFORMANCE OBJECTIVES

[To be completed]

SCHEDULE B – SERIOUS MISCONDUCT

The EXECUTIVE recognizes the special nature of the services to be provided.  Due to the growing nature of the business, and the need for harmony, co-operation, and co-ordination in the Company, the EXECUTIVE accepts that certain types of misconduct may be treated more seriously than in other types of contracts.  At all times during the course of the Employment Agreement, EXECUTIVE acknowledges that s/he is representing the Company.  Without limitation, and subject to applicable law, the following may be considered Serious Misconduct, and may result in the employment being terminated without warning or advance notice:

(a)           publicly criticizing or bringing into disrepute the Company or any of its affiliates;

(b)           aggressive, bullying, or harassing behaviour;

(c)           criminal behaviour;

(d)           civil disorder;

(e)           theft, or unauthorized possession or removal of the Company’s property;

(f)           accepting or failing to report any bribes or attempts to bribe;

(g) violation of the Company’s policies applicable to employees and those provisions of the Code of Conduct and Ethics adopted by Company that are specifically applicable to the Company’s officers and directors ;

(h)           breach of this Agreement;

(i)           wilfully failing to obey a reasonable direction of the Company without providing to the Company reasonable grounds for failure to obey; or

 (j)           knowing use of drugs or alcohol in a manner prohibited by the Company.

The determination of whether Serious Misconduct has occurred shall be made by the Company in its sole discretion and shall be binding on the EXECUTIVE.

END OF SCHEDULE B

SCHEDULE C – FORM OF PROPRIETARY INFORMATION,

WORKS-FOR-HIRE, AND OTHER INVENTIONS AGREEMENT

PROPRIETARY INFORMATION, WORKS-FOR-HIRE,

AND OTHER INVENTIONS AGREEMENT

In consideration and as a condition of my employment, continued employment, or consulting relationship by Westinghouse Solar, Inc., its subsidiaries, successors or assigns (the “Company”), and the compensation paid therefor, I hereby agree as follows:

1.           

1.           Nondisclosure.

1.1      Recognition of Company's Rights; Nondisclosure.  At all times during my engagement and thereafter, I will hold in strictest confidence and will not disclose, use, lecture upon or publish any of the Company's Proprietary Information (defined below), except as such disclosure, use or publication may be required in connection with my work for the Company, or unless an officer of the Company expressly authorizes such in writing.  I will obtain Company's written approval before publishing or submitting for publication any material (written, oral, or otherwise) that relates to my work at Company and/or incorporates any Proprietary Information.  I hereby assign to the Company any rights I may have or acquire in such Proprietary Information and recognize that all Proprietary Information shall be the sole property of the Company and its assigns.

1.2           Proprietary Information.  The term "Proprietary Information" shall mean any and all confidential and/or proprietary works of authorship, knowledge, data, designs or information of the Company.  By way of illustration but not limitation, "Proprietary Information" includes (a) patents, trademarks, trade secrets, inventions, copyrights, mask works, processes, formulas, source and object codes, data, programs, other works of authorship, know-how, improvements, discoveries, developments, designs, artwork, techniques, and any other intellectual property that is protectable under United States or foreign laws (hereinafter collectively referred to as "Inventions"); (b) research, development, new products, marketing and selling, business plans, budgets and unpublished financial statements, licenses, prices and costs, suppliers and customers; and (c) information regarding the skills and compensation of employees and others working with the Company.  Notwithstanding the foregoing, it is understood that, at all such times, I am free to use information which is generally known in the trade or industry, which is not gained as result of a breach of this Agreement, and my own, skill, knowledge, know-how and experience to whatever extent and in whichever way I wish.

1.3           Third Party Information.  I understand, in addition, that the Company has received and in the future will receive from third parties confidential or proprietary information ("Third Party Information"), including, but not limited to, works of authorship, subject to a duty on the Company's part to maintain the confidentiality of such information and to use it only for certain limited purposes.  During the term of my engagement and thereafter, I will hold Third Party Information in the strictest confidence and will not disclose to anyone (other than Company personnel who need to know such information in connection with their work for the Company) or use, except in connection with my work for the Company, Third Party Information unless expressly authorized by an officer of the Company in writing.

1.4           No Improper Use of Information of Prior Employers and Others.  During my engagement by the Company I will not improperly use or disclose any confidential or proprietary information or trade secrets, if any, of any former employer or any other person to whom I have an obligation of confidentiality, and I will not bring onto the premises of the Company any unpublished documents or any property belonging to any former employer or any other person to whom I have an obligation of confidentiality unless consented to in writing by that former employer or person.  I will use in the performance of my duties only information which is generally known and used by persons with training and experience comparable to my own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company.

2.      Assignment of Works for Hire and Other Inventions.

2.1           Proprietary Rights.  The term "Proprietary Rights" shall mean all copyright, trade secret, patent, mask work and other intellectual property rights throughout the world.

2.2           Prior Inventions.  Inventions, if any, patented or unpatented, which I made prior to the commencement of my engagement with the Company are excluded from the scope of this Agreement.  To preclude any possible uncertainty, I have set forth on Exhibit B (Previous Inventions) attached hereto a complete list of all Inventions that I have, alone or jointly with others, conceived, developed or reduced to practice or caused to be conceived, developed or reduced to practice prior to the commencement of my engagement with the Company, that I consider to be my property or the property of third parties and that I wish to have excluded from the scope of this Agreement (collectively referred to as "Prior Inventions").  If disclosure of any such Prior Invention would cause me to violate any prior confidentiality agreement, I understand that I am not to list such Prior Inventions in Exhibit B but am only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such inventions has not been made for that reason. A space is provided on Exhibit B for such purpose.  If no such disclosure is attached, I represent that there are no Prior Inventions.  If, in the course of my engagement with the Company, I incorporate a Prior Invention into a Company product, process or machine, the Company is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license (with rights to sublicense through multiple tiers of sublicensees) to make, have made, modify, use and sell such Prior Invention.  Notwithstanding the foregoing, I agree that I will not incorporate, or permit to be incorporated, Prior Inventions in any Company Inventions without the Company's prior written consent.

2.3           Assignment of Inventions.  Subject to Sections 2.4, and 2.6, I hereby assign and agree to assign in the future (when any such Inventions or Proprietary Rights are first reduced to practice or first fixed in a tangible medium, as applicable) to the Company all my right, title and interest in and to any and all Inventions (and all Proprietary Rights with respect thereto) whether or not patentable or registrable under copyright or similar statutes, made or conceived or reduced to practice or learned by me, either alone or jointly with others, during the period of my engagement with the Company.  Inventions assigned to the Company, or to a third party as directed by the Company pursuant to this Section 2, are hereinafter referred to as "Company Inventions."

2.4           Nonassignable Inventions.  This Agreement does not apply to an Invention which qualifies fully as a nonassignable Invention under Section 2870 of the California Labor Code (hereinafter “Section 2870”).  I have reviewed the notification on Exhibit A (Limited Exclusion Notification) and agree that my signature acknowledges receipt of the notification.

2.5           Obligation to Keep Company Informed.  During the period of my engagement and for six (6) months after termination of my engagement with the Company, I will promptly disclose to the Company fully and in writing all Inventions authored, conceived or reduced to practice by me, either alone or jointly with others.  In addition, I will promptly disclose to the Company all patent applications filed by me or on my behalf within a year after termination of engagement.  At the time of each such disclosure, I will advise the Company in writing of any Inventions that I believe fully qualify for protection under Section 2870; and I will at that time provide to the Company in writing all evidence necessary to substantiate that belief.  The Company will keep in confidence and will not use for any purpose or disclose to third parties without my consent any confidential information disclosed in writing to the Company pursuant to this Agreement relating to Inventions that qualify fully for protection under the provisions of Section 2870.  I will preserve the confidentiality of any Invention that does not fully qualify for protection under Section 2870.

2.6           Government or Third Party.  I also agree to assign all my right, title and interest in and to any particular Company Invention to a third party, including without limitation the United States, as directed by the Company.

2.7           Works for Hire.  I acknowledge that all original works of authorship which are made by me (solely or jointly with others) within the scope of my engagement and which are protectable by copyright are "works made for hire," pursuant to United States Copyright Act (17 U.S.C., Section 101).

2.8           Enforcement of Proprietary Rights.  I will assist the Company in every proper way to obtain, and from time to time enforce, United States and foreign Proprietary Rights relating to Company Inventions in any and all countries.  To that end I will execute, verify and deliver such documents and perform such other acts (including appearances as a witness) as the Company may reasonably request for use in applying for, obtaining, perfecting, evidencing, sustaining and enforcing such Proprietary Rights and the assignment thereof.  In addition, I will execute, verify and deliver assignments of such Proprietary Rights to the Company or its designee.  My obligation to assist the Company with respect to Proprietary Rights relating to such Company Inventions in any and all countries shall continue beyond the termination of my engagement, but the Company shall compensate me at a reasonable rate after my termination for the time actually spent by me at the Company's request on such assistance.

In the event the Company is unable for any reason, after reasonable effort, to secure my signature on any document needed in connection with the actions specified in the preceding paragraph, I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in fact, which appointment is coupled with an interest, to act for and in my behalf to execute, verify and file any such documents and to do all other lawfully permitted acts to further the purposes of the preceding paragraph with the same legal force and effect as if executed by me.  I hereby waive and quitclaim to the Company any and all claims, of any nature whatsoever, which I now or may hereafter have for infringement of any Proprietary Rights assigned hereunder to the Company.

3.      Records.  I agree to keep and maintain adequate and current records (in the form of notes, sketches, drawings and in any other form that may be required by the Company) of all Proprietary Information developed by me and all Inventions made by me during the period of my engagement at the Company, which records shall be available to and remain the sole property of the Company at all times.

4.      Additional Activities.  I agree that for the period of my engagement by the Company and for one (l) year after the date of termination of my engagement by the Company I will not solicit any employee of the Company or any of its affiliates or, to the extent it is protected by trade secret or other applicable law, the business of any client or customer of the Company (other than on behalf of the Company).

5.      No Conflicting Obligation.  I represent that my performance of all the terms of this Agreement and as an independent contractor of the Company does not and will not breach any agreement to keep in confidence information acquired by me in confidence or in trust prior to my engagement by the Company.  I have not entered into, and I agree I will not enter into, any agreement either written or oral in conflict herewith.

6.      Return of Company Documents.  When I leave the engagement with the Company, I will deliver to the Company any and all drawings, notes, memoranda, specifications, devices, formulas, and documents, together with all copies thereof, and any other material containing or disclosing any Company Inventions, Third Party Information or Proprietary Information of the Company.  I further agree that any property situated on the Company's premises and owned by the Company, including disks and other storage media, filing cabinets or other work areas, is subject to inspection by Company personnel at any time with or without notice.  Prior to leaving, I will cooperate with the Company in completing and signing the Company's termination statement.

7.      Legal and Equitable Remedies.  Subject to Section 10.7 hereof, because my services are personal and unique and because I may have access to and become acquainted with the Proprietary Information of the Company, the Company shall have the right to enforce this Agreement and any of its provisions by injunction, specific performance or other provisional relief pursuant to California Code of Civil Procedure Section 1281.8, without prejudice to any other rights and remedies that the Company may have for a breach of this Agreement.

8.      Notices.  Any notices required or permitted hereunder shall be given to the appropriate party at the address specified below or at such other address as the party shall specify in writing.  Such notice shall be deemed given upon personal delivery to the appropriate address or if sent by certified or registered mail, three (3) days after the date of mailing.

9.      Notification of New Employer.  In the event that I leave the engagement of the Company, I hereby consent to the notification of any new contractor or employer by the Company of my rights and obligations under this Agreement.

10.      General Provisions.

10.1           Governing Law.  This Agreement will be governed by and construed according to the laws of the State of California, as such laws are applied to agreements entered into and to be performed entirely within California between California residents.

10.2           Severability.  In case any one or more of the provisions contained in this Agreement shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein.  If moreover, any one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing it, so as to be enforceable to the extent compatible with the applicable law as it shall then appear.

10.3           Successors and Assigns.  This Agreement will be binding upon my heirs, executors, administrators and other legal representatives and will be for the benefit of the Company, its successors, and its assigns.

10.4           Survival.  The provisions of this Agreement shall survive the termination of my engagement and the assignment of this Agreement by the Company to any successor in interest or other assignee.

10.5           Engagement.  I agree and understand that nothing in this Agreement shall confer any right with respect to continuation of engagement by the Company, nor shall it interfere in any way the Company’s right to terminate my engagement.

10.6           Waiver.  No waiver by the Company of any breach of this Agreement shall be a waiver of any preceding or succeeding breach.  No waiver by the Company of any right under this Agreement shall be construed as a waiver of any other right.  The Company shall not be required to give notice to enforce strict adherence to all terms of this Agreement.

10.7.           Mandatory Arbitration.  The Company and I agree that all disputes between us, including all agreements made herein and in the Employment Agreement relating to my employment with the Company (to which a form of this Agreement is attached as Schedule C), shall be submitted to mandatory arbitration before the American Arbitration Association, as set forth in the Section 19 of the Employment Agreement (a form of which is attached hereto as Exhibit C).  I understand that by submitting all disputes to mandatory arbitration, the Company and I mutually are waiving our right to a jury trial or any other relief from court except for provisional relief as provided by California Code of Civil Procedure Section 1281.8.

10.8           Entire Agreement.  The obligations pursuant to Sections 1 and 2 of this Agreement shall apply to any time during which I was previously engaged, or am in the future engaged, by the Company as an employee or independent contractor if no other agreement governs nondisclosure and assignment of inventions during such period.  This Agreement is the final, complete and exclusive agreement of the parties with respect to the subject matter hereof and supersedes and merges all prior discussions between us.  No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in writing and signed by the party to be charged.  Any subsequent change or changes in my duties or compensation will not affect the validity or scope of this Agreement.

This Agreement shall be effective as of the first day of my engagement with the Company.

I have read this Agreement carefully and understand its terms.  I have completely filled out Exhibit B to this Agreement.

Dated:  May 7, 2012

/s/ Margaret Randazzo

MARGARET RANDAZZO

ACCEPTED AND AGREED TO:

Westinghouse Solar,  Inc.

By:  /s/ Ed Roffman

Name: Ed Roffman

Title:  Chair, Special Committee of Westinghouse Solar Board of Directors

Dated:   May 7, 2012

Exhibit A

LIMITED EXCLUSION NOTIFICATION

This is to notify you in accordance with Section 2872 of the California Labor Code that the foregoing Agreement between you and the Company does not require you to assign or offer to assign to the Company any invention that you developed entirely on your own time without using the Company's equipment, supplies, facilities or trade secret information except for those inventions that either:

1. Relate at the time of conception or reduction to practice of the invention to the Company's business, or actual or demonstrably anticipated research or development of the Company;

2. Result from any work performed by you for the Company.

To the extent a provision in the foregoing Agreement purports to require you to assign an invention otherwise excluded from the preceding paragraph, the provision is against the public policy of this state and is unenforceable.

This limited exclusion does not apply to any patent or invention covered by a contract between the Company and the United States or any of its agencies requiring full title to such patent or invention to be in the United States.

I acknowledge receipt of a copy of this notification.

By:  /s/ Margaret Randazzo

(Signature)

Margaret Randazzo

(Printed Name)

Date: May 7, 2012

Witnessed by:

/s/ Jessica Wyckoff

Jessica Wychoff

(Printed Name of Representative)

Exhibit B

TO:  Westinghouse Solar, Inc.

FROM:  Margaret Randazzo

DATE:  May 7, 2012

SUBJECT:  Previous Inventions

1.           Except as listed in Section 2 below, the following is a complete list of all inventions or improvements relevant to the subject matter of my engagement by Westinghouse Solar, Inc. (the "Company") that have been made or conceived or first reduced to practice by me alone or jointly with others prior to my engagement by the Company:

x  No inventions or improvements.

¨           See below:

¨           Additional sheets attached.

2.           Due to a prior confidentiality agreement, I cannot complete the disclosure under Section 1 above with respect to inventions or improvements generally listed below, the proprietary rights and duty of confidentiality with respect to which I owe to the following party(ies):

Invention or Improvement                                                                           Party(ies)                      Relationship

1. 

2. 

3. 

¨           Additional sheets attached.

Exhibit C

FORM OF EMPLOYMENT AGREEMENT

END OF SCHEDULE C

SCHEDULE D – FORM OF SEVERANCE AGREEMENT AND RELEASE

___________, 2012

BY [METHOD OF DELIVERY]

To Employee Age 40 or Over

[address]

Re:           Separation Agreement

Dear _______________________:

This letter sets forth the terms of the separation agreement (the “Agreement”) that _______________________ (the “Company”) is offering to you in connection with your employment transition.

1.           Separation Date.  Your last day of employment and your employment termination date is ____________________ (the “Separation Date”).  On the Separation Date, the Company will provide you with your final pay, which includes payment of base salary and anyaccrued and unused vacation time as of the Separation Date.  You are entitled to these payments by law.  

2.           Severance Compensation.

                      (a)  Payment of Severance Compensation.  Although the Company is not otherwise obligated to do so, if you timely sign, date, and return this fully signed Agreement to the Company no later than _________________ and allow it to become effective, and you comply with your obligations hereunder, the Company will pay you severance compensation in the form of a continuance of the base salary (not bonus compensation) provided for in the Employment Agreement entered into between you and the Company effective ____________, 2012, payable according to the Company’s regular payroll schedule, policies, and practices, through a date that is 24 months after the effective date of the Employment Agreement, subject to applicable deductions and withholdings (the “Severance Compensation”).  Payment of the Severance Compensation will be made in accordance with the Company’s regular payroll schedule, commencing ____ business days following the Effective Date of this Agreement (as defined in Section 13(d)).  The first installment of the Severance Compensation will include retroactive payment of any compensation that would have accrued after the termination date and would have been payable to you on the Company’s regular payroll schedule but for the termination of the employment.

                      (b)  Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”).  The payment of the Severance Compensation is intended to be interpreted and applied so that the payment either (i) shall be exempt from the requirements of Section 409A of the Code, as amended, and the regulations promulgated thereunder or (ii) shall comply with the requirements of such provision (including the exceptions for short-term deferrals, separation pay arrangements, reimbursements, and in-kind distributions.)  In addition, each payment shall be considered a separate payment for purposes of Section 409A

                      (b)  Short-term Deferral under Code Section 409A.  If the Severance Compensation payment does not qualify as a short-term deferral under Section 409A and Treasury Regulation ("Treas. Reg.") §1.409A-1(b)(4) or any similar or successor provisions, and you are a specified employee (as defined in Section 409A and Treas. Reg. 1.409A-1(c)(i) or any similar or successor provisions) as of the Separation Date, distributions to you may not be made before the date that is six (6) months and one (1) day after the Separation Date or, if earlier, the date of the your death (the "Six-Month Delay Rule"). Payments to which you would otherwise be entitled during the first six months following the Separation Date (the "Six-Month Delay") will be accumulated and paid on the first day of the seventh month following the Separation Date.

                      (c)  Lump Sum Payments during Six Month Delay under Code Section 409A.  Notwithstanding the Six-Month Delay Rule set forth above, to the maximum extent permitted under Code Section 409A and Treas. Reg. §1.409A-1(b)(9)(iii) or any similar or successor provisions, during the Six-Month Delay, the Company will pay to you in a lump sum an amount equal to the lesser of (i) the total termination benefits provided in Sections 2(a) above, or (ii) the lesser of (A) the maximum amount that may be taken into account under a qualified plan pursuant to Code Section 401(a)(17) for the year in which the Separation Date occurs, and (B) the sum of the your annual base salary based upon the annual rate of pay for services provided to the Company for the taxable year preceding the taxable year of the Separation Date; provided that amounts paid under this sentence will count toward, and will not be in addition to, the total payment of termination benefits required to be made to you by the Company under this Section 2.

3.           Health Insurance.  To the extent provided by the federal COBRA law or, if applicable, state insurance laws (collectively, “COBRA”), and by the Company’s current group health insurance policies, you will be eligible to continue your group health insurance benefits at your own expense after the Separation Date.  You will be provided with a separate notice describing your rights and obligations under COBRA laws on or after the Separation Date.

4.           Stock Options.  The Company and Employee have entered into _____<#> Stock Option Agreements, each granting Employee the option to purchase shares of the Company's common stock subject to the terms and conditions of the __________________________ [Stock Option / Stock Issuance Plan and the Stock Option Agreements (collectively the "Stock Agreements")].  The exercise of Employee's vested options and shares shall continue to be governed by the terms and conditions of the Company's Stock Agreements.

5.           Expense Reimbursements.  You agree that, within thirty (30) days of the Separation Date, you will submit your final documented expense reimbursement statement reflecting all business expenses you incurred through the Separation Date, if any, for which you seek reimbursement.  The Company will reimburse you for any final documented expenses pursuant to its regular business practice and reimbursement policy.

6.          No Other Compensation or Benefits.  You acknowledge that, except as expressly provided in this Agreement, you have not earned and will not receive from the Company any additional compensation, severance, or benefits on or after the Separation Date.  By way of example, except as otherwise referenced in this Agreement, you acknowledge and agree that you have not earned and are not owed any bonus, incentive compensation, commissions or equity.

7.          Return of Company Property.  You agree to return to the Company, no later than three (3) business days after the Separation Date, all Company documents (and all copies thereof) and other property of the Company in your possession or control, whether tangible or intangible, including, but not limited to, Company files, notes, correspondence, memoranda, notebooks, drawings, records, reports, lists, compilations of data, proposals, agreements, drafts, minutes, studies, plans, forecasts, purchase orders, financial and operational information, product and training information, research and development information, sales and marketing information, personnel and compensation information, vendor information, promotional literature and instructions, product specifications and manufacturing information, computer-recorded information, electronic information (including e-mail and correspondence), other tangible property and equipment (including, but not limited to, computer equipment, PDAs, facsimile machines, and cellular telephones), credit cards, entry cards, identification badges and keys; and any materials of any kind that contain or embody any proprietary or confidential information of the Company (and all reproductions thereof in whole or in part), as well as intangible property such as passwords, access codes, identification keys and/or any other information relating to the business of the Company in your possession, custody, knowledge and/or control.  You agree that you will make a diligent search to locate any such documents, property and information within the timeframe referenced above.  In addition, if you have used any personally owned computer, server, or e-mail system to receive, store, review, prepare or transmit any Company confidential or proprietary data, materials or information, then you agree to provide the Company, within five (5) business days after the Separation Date, with a computer-useable copy of all such information and then permanently delete and expunge such Company confidential or proprietary information from those systems without retaining any reproductions (in whole or in part); and you agree to provide the Company access to your system as requested to verify that the necessary copying and/or deletion is done.  Your timely compliance with this Section 7 is a precondition to your receipt of the Severance Compensation.

8.           Confidentiality.  The provisions of this Agreement will be held in strictest confidence by you and will not be publicized or disclosed in any manner whatsoever; provided, however, that:  (a) you may disclose this Agreement in confidence to your immediate family; (b) you may disclose this Agreement in confidence to your attorneys, accountants, auditors, tax preparers, and financial advisors; and (c) you may disclose this Agreement insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law.  In particular, and without limitation, you agree not to disclose the existence or terms of this Agreement to any current or former Company employee, contractor or consultant.

9.           Nondisparagement.  You agree not to disparage the Company, its products or services, business, technologies, market position, performance and other similar information concerning the Company, or the Company’s officers, directors, employees, shareholders and agents, in any manner likely to be harmful to them or their business, business reputations or personal reputations; provided that you may respond accurately and fully to any request for information to the extent required by legal process.

10.          Nonsolicitation of Employees.  You agree that, for one (1) year after the Separation Date, you will not solicit, urge, encourage, or attempt to solicit, urge or encourage, any employees or independent contractors of the Company to terminate or otherwise alter his or her employment or contractor relationship with the Company in order to obtain a new employment or contractor relationship with another entity or person.

11.           No Voluntary Adverse Action; and Cooperation.  To the extent allowed by law, you agree that you will not voluntarily (except in response to legal compulsion) assist any person in bringing or pursuing any proposed or pending litigation, arbitration, administrative claim or other formal proceeding against the Company, its parent or subsidiary entities, affiliates, officers, directors, employees or agents.  In addition, you agree to cooperate fully with the Company in connection with its actual or contemplated defense, prosecution, or investigation of any claims or demands by or against third parties, or other matters arising from events, acts, or failures to act that occurred during the period of your employment by the Company.  Such cooperation includes, without limitation, making yourself available to the Company upon reasonable notice, without subpoena, to provide complete, truthful and accurate information in witness interviews, depositions, and trial testimony.  The Company will reimburse you for reasonable out-of-pocket expenses you incur in connection with any such cooperation (excluding forgone wages, salary, or other compensation) and will make reasonable efforts to accommodate your scheduling needs.  In addition, you agree to execute all documents (if any) necessary to carry out the terms of this Agreement.

12. No Admissions.  Nothing contained in this Agreement shall be construed as an admission by you or the Company of any liability, obligation, wrongdoing or violation of law.

13.Release of Claims.

 (a)           General Release.  In exchange for the consideration provided to you under this Agreement to which you would not otherwise be entitled, including but not limited to the Severance Compensation, you hereby generally and completely release the Company and its current and former directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns (collectively, the “Released Parties”) of and from any and all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct, or omissions occurring prior to or on the date you sign this Agreement (collectively, the “Released Claims”).

 (b)           Scope of Release.  The Released Claims include, but are not limited to:  (i) all claims arising out of or in any way related to your employment with the Company, or the termination of that employment; (ii) except as expressly provided for and/or referenced in this Agreement, all claims related to your compensation or benefits from the Company, including salary, bonuses, commissions, vacation pay, expense reimbursements, severance pay, fringe benefits, stock, stock options, or any other ownership interests in the Company; (iii) all claims for breach of contract, wrongful termination, and breach of the implied covenant of good faith and fair dealing (including but not limited to any claims based on or arising from the Employment Agreement); (iv) all tort claims, including claims for fraud, defamation, emotional distress, and discharge in violation of public policy; and (v) all federal, state, and local statutory claims, including claims for discrimination, harassment, retaliation, attorneys’ fees, or other claims arising under the federal Civil Rights Act of 1964 (as amended), the federal Americans with Disabilities Act of 1990, the federal Age Discrimination in Employment Act of 1967 (as amended) (the “ADEA”), the Civil Rights Act of 1991, the California Labor Code (as amended), and the California Fair Employment and Housing Act (as amended).

 (c)           Excluded Claims. Notwithstanding the foregoing, the following are not included in the Released Claims (the “Excluded Claims”): (i) any rights or claims for indemnification you may have pursuant to any written indemnification agreement with the Company to which you are a party, the charter, bylaws, or operating agreements of the Company, or under applicable law; (ii) any rights that are not waivable as a matter of law; and (iii) any claims for breach of this Agreement.  In addition, nothing in this Agreement prevents you from filing, cooperating with, or participating in any proceeding before the Equal Employment Opportunity Commission, the Department of Labor, the California Department of Fair Employment and Housing, or any other government agency, except that you acknowledge and agree that you are hereby waiving your right to any monetary benefits in connection with any such claim, charge or proceeding.  You hereby represent and warrant that, other than the Excluded Claims, you are not aware of any claims you have or might have against any of the Released Parties that are not included in the Released Claims.

 (d)           ADEA Waiver.  You acknowledge that you are knowingly and voluntarily waiving and releasing any rights you may have under the ADEA, and that the consideration given for the waiver and release in this Section 13 is in addition to anything of value to which you are already entitled.  You further acknowledge that you have been advised, as required by the ADEA, that:  (i) your waiver and release do not apply to any rights or claims that may arise after the date that you sign this Agreement; (ii) you should consult with an attorney prior to signing this Agreement (although you may choose voluntarily not to do so); (iii) you have twenty-one (21) days in which to consider this Agreement (although you may choose voluntarily to sign it earlier); (iv) you have seven (7) days following the date you sign this Agreement to revoke the Agreement (by providing written notice of your revocation to the Company); and (v) this Agreement will not be effective until the date upon which the revocation period has expired, which will be the eighth day after the date that this Agreement is signed by you provided that you do not revoke it (the “Effective Date”).

 (e)           Section 1542 Waiver.  In giving the releases set forth in this Agreement, which include claims which may be unknown to you at present, you acknowledge that you have read and understand Section 1542 of the California Civil Code which reads as follows:  “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.”  You hereby expressly waive and relinquish all rights and benefits under that section and any law or legal principle of similar effect in any jurisdiction with respect to the releases granted herein, including but not limited to the release of unknown and unsuspected claims granted in this Agreement.

 (f)           Timing of Delivery of Release.  Subject to and without waiver of the execution and delivery timing requirements of paragraph 13(d), above,in order for the Release referred to herein to be effective under any circumstances, this Agreement must be executed by you and  delivered to the Company no later than the fiftieth (50th) day following the date your employment is terminated, and must not be revoked during the seven (7) days following such delivery (“Effective Release”).  If the Effective Release does not occur by the fifty-seventh (57th) day following the date your employment is terminated, your right to the Severance Compensation is forfeited.

14Representations.  You hereby represent that you have been paid all compensation owed and for all hours worked, have received all the leave and leave benefits and protections for which you are eligible pursuant to any applicable law or Company policy, and have not suffered any on-the-job injury for which you have not already filed a workers’ compensation claim.

 15.           Job Verification.  Any and all requests by third parties for job verifications or references regarding your employment at the Company should be directed exclusively to the Company’s Human Resources personnel.  In response to any such requests, the Company’s response will be limited to confirming the starting and ending dates that you worked for the Company, and the last job title held by you.  No other information or reference will be provided.

 16.           Dispute Resolution.  To aid in the rapid and economical resolution of any disputes that may arise under this Agreement, you and the Company agree that any and all claims, disputes or controversies of any nature whatsoever arising from or regarding the interpretation, performance, negotiation, execution, enforcement or breach of this Agreement, your employment, or the termination of your employment, shall be resolved by confidential, final and binding arbitration conducted before a single arbitrator with JAMS, Inc. (“JAMS”) in San Francisco, California, in accordance with JAMS’ then-applicable arbitration rules.  The parties acknowledge that by agreeing to this arbitration procedure, they waive the right to resolve any such dispute through a trial by jury, judge or administrative proceeding.  You will have the right to be represented by legal counsel at any arbitration proceeding.  The arbitrator shall:  (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be available under applicable law in a court proceeding; and (b) issue a written statement signed by the arbitrator regarding the disposition of each claim and the relief, if any, awarded as to each claim, the reasons for the award, and the arbitrator’s essential findings and conclusions on which the award is based.  The Company shall bear JAMS’ arbitration fees and administrative costs.  Consistent with the provisions of California Code of Civil Procedure Section 1281.8, nothing in this Agreement shall prevent either you or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration.  Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction.  This Section 15 shall supersede and replace any Agreement to Arbitrate Employment Disputes previously entered into between you and the Company.

 17.           Miscellaneous.  This Agreement constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to its subject matter.  It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations.  This Agreement may not be modified or amended except in a written agreement signed by both you and a duly authorized officer of the Company.  This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, and their heirs, successors and assigns.  If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question shall be deemed modified so as to be rendered enforceable in a manner consistent with the intent of the parties, insofar as possible under applicable law.  Any ambiguity in this Agreement shall not be construed against either party as the drafter.  Any waiver of a breach of this Agreement, or rights hereunder, shall be in writing and shall not be deemed to be a waiver of any successive breach or rights hereunder.  This Agreement shall be deemed to have been entered into, and shall be construed and enforced, in accordance with the laws of the State of California without regard to conflicts of law principles.  This Agreement may be executed in counterparts, each of which shall be deemed to be part of one original, and facsimile signatures shall be equivalent to original signatures.  You have the option to review this Agreement with legal counsel of your choice, at your expense.

REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

If this Agreement is acceptable to you, no later than twenty-one (21) days after your receipt of this Agreement, please sign below and return the signed Agreement to the Company.  If you do not sign and return this Agreement to the Company within the aforementioned timeframe, the Company’s offer to enter into this Agreement will expire.

Sincerely,

[COMPANY]

By:                                                                

      Name

      Title

Understood and Agreed:

[NAME]

Date: ______________________

END OF SCHEDULE D

SCHEDULE E – EMPLOYMENT ARBITRATION RULES

OF THE AMERICAN ARBITRATION ASSOCIATION

EX-31

Exhibit 31

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND FINANCIAL OFFICER UNDER SECTION 302 OF THE

SARBANES-OXLEY ACT

I, Margaret R. Randazzo, certify that:

1.   I have reviewed this Quarterly Report on Form 10-Q of Westinghouse Solar, Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.   I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;
b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.   I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:  August 14, 2012	/s/ Margaret R. Randazzo
	Margaret R. Randazzo
	Chief Executive Officer and Chief Financial Officer

EX-32

Exhibit 32

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Westinghouse Solar, Inc. (the “Company”) for the period ended June 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Margaret R. Randazzo, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:  August 14, 2012

/s/ Margaret R. Randazzo

Margaret R. Randazzo

Chief Executive Officer and Chief Financial Officer

XML

Note 3 - Discontinued Operations (Detail) - Assets and Liabilities Of Discontinued Operations (USD $)	Jun. 30, 2012	Dec. 31, 2011
Accounts receivable and other receivables	$ 7,383	$ 41,762
Prepaid expenses and other current assets		34,415
Other assets	9,913	11,278
Total current assets of discontinued operations	17,296	87,455
Security deposits on operating leases		9,913
Security deposit – escrow account for installation jobs	200,000	200,000
Total assets of discontinued operations	217,296	297,368
Accrued liabilities	36,682	124,751
Accrued warranty	1,081,317	1,133,549
Deferred revenue		50,520
Total current liabilities	1,117,999	1,308,820
Other long-term liabilities		10,200
Total discontinued operations liabilities	$ 1,117,999	$ 1,319,020

XML

Note 12 - Stock Warrants and Warrant Liability (Detail) - Warrant Activity (USD $)	6 Months Ended
	Jun. 30, 2012
Outstanding at January 1, 2012	4,106,016
Outstanding at January 1, 2012 (in Dollars per Item)	3.57
Exercised	(472,222)
Exercised (in Dollars per share)	$ 0.60
Outstanding at June 30, 2012	3,633,794
Outstanding at June 30, 2012 (in Dollars per Item)	3.89

XML

Note 10 - Convertible Redeemable Preferred Stock and Preferred Deemed Dividend (Detail) (USD $)	1 Months Ended	6 Months Ended		15 Months Ended			1 Months Ended						0 Months Ended	1 Months Ended		15 Months Ended
	Feb. 28, 2011	Jun. 30, 2012	Jun. 30, 2011	May 10, 2012	Dec. 31, 2011	Feb. 17, 2011	Mar. 30, 2012 Series K Warrants [Member]	Feb. 28, 2011 Series K Warrants [Member]	Dec. 31, 2011 Series K Warrants [Member]	Sep. 28, 2011 Series K Warrants [Member]	Aug. 16, 2011 Series K Warrants [Member]	Feb. 17, 2011 Series K Warrants [Member]	Feb. 08, 2011 Equity Unit [Member]	Feb. 28, 2011 Equity Unit [Member]	Feb. 17, 2011 Equity Unit [Member]	May 10, 2012 Series B Preferred Stock [Member] First Year [Member]	May 10, 2012 Series B Preferred Stock [Member] Second Year and Thereafter [Member]	Dec. 30, 2012 Series B Preferred Stock [Member]	Dec. 31, 2011 Series B Preferred Stock [Member]	Aug. 23, 2011 Series B Preferred Stock [Member]	Feb. 17, 2011 Series B Preferred Stock [Member]
Number of Equity Units Sold During Period	4,000
Equity Units Sold During Period, Price Per Unit (in Dollars per share)	$ 900
Number of Share of Preferred Stock Included in an Equity Unit Sold															1
Convertible Preferred Stock, Shares Issued upon Conversion															500
Convertible Preferred Stock, Conversion Price (in Dollars per share)															$ 1.80			$ 0.60	$ 0.60
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)															425
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)		3.89			3.57		0.40		0.60	0.80	1.01	2.40			2.40
Period from which Warrants Become Exercisable								6 months					6 months
Term of Warrants								5 years 6 months						5 years
Proceeds from Issuance or Sale of Equity (in Dollars)	$ 3,600,000
Payments of Stock Issuance Costs (in Dollars)	532,000	58,180	521,609
Number of Preferred Shares Converted				1,727
Stock Issued During Period, Shares, Conversion of Convertible Securities				891,601
Preferred Stock, Dividend Rate, Percentage																4.00%	8.00%
Preferred Stock, Value, Issued (in Dollars)		751,223			751,223																1,000,000
Warrants and Rights Outstanding (in Dollars)						2,600,000	481,000
Fair Value Assumptions, Risk Free Interest Rate							0.50%	1.40%
Fair Value Assumptions, Expected Term							3 years	4 years 36 days
Fair Value Assumptions, Expected Volatility Rate							109.30%	103.20%
Redeemable Preferred Stock Dividends (in Dollars)	$ 975,000		$ 975,460
Conversion Price Floor of Preferred Stock (in Dollars per share)																				$ 0.10

XML

Note 13 - Earnings Per Share (Detail) - Computation of Basic and Diluted Net Loss Per Share (USD $)	1 Months Ended	3 Months Ended		6 Months Ended
	Feb. 28, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Net loss		$ (2,196,814)	$ (1,327,762)	$ (5,047,902)	$ (2,641,251)
Net loss allocated to participating securities		56,260	24,695	115,380	41,312
Net loss attributable to stockholders		(2,140,554)	(1,303,067)	(4,932,522)	(2,599,939)
Preferred stock dividend		(21,028)		(42,287)
Preferred deemed dividend	(975,000)				(975,460)
		(2,161,582)	(1,303,067)	(4,974,809)	(3,575,399)
		$ (2,161,582)	$ (1,303,067)	$ (4,974,809)	$ (3,575,399)
Weighted-average shares outstanding (in Shares)		18,944,321	11,603,691	17,707,296	11,555,616
Weighted-average unvested restricted shares outstanding (in Shares)		(485,162)	(215,817)	(404,735)	(180,744)
Denominator for basic calculation (in Shares)		18,459,159	11,387,874	17,302,561	11,374,872
Weighted-average effect of dilutive stock options (in Shares)		0	0	0	0
Denominator for diluted net loss per share (in Shares)		18,459,159	11,387,784	11,302,561	11,374,872
Diluted net loss per share attributable to common stockholders (in Dollars per share)		$ (0.12)	$ (0.11)	$ (0.29)	$ (0.31)
Basic net loss per share attributable to common stockholders (in Dollars per share)		$ (0.12)	$ (0.11)	$ (0.29)	$ (0.31)

XML

Note 8 - Credit Facility (Detail) (USD $)	Jun. 30, 2012	Dec. 31, 2011	Feb. 15, 2011
Line of Credit Facility, Maximum Borrowing Capacity			$ 750,000
Percentage of Gross Eligible Account Receivables			50.00%
Gross Eligible Accounts Receivables			1,500,000
Debt Instrument, Basis Spread on Variable Rate			3.00%
Line of Credit Facility, Amount Outstanding	$ 94,000	$ 92,000

XML

Note 14 - Concentration of Risk (Tables)

6 Months Ended

Jun. 30, 2012

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
Lennar Corporation		—			21.2	%		12.6	%		14.6	%
Lennox International Inc.		26.0	%		25.2	%		39.2	%		32.3	%
Lowe’s Companies, Inc.		13.7	%		1.8	%		8.0	%		1.6	%

XML

Note 14 - Concentration of Risk (Detail) (USD $)	1 Months Ended		6 Months Ended						6 Months Ended
	Mar. 31, 2012	Jul. 31, 2011	Jun. 30, 2012	Dec. 31, 2011	Jun. 30, 2012 Lennox International Inc. [Member] Accounts Receivable [Member]	Dec. 31, 2011 Lennox International Inc. [Member] Accounts Receivable [Member]	Jun. 30, 2012 Lowe's Companies, Inc. [Member] Accounts Receivable [Member]	Dec. 31, 2011 Lowe's Companies, Inc. [Member] Accounts Receivable [Member]	Jun. 30, 2012 Supplier Concentration Risk [Member]	Jun. 30, 2011 Supplier Concentration Risk [Member]	Dec. 31, 2011 Supplier Concentration Risk [Member]
Cash, Uninsured Amount (in Dollars)				$ 1,100,000
Cash, FDIC Insured Amount (in Dollars)				250,000
Concentration Risk, Percentage					23.50%	23.10%	10.50%	13.90%
Concentration Risk, Percentage									46.20%	58.00%
Accounts Payable (in Dollars)									1,100,000		3,300,000
Stock Issued During Period, Shares, Purchase of Assets (in Shares)	1,900,000	361,111
Stock Issued During Period, Value, Purchase of Assets (in Dollars)	$ 1,045,000	$ 520,000	$ 1,132,871

XML

Note 2 - Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Product Warranty Liability [Table Text Block]

	June 30, 2012 (Unaudited)			December 31, 2011
Beginning accrued warranty balance (January 1)	$	217,812		$	51,860
Reduction for labor payments and claims made under the warranty		(1,388	)		—
Accruals related to warranties issued during the period		77,612			165,952
Ending accrued warranty balance	$	294,036		$	217,812

XML

Note 11 - Stock Option Plan and Stock Incentive Plan (Detail) - Summary of Restricted Stock Activity (USD $)	12 Months Ended	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2012 Restricted Stock [Member]
Outstanding and not vested beginning balance at January 1, 2012		289,795
Outstanding and not vested beginning balance at January 1, 2012 (in Dollars per share)		$ 1.92
Granted		551,839
Granted (in Dollars per share)		$ 0.48
Forfeited/cancelled		(84,150)
Forfeited/cancelled (in Dollars per share)		$ 2.22
Released/vested	331,019	(408,511)
Released/vested (in Dollars per share)		$ 0.75
Outstanding and not vested at June 30, 2012		348,973
Outstanding and not vested at June 30, 2012 (in Dollars per share)		$ 0.95

XML

Note 5 - Inventory (Detail) (USD $)	Jun. 30, 2012	Dec. 31, 2011
Inventory, Net	$ 2,319,705	$ 4,172,809
Restricted Stock Grant for a Supply Agreement [Member]
Other Inventory, Capitalized Costs, Gross	17,000	75,000
Rent, Depreciation and Salary Costs [Member]
Other Inventory, Capitalized Costs, Gross	$ 42,000	$ 12,000

XML

Note 2 - Significant Accounting Policies (Detail) - Liability for Manufacturing Warranty (USD $)	6 Months Ended	12 Months Ended
	Jun. 30, 2012	Dec. 31, 2011
Beginning accrued warranty balance (January 1)	$ 217,812	$ 51,860
Reduction for labor payments and claims made under the warranty	(1,388)	0
Accruals related to warranties issued during the period	77,612	165,952
Ending accrued warranty balance	$ 294,036	$ 217,812

XML

Note 11 - Stock Option Plan and Stock Incentive Plan (Detail) - Stock Options Valuation Assumptions	3 Months Ended	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2012	Jun. 30, 2011
Weighted-average volatility	105.50%	105.50%	103.10%
Expected dividends	0.00%	0.00%	0.00%
Expected life (years)	2 years 219 days	2 years 219 days	3 years
Weighted-average risk-free interest rate	0.40%	0.40%	1.20%

XML

Note 15 - Fair Value Measurement (Detail) - Changes in Level 3 Liabilities Measured at Fair Value on Recurring Basis (USD $)	6 Months Ended
	Jun. 30, 2012
Beginning balance – January 1, 2012	$ 397,378
Total realized and unrealized gains or losses	426,862
Repayments	(44,928)
Net transfers in and/or (out) of level 3	(734,007)
Ending balance – June 30, 2012	45,305
Accrued and Other Long-term Liabilities [Member]
Beginning balance – January 1, 2012	79,888	[1]
Total realized and unrealized gains or losses	222	[1]
Repayments	(44,928)	[1]
Ending balance – June 30, 2012	35,182	[1]
Common Stock Warrant Liability [Member]
Beginning balance – January 1, 2012	317,490
Total realized and unrealized gains or losses	426,640
Net transfers in and/or (out) of level 3	(734,007)
Ending balance – June 30, 2012	$ 10,123

[1] Represents the estimated fair value of the office closures included in accrued and other long-term liabilities.

XML

Note 9 - Stockholders' Equity (Detail) (USD $)	1 Months Ended						6 Months Ended		12 Months Ended	1 Months Ended			1 Months Ended			1 Months Ended										9 Months Ended
	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Aug. 31, 2011	Jul. 31, 2011	Feb. 28, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Aug. 31, 2011 Series L Warrants [Member]	Sep. 28, 2011 Series L Warrants [Member]	Aug. 16, 2011 Series L Warrants [Member]	Oct. 31, 2010 Series J Warrants [Member]	Aug. 16, 2011 Series J Warrants [Member]	Oct. 07, 2010 Series J Warrants [Member]	Sep. 30, 2011 Series M Warrants [Member]	Feb. 28, 2011 Series K Warrants [Member]	Mar. 30, 2012 Series K Warrants [Member]	Dec. 31, 2011 Series K Warrants [Member]	Sep. 28, 2011 Series K Warrants [Member]	Aug. 16, 2011 Series K Warrants [Member]	Feb. 17, 2011 Series K Warrants [Member]	Dec. 30, 2012 Series B Preferred Stock [Member]	Jun. 30, 2012 Series B Preferred Stock [Member]	Dec. 31, 2011 Series B Preferred Stock [Member]	Sep. 30, 2011 September 28, 2011 [Member]
Number of Equity Units Sold During Period						4,000
Equity Units Sold During Period, Price Per Unit (in Dollars per share)						$ 900
Stock Issued During Period, Value, Purchase of Assets (in Dollars)	$ 1,045,000				$ 520,000		$ 1,132,871
Stock Issued During Period, Shares, Purchase of Assets (in Shares)	1,900,000				361,111
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					1 year
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period									331,019
Stock Issued During Period, Value, New Issues (in Dollars)			500,000	990,099
Price Per Share of Common Stock Issued (in Dollars per share)		$ 0.60	$ 0.80	$ 1.01
Number of Warrants Issued During Period (in Shares)										643,564			400,001			325,000	1,700,002
Percentage of Number of Shares of Common Stock Initially Issued										65.00%						65.00%
Warrants Issued, Weighted Average Exercise Price (in Dollars per share)										$ 1.17			$ 2.44			$ 0.81	$ 2.40
Proceeds from Issuance of Common Stock and Warrants (in Dollars)										1,000,000																500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)		3.57					3.89		3.89		0.81	1.17		1.17	2.44			0.40	0.60	0.80	1.01	2.40
Period from which Warrants Become Exercisable										6 months						6 months	6 months
Term of Warrants										5 years 6 months						5 years 6 months	5 years 6 months
Stock Issued During Period, Shares, New Issues (in Shares)		1,666,667
Proceeds from Issuance of Common Stock (in Dollars)		$ 1,000,000						$ 3,600,000
Convertible Preferred Stock, Conversion Price (in Dollars per share)																							$ 0.60		$ 0.60
Preferred Stock, Shares Outstanding		2,273					2,273		2,273															2,273
Number of Shares of Common Stock Issued Upon Conversion of Preferred Stock																								3,409,029
Share Price (in Dollars per share)	$ 0.55

XML

Note 3 - Discontinued Operations

6 Months Ended

Jun. 30, 2012

Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]

3. Discontinued Operations

On September 10, 2010, we announced that we were exiting the solar panel installation business and we were expanding our distribution business to include sales of our Westinghouse Solar Power Systems directly to dealers in California. The exit from the installation business was essentially completed by the end of 2010. During the six months ended June 30, 2012, we recorded a gain from discontinued operations of approximately $23,000 compared to a gain from discontinued operations of approximately $4,000 during the six months ended June 30, 2011. The assets and liabilities of discontinued operations are presented separately under the captions “Assets of discontinued operations,” “Liabilities of discontinued operations” and “Long-term liabilities of discontinued operations,” respectively, in the accompanying condensed consolidated balance sheets at June 30, 2012 and December 31, 2011, and consist of the following:

Assets of discontinued operations:	June 30, 2012 (unaudited)		December 31, 2011
Accounts receivable and other receivables	$	7,383	$	41,762
Prepaid expenses and other current assets		—		34,415
Other assets		9,913		11,278
Total current assets of discontinued operations		17,296		87,455
Security deposits on operating leases		—		9,913
Security deposit – escrow account for installation jobs		200,000		200,000
Total assets of discontinued operations	$	217,296	$	297,368

Liabilities of discontinued operations:	June 30, 2012 (unaudited)		December 31, 2011
Accrued liabilities	$	36,682	$	124,751
Accrued warranty		1,081,317		1,133,549
Deferred revenue		—		50,520
Total current liabilities		1,117,999		1,308,820
Other long-term liabilities		—		10,200
Total discontinued operations liabilities	$	1,117,999	$	1,319,020

We entered into a Supply and Warranty Agreement and Master Assignment Agreement with Real Goods Solar, Inc. (Real Goods), pursuant to which Real Goods has agreed to perform certain warranty work. The terms of the agreement provide that an escrow account be established as a source of funds from which to satisfy our obligation to pay Real Goods for its fees and reimburse it for its expenses for this warranty work. In March 2011, we entered into an Escrow Agreement with Real Goods and deposited $200,000 into an escrow account. The amount is reflected in long-term assets of discontinued operations in the balance sheet. The escrow deposit will be released to us in the amount of $40,000, or one-fifth of the remaining escrow funds, per year after each of the fifth through the ninth anniversary of the escrow agreement.

In connection with the announcement of our exit from the solar panel installation business, we reclassified certain assets as “Assets held for sale,” in the accompanying condensed consolidated balance sheets at June 30, 2012 and December 31, 2011, which consists of inventory of solar inverters of approximately $16,000 and $18,000, respectively.

XML

Note 16 - Income Taxes (Detail)	Jun. 30, 2012
Valuation Allowance as Percentage of Deferred Tax Asset	100.00%

XML

Note 6 - Property and Equipment, Net (Detail) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Depreciation	$ 40,000	$ 44,000	$ 80,416	$ 108,691

XML

Note 7 - Accrued Liabilities (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Accrued Liabilities [Table Text Block]

	June 30, 2012 (Unaudited)		December 31,  2011
Accrued salaries, wages, benefits and bonus	$	63,494	$	92,692
Accrued accounting and legal fees		167,973		138,233
Allowance for returns		—		20,081
Customer deposit payable		44,345		13,819
Accrued tariff		66,751		—
Royalty payable		292,500		125,000
Accrued interest		36,337
Other accrued liabilities		53,791		38,988
	$	725,191	$	428,813

XML

Note 6 - Property and Equipment, Net (Tables)

6 Months Ended

Jun. 30, 2012

Property, Plant and Equipment [Table Text Block]

	June 30, 2012 (Unaudited)			December 31,  2011
Office equipment	$	573,852		$	573,852
Leasehold improvements		148,759			148,759
Vehicles		17,992			17,992
		740,603			740,603
Less: Accumulated depreciation and amortization		(624,301	)		(543,885	)
	$	116,302		$	196,718

XML

Note 13 - Earnings Per Share (Detail) - Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share	6 Months Ended
	Jun. 30, 2012	Dec. 31, 2011
Stock Options [Member]
Antidilutive Securities	704,869	1,077,744
Restricted Stock [Member]
Antidilutive Securities	348,973	289,795
Warrant [Member]
Antidilutive Securities	3,633,794	4,106,016
Preferred Stock - Convertible [Member]
Antidilutive Securities	3,409,029	3,409,029

XML

Note 6 - Property and Equipment, Net (Detail) - Property and Equipment, Net (USD $)	Jun. 30, 2012	Dec. 31, 2011
Property and equipment, gross	$ 740,603	$ 740,603
Less: Accumulated depreciation and amortization	(624,301)	(543,885)
	116,302	196,718
Office Equipment [Member]
Property and equipment, gross	573,852	573,852
Leasehold Improvements [Member]
Property and equipment, gross	148,759	148,759
Vehicles [Member]
Property and equipment, gross	$ 17,992	$ 17,992

XML

Note 11 - Stock Option Plan and Stock Incentive Plan (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]

	Number of Restricted Shares			Weighted-Average Grant Date Fair Value
Outstanding and not vested beginning balance at January 1, 2012		289,795		$	1.92
Granted		551,839		$	0.48
Forfeited/cancelled		(84,150	)	$	2.22
Released/vested		(408,511	)	$	0.75
Outstanding and not vested at June 30, 2012		348,973		$	0.95

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	Number of Shares Subject to Option			Weighted- Average Exercise Price
Outstanding at January 1, 2012		1,077,744		$	5.47
Granted		25,000		$	0.40
Forfeited/cancelled/expired		(397,875	)	$	7.82
Exercised		—		$	—
Outstanding at June 30, 2012		704,869		$	3.97
Exercisable at June 30, 2012		412,122		$	5.01

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	Three Months Ended June 30,					Six Months Ended June 30,
	2012			2011		2012			2011
Weighted-average volatility		105.5			—		105.5			103.1	%
Expected dividends		0.0	%		—		0.0	%		0.0	%
Expected life (years)	2.6				—	2.6			3.0
Weighted-average risk-free interest rate		0.4	%		—		0.4	%		1.2	%

XML

Note 12 - Stock Warrants and Warrant Liability (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

	Warrants for Number of Shares			Weighted-Average Exercise Price
Outstanding at January 1, 2012		4,106,016		$	3.57
Issued		—		$	—
Exercised		(472,222	)	$	0.60
Cancelled/expired		—		$	—
Outstanding at June 30, 2012		3,633,794		$	3.89

XML

Note 2 - Significant Accounting Policies

6 Months Ended

Jun. 30, 2012

Significant Accounting Policies [Text Block]

2. Significant Accounting Policies

Liquidity and Financial Position

For the six months ending June 30, 2012, and for each of the two years in the period ending December 31, 2011, we have incurred net losses and negative cash flows from operations. In addition, we expect to incur a net loss from operations for our year ending December 31, 2012. During recent years, we have undertaken several equity financing transactions to provide the capital needed to sustain and to grow our business. Based on current cash projections for 2012, which contemplate a smaller operating loss, we intend to address ongoing working capital needs through cost reduction measures recently implemented and utilization of existing inventory, along with utilizing our available credit facility and raising additional equity. In the event that revenue is lower, further staffing reductions and expense cuts could occur.

As of June 30, 2012, we had approximately $193,000 in cash on hand and $656,000 available under our credit facility. As an additional source of capital, outstanding warrants provide the possibility to receive additional proceeds upon exercise, depending on market conditions (See “Stock Warrants and Warrant Liability”). During the three months ending March 31, 2012, warrants to purchase 472,222 shares of common stock with an exercise price of $0.60 per share were exercised, resulting in approximately $283,000 in proceeds. We are seeking potential investors to obtain additional funding, and we have engaged an investment banker to facilitate these efforts.

The accompanying consolidated financial statements have been prepared assuming we will continue as a going concern. Our significant operating losses and negative cash flow from operations raise substantial doubt about our ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty and contemplate the realization of assets and the settlement of liabilities and commitments in the normal course of business. We believe our current cash balance, projected financial results and the amounts that should be available through debt and equity financing provide sufficient resources and operating flexibility through at least the next 12 months, however, there can be no assurance that we will be able to raise additional funds on commercially reasonable terms, if at all.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Revenue Recognition

Revenue from sales of products is recognized when: (1) persuasive evidence of an arrangement exists, (2) delivery has occurred or services have been rendered, (3) the sale price is fixed or determinable, and (4) collection of the related receivable is reasonably assured. We recognize revenue when the solar power systems are shipped to the customer.

Cash and Cash Equivalents

We consider all highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. We maintain cash and cash equivalents which consist principally of demand deposits with high credit quality financial institutions. At certain times, such amounts exceed FDIC insurance limits. We have not experienced any losses on these investments.

Accounts Receivable

Accounts receivable consist of trade receivables. We regularly evaluate the collectability of our accounts receivable. An allowance for doubtful accounts is maintained for estimated credit losses, and such losses have historically been minimal and within our expectations. We consider a number of factors when estimating credit losses, including the aging of a customer’s account, creditworthiness of specific customers, historical trends and other information.

Discontinued operations

Discontinued operations are presented and accounted for in accordance with Accounting Standards Codification (ASC) 360, “Impairment or Disposal of Long-Lived Assets,”(ASC 360). When a qualifying component of the Company is disposed of or has been classified as held for sale, the operating results of that component are removed from continuing operations for all periods presented and displayed as discontinued operations if: (a) elimination of the component’s operations and cash flows from the Company’s ongoing operations has occurred (or will occur) and (b) significant continuing involvement by the Company in the component’s operations does not exist after the disposal transaction.

On September 10, 2010, we announced that we were exiting the solar panel installation business. The exit from the installation business was essentially completed by the end of 2010, other than potential warranty payments related to past installations. (See “Manufacturer and Installation Warranties”). The exit from the installation business was therefore classified as discontinued operations for all periods presented under the requirements of ASC 360.

Manufacturer and Installation Warranties

The manufacturer directly warrants the solar panels and inverters for a range from 15 to 25 years. We warrant the balance of system components of our products against defects in material and workmanship for five years. We assist our customers in the event of a claim under the manufacturer warranty to replace a defective solar panel or inverter. The warranty liability for the material and the workmanship of the balance of system components of approximately $294,000 at June 30, 2012 and $218,000 at December 31, 2011, is included within “Accrued warranty” in the accompanying condensed consolidated balance sheets.

The liability for our manufacturing warranty consists of the following:

	June 30, 2012 (Unaudited)			December 31, 2011
Beginning accrued warranty balance (January 1)	$	217,812		$	51,860
Reduction for labor payments and claims made under the warranty		(1,388	)		—
Accruals related to warranties issued during the period		77,612			165,952
Ending accrued warranty balance	$	294,036		$	217,812

We previously recorded a provision for warranty liability related to our discontinued installation operations. We provided for a 5-year or a 10-year warranty on the installation of a system and all equipment and incidental supplies other than solar panels and inverters that are covered under the manufacturer warranty. The liability for the installation warranty of approximately $1.1 million at June 30, 2012 and December 31, 2011 is included within “Liabilities of Discontinued Operations” in the accompanying condensed consolidated balance sheets. Defective solar panels or inverters are covered under the manufacturer warranty. In the event that a panel or inverter needs to be replaced, we will replace the defective item within the manufacturer’s warranty period (between 5-25 years).

Patent Costs

We capitalize external legal costs and filing fees associated with obtaining or defending our patents. Upon issuance of new patents or successful defense of existing patents, we amortize these costs using the straight line method over the shorter of the legal life of the patent or its economic life. We believe the remaining useful life we assign to these patents, approximately 12.5 years as of June 30, 2012, are reasonable. As a result of the settlement of various legal disputes with Zep Solar, Inc., (Zep) (see “Commitments and Contingencies”) during the quarter ended June 30, 2012, we reclassified approximately $1.3 million in legal costs from other long-term assets to patents, both included in "other assets, net" in the accompanying balance sheets, which is being amortized over 12.5 years. We periodically review our patents to determine whether any such cost have been impaired and are no longer being used. To the extent we are no longer using certain patents, the associated costs will be written off at that time.

Common Stock Warrant Liabilities

In March 2009 and February 2011, we issued warrants to purchase shares of our common stock in connection with certain capital financing transactions. The terms of the March 2009 warrant agreements include a cash-out provision which may be triggered at the option of the warrant holders if the Company “goes private,” is acquired for all cash or upon the occurrence of certain other fundamental transactions involving the Company. Under the Financial Accounting Standards Board (“FASB”) Topic 480, Distinguishing Liabilities from Equity (“ASC 480”), financial instruments that may require the issuer to settle the obligation by transferring assets or to reduce the exercise price of its warrants to purchase shares of its common stock are classified as a liability. Therefore, we classified these warrants as liabilities and we record mark-to-market adjustments to reflect the fair value at each period-end. On March 30, 2012, the February 2011 warrants were amended to remove any future price adjustment to the exercise price. (See Note 12. “Stock Warrants” relating to the accounting treatment of the Series E and K warrants).

Significant Accounting Policies and Estimates

There have been no material developments or changes to the significant accounting policies discussed in our 2011 Annual Report on Form 10-K or accounting pronouncements issued or adopted, except as described below.

Recently Adopted Accounting Standards

In June 2011, the FASB issued ASU No. 2011-05, Comprehensive Income (Topic 220): Presentation of Comprehensive Income (ASU No. 2011-05). ASU No. 2011-05 requires that all non-owner changes in stockholders’ equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements, eliminating the option to present other comprehensive income in the statement of changes in equity. Under either choice, items that are reclassified from other comprehensive income to net income are required to be presented on the face of the financial statements where the components of net income and the components of other comprehensive income are presented. We adopted ASU No. 2011-05 on January 1, 2012 and the adoption of this guidance did not have a material impact on our financial position, results of operations or cash flows.

XML

Note 13 - Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Calculation of Numerator and Denominator in Earnings Per Share [Table Text Block]

	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
Basic:
Numerator:
Net loss	$	(2,196,814	)	$	(1,327,762	)	$	(5,047,902	)	$	(2,641,251	)
Less: Net loss allocated to participating securities		56,260			24,695			115,380			41,312
Net loss attributable to stockholders		(2,140,554	)		(1,303,067	)		(4,932,522	)		(2,599,939	)
Preferred stock dividend		(21,028	)		—			(42,287	)		—
Preferred deemed dividend		—			—			—			(975,460	)
	$	(2,161,582	)	$	(1,303,067	)	$	(4,974,809	)	$	(3,575,399	)
Denominator:
Weighted-average shares outstanding		18,944,321			11,603,691			17,707,296			11,555,616
Weighted-average unvested restricted shares outstanding		(485,162	)		(215,817	)		(404,735	)		(180,744	)
Denominator for basic net loss per share		18,459,159			11,387,874			17,302,561			11,374,872
Basic net loss per share attributable to common stockholders	$	(0.12	)	$	(0.11	)	$	(0.29	)	$	(0.31	)
Diluted:
Numerator:
Net loss	$	(2,196,814	)	$	(1,327,762	)	$	(5,047,902	)	$	(2,641,251	)
Less: Net loss allocated to participating securities		56,260			24,695			115,380			41,312
Net loss attributable to stockholders		(2,140,554	)		(1,303,067	)		(4,932,522	)		(2,599,939	)
Preferred stock dividend		(21,028	)		—			(42,287	)		—
Preferred deemed dividend		—			—			—			(975,460	)
	$	(2,161,582	)	$	(1,303,067	)	$	(4,974,809	)	$	(3,575,399	)
Denominator:
Denominator for basic calculation		18,459,159			11,387,874			17,302,561			11,374,872
Weighted-average effect of dilutive stock options		—			—			—			—
Denominator for diluted net loss per share		18,459,159			11,387,784			11,302,561			11,374,872
Diluted net loss per share attributable to common stockholders	$	(0.12	)	$	(0.11	)	$	(0.29	)	$	(0.31	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

	June 30, 2012		December 31, 2011
Stock options outstanding		704,869		1,077,744
Unvested restricted stock		348,973		289,795
Warrants to purchase common stock		3,633,794		4,106,016
Preferred stock convertible into common stock		3,409,029		3,409,029

XML

Note 4 - Accounts Receivable (Detail) - Accounts Receivable (USD $)	Jun. 30, 2012	Dec. 31, 2011
Trade accounts	$ 728,056	$ 1,230,895
Less: Allowance for bad debts	(141,000)	(39,000)
Less: Allowance for returns	(13,504)	(95,315)
	$ 573,552	$ 1,096,580

XML

Note 12 - Stock Warrants and Warrant Liability (Detail) (USD $)	1 Months Ended	6 Months Ended		1 Months Ended	3 Months Ended	6 Months Ended	1 Months Ended						1 Months Ended				1 Months Ended				3 Months Ended	6 Months Ended					1 Months Ended				1 Months Ended
	Dec. 31, 2011	Jun. 30, 2012	Feb. 17, 2011	Mar. 31, 2009 Series E Warrants [Member]	Jun. 30, 2012 Series E Warrants [Member]	Jun. 30, 2012 Series E Warrants [Member]	Jun. 30, 2009 Series G Warrants [Member]	May 31, 2010 Series H Warrants [Member]	Jun. 30, 2009 Series H Warrants [Member]	Oct. 31, 2010 Series I Warrants [Member]	May 31, 2010 Series I Warrants [Member]	Oct. 07, 2010 Series I Warrants [Member]	Aug. 31, 2011 Series J Warrants [Member]	Oct. 31, 2010 Series J Warrants [Member]	Aug. 16, 2011 Series J Warrants [Member]	Oct. 07, 2010 Series J Warrants [Member]	Mar. 30, 2012 Series K Warrants [Member]	Sep. 30, 2011 Series K Warrants [Member]	Aug. 31, 2011 Series K Warrants [Member]	Feb. 28, 2011 Series K Warrants [Member]	Jun. 30, 2012 Series K Warrants [Member]	Jun. 30, 2012 Series K Warrants [Member]	Dec. 31, 2011 Series K Warrants [Member]	Sep. 28, 2011 Series K Warrants [Member]	Aug. 16, 2011 Series K Warrants [Member]	Feb. 17, 2011 Series K Warrants [Member]	Feb. 28, 2011 Placement Agent Fee Warrants [Member]	Aug. 31, 2011 Series L Warrants [Member]	Sep. 28, 2011 Series L Warrants [Member]	Aug. 16, 2011 Series L Warrants [Member]	Sep. 30, 2011 Series M Warrants [Member]
Number of Warrants Issued During Period (in Shares)				334,822					156,250		339,677			400,001						1,700,002							60,000	643,564			325,000
Warrants Issued, Weighted Average Exercise Price (in Dollars per share)				$ 5.36					$ 5.36		$ 4.40			$ 2.44						$ 2.40							$ 2.44	$ 1.17			$ 0.81
Fair Value Assumptions, Risk Free Interest Rate				2.69%		0.20%					1.28%			0.54%			0.50%			1.40%							1.40%	0.30%			0.40%
Fair Value Assumptions, Expected Term				5 years		1 year 255 days					4 years 36 days			4 years 36 days			3 years			4 years 36 days							3 years 292 days	4 years 36 days			4 years 36 days
Fair Value Assumptions, Expected Volatility Rate				112.00%		120.50%					107.00%			103.70%			109.30%			103.20%							103.20%	109.50%			109.10%
Fair Value Assumptions, Expected Dividend Rate				0.00%		0.00%					0.00%			0.00%			0.00%			0.00%							0.00%	0.00%			0.00%
Warrants Issued During Period, Value (in Dollars)				$ 1,000,000							$ 950,000			$ 694,000						$ 2,600,000							$ 89,000	$ 554,000			$ 193,000
Derivative Liabilities, Current (in Dollars)	317,490	10,123		1,000,000																2,600,000
Warrants and Rights Outstanding (in Dollars)			2,600,000		10,000	10,000											481,000
Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (in Dollars)					(10,000)																425,000
Stock Issued During Period, Shares, New Issues (in Shares)	1,666,667						156,250
Proceeds from Warrant Exercises (in Dollars)		283,334					700,000															283,000
Term of Warrants									9 months											5 years 6 months							5 years	5 years 6 months			5 years 6 months
Estimated Value Assigned to Extension of Warrants (in Dollars)								210,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)	3.57	3.89										2.44			1.17	2.44	0.40						0.60	0.80	1.01	2.40			0.81	1.17
Percentage of Shares of Common Stock Subject to a Class of Warrants												45.00%
Period from which Warrants Become Exercisable										6 months										6 months								6 months			6 months
Warrants Exercisable Period										5 years
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)												339,677
Estimated Value Assigned to Reduction in Exercise Price and Extension of Warrants (in Dollars)										97,000			86,000																		31,000
Estimated Value Assigned to Reduction In Exercise Price (in Dollars)																		50,000	270,000
Number of Warrants Exercised During Period (in Shares)		472,222																				472,222
Warrants Exercised, Weighted Average Exercise Price (in Dollars per share)		$ 0.60																				$ 0.60
Change in Estimated Value Assigned to Warrants Classified as Increase to Equity and Decrease to Warrant Liability (in Dollars)																						$ 253,000

XML

Condensed Consolidated Balance Sheets (USD $)	Jun. 30, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 192,544	$ 1,346,777
Accounts receivable, net	573,552	1,096,580
Other receivables	467,401	469,469
Inventory, net	2,319,705	4,172,809
Prepaid expenses and other current assets, net	474,423	978,709
Assets of discontinued operations	17,296	87,455
Assets held for sale – discontinued operations	15,570	18,293
Total current assets	4,060,491	8,170,092
Property and equipment, net	116,302	196,718
Other assets, net	1,546,427	955,570
Assets of discontinued operations – long-term	200,000	209,913
Total assets	5,923,220	9,532,293
Current liabilities:
Accounts payable	3,100,461	3,865,039
Accrued liabilities	725,191	428,813
Accrued warranty	294,036	217,812
Common stock warrant liability	10,123	317,490
Credit facility	94,077	92,266
Capital lease obligations – current portion	4,731	4,699
Note payable – current portion	95,067	283,252
Liabilities of discontinued operations – short-term	1,117,999	1,308,820
Total current liabilities	5,441,685	6,518,191
Capital lease obligations, less current portion	2,362	4,713
Long-term liabilities of discontinued operations		10,200
Total liabilities	5,444,047	6,533,104
Commitments, contingencies and subsequent events (Notes 17 and 18)
Stockholders’ equity:
Convertible redeemable preferred stock, $0.001 par value, 1,000,000 shares authorized; 2,273 shares issued and outstanding on June 30, 2012 and December 31, 2011	751,223	751,223
Common stock, $0.001 par value; 100,000,000 shares authorized; 19,165,060 and 16,040,581 shares issued and outstanding at June 30, 2012 and December 31, 2011, respectively (Note 1)	19,165	16,041
Additional paid-in capital	75,250,830	72,683,781
Accumulated deficit	(75,542,045)	(70,451,856)
Total stockholders’ equity	479,173	2,999,189
Total liabilities and stockholders’ equity	$ 5,923,220	$ 9,532,293

XML

Note 7 - Accrued Liabilities (Detail) - Accrued Liabilities (USD $)	Jun. 30, 2012	Dec. 31, 2011
Accrued salaries, wages, benefits and bonus	$ 63,494	$ 92,692
Accrued accounting and legal fees	167,973	138,233
Allowance for returns		20,081
Customer deposit payable	44,345	13,819
Accrued tariff	66,751
Royalty payable	292,500	125,000
Accrued interest	36,337
Other accrued liabilities	53,791	38,988
	$ 725,191	$ 428,813

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities
Net loss	$ (5,047,902)	$ (2,641,251)
Adjustments to reconcile net loss to net cash used in by operations:
Depreciation	80,416	108,691
Amortization of patents	12,402	2,927
Bad debt expense	102,000	10,000
Unrealized gain (loss) on fair value adjustment of common stock warrants	426,640	(1,130,989)
Non-cash stock-based compensation expense	440,342	606,317
Loss on assets held for sale		10,840
Changes in assets and liabilities:
Accounts receivable	421,028	(335,691)
Other receivables	2,068	8,336
Inventory	1,940,974	1,270,448
Prepaid expenses and other current assets	504,286	(2,438)
Assets of discontinued operations – short term	70,159	566,363
Assets held for sale	2,723	20,738
Other assets	(603,259)	(101,454)
Assets of discontinued operations – long-term	9,913	(200,000)
Accounts payable	280,422	697,499
Accrued liabilities and accrued warranty	372,603	(55,099)
Liabilities of discontinued operations	(201,022)	(279,825)
Net cash used in operating activities	(1,186,207)	(1,444,588)
Cash flows from investing activities
Acquisition of property and equipment		(28,564)
Proceeds from disposal of property and equipment		18,800
Proceeds from disposal of property and equipment from discontinued operations		189,019
Net cash provided by (used in) investing activities		179,255
Cash flows from financing activities
Repayment of notes payable	(188,185)	(95,425)
Borrowing on line of credit	94,077
Repayment on line of credit	(92,266)	(540,250)
Repayments on capital lease obligations	(2,319)	(1,431)
Repayments on capital lease obligations from discontinued operations		(5,662)
Restricted cash		540,250
Proceeds from stock offering		3,600,000
Proceeds from exercise of warrants	283,334
Payment of placement agent and registration fees and other direct costs	(58,180)	(521,609)
Employee taxes paid for vesting of restricted stock	(4,487)	(18,224)
Net cash provided by financing activities	31,974	2,957,649
Net increase (decrease) in cash and cash equivalents	(1,154,233)	1,692,316
Cash and cash equivalents
Beginning of period	1,346,777	596,046
End of period	192,544	2,288,362
Supplemental cash flows disclosures:
Cash paid during the period for interest	25,213	11,092
Supplemental disclosure of non-cash financing activity:
Fair value of warrants issued in stock offering		2,713,550
Conversion of common stock warrant liability upon exercise of warrants	252,765
Common stock warrant liability issued in connection with agency placement fee		89,010
Reclassification of common stock liability upon modification of warrants	481,242
Preferred deemed dividend		975,460
Preferred stock dividends paid in common stock	42,287
Stock issued	1,132,871
Property and equipment acquired through capital lease		11,000
Satisfaction of Accounts Payable [Member]
Supplemental disclosure of non-cash financing activity:
Stock issued	1,045,000
Inventory Procurement [Member]
Supplemental disclosure of non-cash financing activity:
Stock issued	$ 87,871

XML

Note 15 - Fair Value Measurement (Detail)	6 Months Ended
	Jun. 30, 2012
Minimum [Member]
Fair Value Inputs, Discount Rate	0.00%
Maximum [Member]
Fair Value Inputs, Discount Rate	1.20%

XML

Note 1 - Basis of Presentation and Description of Business (Detail)	May 07, 2012
Number of Shares of Target Company that Each Share of Common Stock Receives in a Merger Transaction (in Shares)	3.7
Percentage of Target Company Held by Stockholders on As-converted Basis	15.00%

XML

Note 16 - Income Taxes

6 Months Ended

Jun. 30, 2012

Income Tax Disclosure [Text Block]

16. Income Taxes

Deferred income taxes arise from timing differences resulting from income and expense items reported for financial account and tax purposes in different periods. A deferred tax asset valuation allowance is recorded when it is more likely than not that deferred tax assets will not be realized. During the three and six months ended June 30, 2012, there was no income tax expense or benefit for federal and state income taxes in the accompanying condensed consolidated statements of operations due to our net loss and a valuation allowance on the resulting deferred tax asset. Our deferred tax asset has a 100% valuation allowance.

XML

Note 2 - Significant Accounting Policies (Detail) (USD $)	3 Months Ended	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2012	Dec. 31, 2011	Jun. 30, 2011	Dec. 31, 2010
Cash and Cash Equivalents, at Carrying Value (in Dollars)	$ 192,544	$ 192,544	$ 1,346,777	$ 2,288,362	$ 596,046
Line of Credit Facility, Remaining Borrowing Capacity (in Dollars)	656,000	656,000
Number of Warrants Exercised During Period (in Shares)		472,222
Warrants Exercised, Weighted Average Exercise Price (in Dollars per share)		$ 0.60
Proceeds from Warrant Exercises (in Dollars)		283,334
Product Warranty Accrual, Current (in Dollars)	294,036	294,036	217,812
Amount of Legal Costs Reclassified from Other Long-term Assets to Patents (in Dollars)	1,300,000
Minimum [Member] | Solar Panels and Inverters [Member]
Warranty Period		15 years
Minimum [Member] | Installation [Member]
Warranty Period		5 years
Minimum [Member] | Defective Products [Member]
Warranty Period		5 years
Maximum [Member] | Solar Panels and Inverters [Member]
Warranty Period		25 years
Maximum [Member] | Installation [Member]
Warranty Period		10 years
Maximum [Member] | Defective Products [Member]
Warranty Period		25 years
Material and Workmanship [Member]
Warranty Period		5 years
Installation [Member]
Disposal Group, Including Discontinued Operation, Other Current Liabilities (in Dollars)	$ 1,100,000	$ 1,100,000	$ 1,100,000
Patents [Member]
Finite-Lived Intangible Asset, Useful Life		12 years 6 months

XML

Accounting Policies, by Policy (Policies)	6 Months Ended
	Jun. 30, 2012
Liquidity Disclosure [Policy Text Block]	Liquidity and Financial Position For the six months ending June 30, 2012, and for each of the two years in the period ending December 31, 2011, we have incurred net losses and negative cash flows from operations. In addition, we expect to incur a net loss from operations for our year ending December 31, 2012. During recent years, we have undertaken several equity financing transactions to provide the capital needed tosustain and to grow our business. Based on current cash projections for2012, which contemplate a smaller operating loss, we intend to address ongoing working capital needs through cost reduction measures recently implemented andutilization of existing inventory,along with utilizing our available credit facility and raising additional equity. In the event that revenue is lower, further staffing reductions and expense cuts could occur. As of June 30, 2012, we had approximately $193,000 in cash on hand and $656,000 available under our credit facility. As an additional source of capital, outstanding warrants provide the possibility to receive additional proceeds upon exercise, depending on market conditions (See "Stock Warrants and Warrant Liability"). During the three months ending March 31, 2012, warrants to purchase 472,222 shares of common stock with an exercise price of $0.60 per share were exercised, resulting in approximately $283,000 in proceeds. We are seeking potential investors to obtain additional funding, and we have engaged an investment banker to facilitate these efforts. The accompanying consolidated financial statements have been prepared assuming we will continue as a going concern.Our significant operating losses and negative cash flow from operations raise substantial doubt about our ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty and contemplate the realization of assets and the settlement of liabilities and commitments in the normal course of business. We believe our current cash balance, projected financial results and the amounts that should be available through debt and equity financing provide sufficient resources and operating flexibility through at least the next 12 months, however, there can be no assurance that we will be able to raise additional funds on commercially reasonable terms, if at all.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition Revenue from sales of products is recognized when: (1)persuasive evidence of an arrangement exists, (2)delivery has occurred or services have been rendered, (3) the sale price is fixed or determinable, and (4)collection of the related receivable is reasonably assured. We recognize revenue when the solar power systems are shipped to the customer.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents We consider all highly liquid investments with maturities of three months or less, when purchased, to be cash equivalents. We maintain cash and cash equivalents which consist principally of demand deposits with high credit quality financial institutions. At certain times, such amounts exceed FDIC insurance limits. We have not experienced any losses on these investments.
Receivables, Policy [Policy Text Block]	Accounts Receivable Accounts receivable consist of trade receivables. We regularly evaluate the collectability of our accounts receivable. An allowance for doubtful accounts is maintained for estimated credit losses, and such losses have historically been minimal and within our expectations. We consider a number of factors when estimating credit losses, including the aging of a customer's account, creditworthiness of specific customers, historical trends and other information.
Discontinued Operations, Policy [Policy Text Block]	Discontinued operations Discontinued operations are presented and accounted for in accordance with Accounting Standards Codification (ASC) 360, "Impairment or Disposal of Long-Lived Assets,"(ASC 360). When a qualifying component of the Company is disposed of or has been classified as held for sale, the operating results of that component are removed from continuing operations for all periods presented and displayed as discontinued operations if: (a) elimination of the component's operations and cash flows from the Company's ongoing operations has occurred (or will occur) and (b) significant continuing involvement by the Company in the component's operations does not exist after the disposal transaction. On September 10, 2010, we announced that we were exiting the solar panel installation business. The exit from the installation business was essentially completed by the end of 2010, other than potential warranty payments related to past installations. (See "Manufacturer and Installation Warranties"). The exit from the installation business was therefore classified as discontinued operations for all periods presented under the requirements of ASC 360.
Standard Product Warranty, Policy [Policy Text Block]	Manufacturer and Installation Warranties The manufacturer directly warrants the solar panels and inverters for a range from 15 to 25years. We warrant the balance of system componentsof our products against defects in material and workmanship forfive years. We assist our customers in the event of a claim under the manufacturer warranty to replace a defectivesolar panel or inverter. The warrantyliability for thematerial and the workmanship of the balance of system components of approximately $294,000 at June 30, 2012 and $218,000 at December 31, 2011, is included within "Accrued warranty" in the accompanying condensed consolidated balance sheets. The liability for our manufacturing warranty consists of the following: June 30, 2012(Unaudited) December 31, 2011 Beginning accrued warranty balance (January 1) $ 217,812 $ 51,860 Reduction for labor payments and claims made under the warranty (1,388 ) - Accruals related to warranties issued during the period 77,612 165,952 Ending accrued warranty balance $ 294,036 $ 217,812 We previously recorded a provision for warranty liability related to our discontinued installation operations. We provided for a 5-year or a 10-year warranty on the installation of a system and all equipment and incidental supplies other than solar panels and inverters that are covered under the manufacturer warranty. The liability for the installation warranty of approximately $1.1 million at June 30, 2012 and December 31, 2011 is included within "Liabilities of Discontinued Operations" in the accompanying condensed consolidated balance sheets. Defective solar panels or inverters are covered under the manufacturer warranty. In the event that a panel or inverter needs to be replaced, we will replace the defective item within the manufacturer's warranty period (between 5-25 years).
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	Patent Costs We capitalize external legal costs and filing fees associated with obtaining or defending our patents. Upon issuance of new patents or successful defense of existing patents, we amortize these costs using the straight line method over the shorter of the legal life of the patent or its economic life. We believe the remaining useful life we assign to these patents, approximately 12.5 years as of June 30, 2012, are reasonable. As a result of the settlement of various legal disputes with Zep Solar, Inc., (Zep) (see "Commitments and Contingencies") during the quarter ended June 30, 2012, we reclassified approximately $1.3 million in legal costs from other long-term assets to patents, both included in "other assets, net" in the accompanying balance sheets, which is being amortized over 12.5 years. We periodically review our patents to determine whether any such cost have been impaired and are no longer being used. To the extent we are no longer using certain patents, the associated costs will be written off at that time.
Derivatives, Embedded Derivatives [Policy Text Block]	Common Stock Warrant Liabilities In March 2009 and February 2011, we issued warrants to purchase shares of our common stock in connection with certain capital financing transactions. The terms of the March 2009 warrant agreements include a cash-out provision which may be triggered at the option of the warrant holders if the Company "goes private," is acquired for all cash or upon the occurrence of certain other fundamental transactions involving the Company. Under the Financial Accounting Standards Board ("FASB") Topic 480, Distinguishing Liabilities from Equity ("ASC 480"), financial instruments that may require the issuer to settle the obligation by transferring assets or to reduce the exercise price of its warrants to purchase shares of its common stock are classified as a liability. Therefore, we classified these warrants as liabilities and we record mark-to-market adjustments to reflect the fair value at each period-end. On March 30, 2012, the February 2011 warrants were amended to remove any future price adjustment to the exercise price. (See Note 12. "Stock Warrants" relating to the accounting treatment of the Series E and K warrants).
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Standards In June 2011, the FASB issued ASU No.2011-05 , Comprehensive Income (Topic 220): Presentation of Comprehensive Income (ASU No. 2011-05) . ASU No.2011-05 requires that all non-owner changes in stockholders' equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements, eliminating the option to present other comprehensive income in the statement of changes in equity. Under either choice, items that are reclassified from other comprehensive income to net income are required to be presented on the face of the financial statements where the components of net income and the components of other comprehensive income are presented. We adopted ASU No. 2011-05 on January 1, 2012 and the adoption of this guidance did not have a material impact on our financial position, results of operations or cash flows.

XML

Note 1 - Basis of Presentation and Description of Business

6 Months Ended

Jun. 30, 2012

Business Description and Basis of Presentation [Text Block]

1. Basis of Presentation and Description of Business

Basis of Presentation — Interim Financial Information

The accompanying condensed consolidated financial statements are unaudited and have been prepared in accordance with generally accepted accounting principles for interim financial information. They should be read in conjunction with the financial statements and related notes to the financial statements of Westinghouse Solar, Inc. (“we”, “us”, “our” or the “Company”), formerly Akeena Solar, Inc., for the years ended December 31, 2011 and 2010 appearing in our Form 10-K. The June 30, 2012 unaudited interim consolidated financial statements included in this Quarterly Report on Form 10-Q have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements filed with our Annual Report on Form 10-K have been condensed or omitted as permitted by those rules and regulations. In the opinion of management, all adjustments, consisting of normal recurring accruals, necessary for a fair statement of the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the entire year.

Reclassifications

Reverse Stock Split

On April 6, 2011, we filed a Certificate of Amendment to our Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a reverse split of our common stock at a ratio of 1-for-4. The reverse stock split was effective at the close of business on April 13, 2011. All historical share and per share amounts have been adjusted to reflect the reverse stock split. Our par value was not changed by the reverse stock split.

Description of Business

We are a designer and manufacturer of solar power systems and solar panels with integrated microinverters (which we call AC solar panels). We design, market and sell these solar power systems to solar installers, trade workers and do-it-yourself customers through distribution partnerships, our dealer network and retail outlets. Our products are designed for use in solar power systems for residential and commercial rooftop customers. Prior to September 2010, we were also in the solar power installation business. We launched the distribution of our solar power systems in the second quarter of 2009.

On May 17, 2010, we entered into an exclusive worldwide agreement that permits us to manufacture, distribute and market our solar panels under the Westinghouse name. On July 22, 2010, we announced that we will operate under the name “Westinghouse Solar” and, effective July 23, 2010 at the opening of the market, our stock began trading under the stock symbol “WEST” on the NASDAQ Capital Market.

At the Annual Meeting of Stockholders held on March 31, 2011, our stockholders approved an amendment to our Certificate of Incorporation to formally change the name of the company from “Akeena Solar, Inc.” to “Westinghouse Solar, Inc.”. The name change became effective on April 6, 2011.

Our Corporate headquarters is located at 1475 S. Bascom Ave., Campbell, CA 95008. Our telephone number is (408) 402-9400. Additional information about Westinghouse Solar is available on our website at http://www.westinghousesolar.com. The information on our web site is not incorporated herein by reference.

On May 7, 2012, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with CBD Energy Limited, an Australian corporation (“CBD”), and CBD-WS Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of CBD (“Merger Sub”). Under the terms of the Merger Agreement, Merger Sub will be merged with and into the Company, with the Company to be the surviving corporation and a wholly-owned subsidiary of CBD (the “Merger”).

Under the Merger Agreement, our stockholders would receive shares of CBD in exchange for their shares. Our common stockholders will receive approximately 3.7 CBD common shares for each common share held and our preferred stockholders will receive CBD preferred shares which will be convertible into CBD common shares. On an as-converted basis, the holders of our common stock and holders of our Series B preferred stock would collectively hold approximately 15% of the outstanding CBD common shares, calculated as if the Merger was consummated on the signing date. The Merger will not qualify as a “tax free reorganization” for U.S. federal income tax purposes. CBD has applied for listing on the Nasdaq Stock Market, with listing to be effective on or before consummation of the Merger. Completion of the Merger is subject to customary conditions, including (i) the adoption of the Merger Agreement by the required vote of the holders of our outstanding common stock, (ii) the Securities and Exchange Commission (the “SEC”) has declared effective a Registration Statement registering the CBD common shares under the Securities Act of 1933, as amended, (iii) the approval and adoption by the holders of outstanding CBD common shares of the Merger Agreement and the issuance of additional CBD common shares as consideration in the Merger, and (iv) the approval by the Australian Securities Exchange (the “ASX”) and the holders of outstanding CBD common shares of the delisting of the CBD common shares from the ASX. In conjunction with the execution of the Merger Agreement, the holders of a majority of our outstanding Company Series B preferred stock entered into a Waiver and Agreement in substantially the form attached as Exhibit D to the Merger Agreement (and included in Exhibit 2.1 to the Current Report on Form 8-K filed with the SEC on May 9, 2012).

XML

Condensed Consolidated Balance Sheets (Parentheticals) (USD $)	Jun. 30, 2012	Dec. 31, 2011
Convertible redeemable preferred stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Convertible redeemable preferred stock, shares authorized	1,000,000	1,000,000
Convertible redeemable preferred stock, shares issued	2,273	2,273
Convertible redeemable preferred stock, shares outstanding	2,273	2,273
Common stock, par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	19,165,060	16,040,581
Common stock, shares outstanding	19,165,060	16,040,581

XML

Note 11 - Stock Option Plan and Stock Incentive Plan

6 Months Ended

Jun. 30, 2012

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

11. Stock Option Plan and Stock Incentive Plan

On August 8, 2006, we adopted the Westinghouse Solar, Inc. 2006 Stock Incentive Plan (the “Stock Plan”) pursuant to which shares of common stock are available for issuance to employees, directors and consultants under the Stock Plan as restricted stock and/or options to purchase common stock. The Stock Plan allows for issuance of up to 3,000,000 shares and there were 1,843,418 shares available for issuance under the Stock Plan as of June 30, 2012.

Restricted stock and options to purchase common stock may be issued under the Stock Plan. The restriction period on restricted stock grants generally expires at a rate of 25% per year over four years, unless decided otherwise by our Compensation Committee. Options to purchase common stock generally vest and become exercisable as to one-third of the total amount of shares subject to the option on each of the first, second and third anniversaries from the date of grant. Options to purchase common stock generally have a 5-year term.

We use the Black-Scholes-Merton Options Pricing Model (Black-Scholes) to estimate fair value of our employee and our non-employee director stock-based awards. Black-Scholes requires various judgmental assumptions, including estimating stock price volatility, expected option life and forfeiture rates. If we had made different assumptions, the amount of our deferred stock-based compensation, stock-based compensation expense, gross margin, net loss and net loss per share amounts could have been significantly different. We believe that we have used reasonable methodologies, approaches and assumptions to determine the fair value of our common stock, and that our deferred stock-based compensation and related amortization were recorded properly for accounting purposes. If any of the assumptions we used change significantly, stock-based compensation expense may differ materially in the future from that recorded in the current period.

We measure compensation expense for non-employee stock-based compensation under Accounting Standards Codification (ASC) 505-50, “Equity-Based Payments to Non-Employees.” The fair value of the option issued is used to measure the transaction, as this is more reliable than the fair value of the services received. The estimated fair value is measured utilizing Black-Scholes using the value of our common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty’s performance is complete (generally the vesting date). The fair value of the equity instrument is charged directly to expense and additional paid-in capital.

We recognized stock-based compensation expense of approximately $145,000 and $189,000 during the three months ended June 30, 2012 and 2011, respectively, and approximately $440,000 and $606,000 during the six months ended June 30, 2012 and 2011, respectively, relating to compensation expense calculated based on the fair value at the time of grant for restricted stock and based on Black-Scholes for stock options granted under the Stock Plan.

The following table sets forth a summary of restricted stock activity for the six months ended June 30, 2012:

	Number of Restricted Shares			Weighted-Average Grant Date Fair Value
Outstanding and not vested beginning balance at January 1, 2012		289,795		$	1.92
Granted		551,839		$	0.48
Forfeited/cancelled		(84,150	)	$	2.22
Released/vested		(408,511	)	$	0.75
Outstanding and not vested at June 30, 2012		348,973		$	0.95

Restricted stock is valued at the grant date fair value of the common stock and expensed over the requisite service period or vesting period. We estimate forfeitures when recognizing stock-based compensation expense for restricted stock, and the estimate of forfeitures is adjusted over the requisite service period should actual forfeitures differ from such estimates. At June 30, 2012 and December 31, 2011, there was approximately $277,000 and $465,000, respectively, of unrecognized stock-based compensation expense associated with the granted but unvested restricted stock. Stock-based compensation expense relating to these restricted shares is being recognized over a weighted-average period of 1.4 years. The total fair value of shares vested during the six months ended June 30, 2012 and 2011, was approximately $196,000 and $110,000, respectively. Tax benefits resulting from tax deductions in excess of the compensation cost recognized (excess tax benefits) are classified as financing cash flows on our consolidated statements of cash flows. During the three and six months ended June 30, 2012 and 2011, there were no excess tax benefits relating to restricted stock and therefore there is no impact on the accompanying consolidated statements of cash flows.

The following table sets forth a summary of stock option activity for the six months ended June 30, 2012:

	Number of Shares Subject to Option			Weighted- Average Exercise Price
Outstanding at January 1, 2012		1,077,744		$	5.47
Granted		25,000		$	0.40
Forfeited/cancelled/expired		(397,875	)	$	7.82
Exercised		—		$	—
Outstanding at June 30, 2012		704,869		$	3.97
Exercisable at June 30, 2012		412,122		$	5.01

Stock options are valued at the estimated fair value grant date or the measurement date and expensed over the requisite service period or vesting period. The weighted-average volatility was based upon the historical volatility of our common stock price. The fair value of stock option grants during the three and six months ended June 30, 2012 and 2011 was estimated using the Black-Scholes option-pricing model with the following assumptions:

	Three Months Ended June 30,					Six Months Ended June 30,
	2012			2011		2012			2011
Weighted-average volatility		105.5			—		105.5			103.1	%
Expected dividends		0.0	%		—		0.0	%		0.0	%
Expected life (years)	2.6				—	2.6			3.0
Weighted-average risk-free interest rate		0.4	%		—		0.4	%		1.2	%

The weighted-average fair value per share of the stock options as determined on the date of grant was $0.24 for the stock options to purchase 25,000 shares of common stock granted during the six months ended June 30, 2012. The weighted-average remaining contractual term for the stock options outstanding (vested and expected to vest) and exercisable as of June 30, 2012 and December 31, 2011, was 3.1 years and 3.2 years, respectively. The total estimated fair value of stock options vested during the three and six months ended June 30, 2012 was approximately $8,000 and $333,000, respectively.The aggregate intrinsic value of stock options outstanding as of June 30, 2012 was zero.

We estimate forfeitures when recognizing stock-based compensation expense for stock options and the estimate of forfeitures is adjusted over the requisite service period should actual forfeitures differ from such estimates. At June 30, 2012 and December 31, 2011, there was approximately $110,000 and $520,000, respectively, of unrecognized stock-based compensation expense associated with stock options granted. Stock-based compensation expense relating to these stock options is being recognized over a weighted-average period of approximately 11 months. Tax benefits resulting from tax deductions in excess of the compensation cost recognized (excess tax benefits) is classified as financing cash flows on our consolidated statements of cash flows. During the three and six months ended June 30, 2012, there were no excess tax benefits relating to stock options and therefore there is no impact on the accompanying consolidated statements of cash flows.
 

XML

Document And Entity Information	6 Months Ended
	Jun. 30, 2012	Aug. 10, 2012
Document and Entity Information [Abstract]
Entity Registrant Name	Westinghouse Solar, Inc.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		19,148,083
Amendment Flag	false
Entity Central Index Key	0001347452
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Jun. 30, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q2

XML

Note 12 - Stock Warrants and Warrant Liability

6 Months Ended

Jun. 30, 2012

Derivatives and Fair Value [Text Block]

12. Stock Warrants and Warrant Liability

During March 2009, in connection with an equity financing, we issued Series E Warrants to purchase 334,822 shares of common stock at an exercise price of $5.36 per share. The fair value of the warrants was estimated using Black-Scholes with the following weighted average assumptions: risk-free interest rate of 2.69%, an expected life of five years; an expected volatility factor of 112% and a dividend yield of 0.0%. The value assigned to these warrants was approximately $1.0 million, of which $1.0 million was reflected as common stock warrant liability with an offset to additional paid-in capital as of the offering close date. As of June 30, 2012, the fair value of the warrants was estimated using Black-Scholes with the following weighted average assumptions: risk-free interest rate of 0.2%, an expected life of 1.7 years; an expected volatility factor of 120.5% and a dividend yield of 0.0%. The fair value of the warrants decreased to $10,000 as of June 30, 2012 and we recognized a $10,000 unfavorable non-cash adjustment from the change in fair value of these warrants for the three months ended June 30, 2012.

On June 1, 2009, we entered into an amendment agreement (the “Amendment Agreement”) with investors who had previously acquired Series G Warrants. Pursuant to the Amendment Agreement, the investors purchased 156,250 shares of our common stock through the exercise of a portion of their Series G Warrants, with gross proceeds to us of $700,000. In conjunction with that exercise, we issued new Series H Warrants to purchase up to an aggregate of 156,250 shares of Common Stock at a strike price of $5.36 per share. The Series H Warrants became exercisable on December 1, 2009 and had a term of nine months from the day they first become exercisable. In conjunction with the May 17, 2010 transaction discussed below, the expiration date for the Series H Warrants was extended.

On May 17, 2010, we entered into a Securities Purchase Agreement and issued Series I Warrants to purchase 339,677 shares of common stock at an exercise price of $4.40 per share (the “Series I Warrants”). The fair value of the warrants was estimated using Black-Scholes with the following weighted-average assumptions:  risk-free interest rate of 1.28%, an expected life of 4.1 years; an expected volatility factor of 107% and a dividend yield of 0.0%. The estimated value of these warrants was approximately $950,000. Under the May 17, 2010 Securities Purchase Agreement, we also agreed to extend the term of the remainder of our outstanding Series H Warrants until December 1, 2011. The estimated value assigned to the extension of these warrants was approximately $210,000.

On October 7, 2010, we entered into a securities purchase agreement and issued Series J Warrants to purchase 400,001 shares of common stock at an exercise price of $2.44 per share. The fair value of the warrants was estimated using Black-Scholes with the following weighted-average assumptions:  risk-free interest rate of 0.54%, an expected life of 4.1 years; an expected volatility factor of 103.7% and a dividend yield of 0.0%. The estimated value of these warrants was approximately $694,000, which was allocated to additional paid in capital. Under the securities purchase agreement, we also agreed to amend the outstanding Series I Warrants, such that the exercise price of the Series I Warrants was reduced to $2.44 per share. In addition, with respect to 45% of the shares of common stock subject to each of the Series I Warrants, (i) each warrant was not exercisable until the six month anniversary of the closing under the securities Purchase agreement, and (ii) the expiration date was extended such that the warrant is exercisable for five years from the delayed initial exercise date. The outstanding Series I Warrants were originally issued on May 17, 2010, and represent the right to purchase up to an aggregate of 339,677 shares of our common stock. The estimated value assigned to the reduction in exercise price and extension of these warrants was approximately $97,000. As the terms of the Series I Warrants are classified as equity, as opposed to liability, there was no accounting impact as a result of the amendment to the Series I Warrant agreement.

On February 17, 2011, we entered into a securities purchase agreement and issued Series K Warrants to purchase up to 1,700,002 shares of common stock at an exercise price of $2.40 per share, which warrants are not exercisable until six months after issuance and have a term of 5.5 years. The fair value of the warrants was estimated using Black-Scholes with the following weighted-average assumptions:  risk-free interest rate of 1.4%, an expected life of 4.1 years; an expected volatility factor of 103.2% and a dividend yield of 0.0%. The estimated value of these warrants was approximately $2.6 million, of which $2.6 million was reflected as common stock warrant liability with an offset to preferred stock as of the offering close date. As a result of the August 16, 2011 security sale, the exercise price of the Series K warrants was reduced from $2.40 to $1.01; as a result of the September 28, 2011 security sale, the exercise price of the Series K warrants was further reduced from $1.01 to $0.80. The estimated value assigned to the reduction in exercise price was $270,000 and $50,000, respectively, on August 16, 2011 and September 28, 2011, and we recognized a non-cash charge from the change in the fair value of the warrants. During the six months ended June 30, 2012, 472,222 Series K Warrants were exercised at a price of $0.60 and total proceeds of approximately $283,000. As a result of the exercise, we recognized approximately $253,000 in the change in the estimated value assigned to the warrants as an increase to equity and a decrease to the warrant liability. On March 30, 2012, we entered into an Amendment to Securities Purchase Agreement with the holders of the remaining Series K warrants (Series K Amendment) reducing the exercise price to $0.40 and removing provisions for any future price adjustment to the exercise price. On March 30, 2012, the fair value of the warrants was estimated using Black-Scholes with the following weighted average assumptions: risk-free interest rate of 0.5%, an expected life of 3.0 years; an expected volatility factor of 109.3% and a dividend yield of 0.0%. The fair value of the warrants increased to approximately $481,000 as of March 30, 2012 and we recognized a $425,000 unfavorable non-cash adjustment from the change in fair value of these warrants for the three months ended March 31, 2012. On March 30, 2012, as a result of the Series K Amendment, the fair value of the warrants of approximately $481,000 was reclassified from warrant liability to equity.

In connection with the February 17, 2011 securities purchase agreement, we issued as a placement agent fee to our financial advisory firm warrants to purchase 60,000 shares of common stock at an exercise price of $2.44 per share, with a term of five years. The fair value of the warrants was estimated using Black-Scholes with the following weighted-average assumptions:  risk-free interest rate of 1.4%, an expected life of 3.8 years; an expected volatility factor of 103.2% and a dividend yield of 0.0%. The estimated value of these warrants was approximately $89,000 which was reflected as a reduction in the net proceeds of the preferred stock with an offset to additional paid in capital as of the offering close date.

On August 16, 2011, we entered into a securities purchase agreement and issued Series L Warrants to purchase up to 643,564 shares of common stock at an exercise price of $1.17 per share, which warrants were not exercisable until six months after issuance and have a term of 5.5 years. The fair value of the warrants was estimated using Black-Scholes with the following weighted-average assumptions:  risk-free interest rate of 0.3%, an expected life of 4.1 years; an expected volatility factor of 109.5% and a dividend yield of 0.0%. The estimated value of these warrants was approximately $554,000. In connection with the August 16, 2011 securities purchase agreement, we agreed to extend the term of the remainder of our outstanding Series J Warrants until March 28, 2017. The estimated value assigned to the reduction in exercise price and extension of these warrants was approximately $86,000. As the terms of the Series J Warrants are classified as equity, as opposed to liability, there was no accounting impact as a result of the amendment to the Series J Warrant agreement.

On September 28, 2011, we entered into a securities purchase agreement and issued Series M Warrants to purchase up to 325,000 shares of common stock at an exercise price of $0.81 per share, which warrants are not exercisable until six months after issuance and have a term of 5.5 years. The fair value of the warrants was estimated using Black-Scholes with the following weighted-average assumptions:  risk-free interest rate of 0.4%, an expected life of 4.1 years; an expected volatility factor of 109.1% and a dividend yield of 0.0%. The estimated value of these warrants was approximately $193,000. In connection with the September 28, 2011 securities purchase agreement, we agreed to extend the term of the remainder of our outstanding Series L Warrants until March 28, 2017. The estimated value assigned to the reduction in exercise price and extension of these warrants was approximately $31,000. As the terms of the Series L Warrants are classified as equity, as opposed to liability, there was no accounting impact as a result of the amendment to the Series L Warrant agreement.

The following table summarizes the Warrant activity for the six months ending June 30, 2012:

	Warrants for Number of Shares			Weighted-Average Exercise Price
Outstanding at January 1, 2012		4,106,016		$	3.57
Issued		—		$	—
Exercised		(472,222	)	$	0.60
Cancelled/expired		—		$	—
Outstanding at June 30, 2012		3,633,794		$	3.89

XML

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Net revenue	$ 1,209,211	$ 2,757,729	$ 3,631,551	$ 4,752,091
Cost of goods sold	1,243,034	2,563,842	3,423,003	4,280,405
Gross profit	(33,823)	193,887	208,548	471,686
Operating expenses
Sales and marketing	467,523	700,103	1,090,703	1,046,431
General and administrative	1,663,885	1,464,269	3,727,294	3,143,214
Total operating expenses	2,131,408	2,164,372	4,817,997	4,189,645
Loss from continuing operations	(2,165,231)	(1,970,485)	(4,609,449)	(3,717,959)
Other income (expense)
Interest income (expense), net	(39,006)	(35,148)	(34,786)	(57,849)
Adjustment to the fair value of common stock warrants	10,303	668,041	(426,640)	1,130,989
Total other income (expense)	(28,703)	632,893	(461,426)	1,073,140
Loss before provision for income taxes and discontinued operations	(2,193,934)	(1,337,592)	(5,070,875)	(2,644,819)
Provision for income taxes
Net loss from continuing operations (Note 3)	(2,193,934)	(1,337,592)	(5,070,875)	(2,644,819)
Net income (loss) from discontinued operations, net of tax	(2,880)	9,830	22,973	3,568
Net loss	(2,196,814)	(1,327,762)	(5,047,902)	(2,641,251)
Preferred stock dividend	(21,028)		(42,287)
Preferred deemed dividend				(975,460)
Net loss attributable to common stockholders	$ (2,217,842)	$ (1,327,762)	$ (5,090,189)	$ (3,616,711)
Net loss attributable to common stockholders per common and common equivalent share (basic and diluted) (in Dollars per share)	$ (0.12)	$ (0.11)	$ (0.29)	$ (0.31)
Weighted average shares used in computing loss per common share: (basic and diluted) (in Shares)	18,459,159	11,387,874	17,302,561	11,374,872

XML

Note 6 - Property and Equipment, Net

6 Months Ended

Jun. 30, 2012

Property, Plant and Equipment Disclosure [Text Block]

6. Property and Equipment, Net

Property and equipment, net consist of the following:

	June 30, 2012 (Unaudited)			December 31,  2011
Office equipment	$	573,852		$	573,852
Leasehold improvements		148,759			148,759
Vehicles		17,992			17,992
		740,603			740,603
Less: Accumulated depreciation and amortization		(624,301	)		(543,885	)
	$	116,302		$	196,718

Depreciation expense for the three months ended June 30, 2012 and 2011 was approximately $40,000 and $44,000, respectively. For the six months ended June 30, 2012 and 2011, depreciation expense was approximately $80,000 and $109,000, respectively.

XML

Note 5 - Inventory

6 Months Ended

Jun. 30, 2012

Inventory Disclosure [Text Block]

5. Inventory

Our inventory, which consists entirely of finished goods inventory, was approximately $2.3 million and $4.2 million at June 30, 2012 and December 31, 2011, respectively. As of June 30, 2012 and December 31, 2011, there was approximately $17,000 and $75,000, respectively, capitalized in inventory related to the restricted stock grant for a supply agreement with Light Way Green New Energy Co., Ltd, (Lightway) and approximately $42,000 and $12,000, respectively, related to rent, depreciation and salary costs.

XML

Note 17 - Commitments and Contingencies

6 Months Ended

Jun. 30, 2012

Commitments and Contingencies Disclosure [Text Block]

17. Commitments and Contingencies

Litigation

We have been involved in various patent litigation with Zep Solar, Inc. (“Zep”) and other parties, including (1) an action we filed on October 22, 2009 against Zep and several other defendants in the United States District Court for the Northern District of California, San Francisco Division for infringement of U.S. Patent No. 7,406,800 (the “’800 District Court Action”), (2) an action Zep and Trina Solar filed on August 2, 2011 against us in the United States District Court for the Northern District of California, San Francisco Division for declaratory judgment of non-infringement of U.S. Patent No. 7,987,641 issued to our subsidiary Andalay Solar on August 2, 2011 (the “’641 District Court Action”), (3) an action we filed with the United States International Trade Commission (“ITC”) on October 4, 2011 accusing Zep and Canadian Solar of infringing the ’800 patent and the ’641 patent (the “ITC Action”), and (4) an action Zep filed against us and other defendants in the United States District Court for the Northern District of California, San Francisco Division alleging that the our products infringe U.S. Patent No. 7,952,537 (the “’537 District Court Action”).

On May 25, 2012, we and Zep entered into a final and comprehensive settlement of these legal disputes. In June 2012, the three actions pending in the United States District Court for the Northern District of California and the ITC Action were all dismissed and the cases were terminated. The specific terms of the global settlement are confidential.  The settlement extends to all customers, suppliers, licensees and business partners of both Zep and us who were named in one or more of the proceedings.

On May 1, 2012, Suntech America, Inc., a Delaware corporation (Suntech America), filed a complaint for breach of contract, goods sold and delivered, account stated and open account against us in the Superior Court of the State of California, County of San Francisco. Suntech America alleged that it delivered products to us and did not receive full payment by us. On July 31, 2012, we and Suntech entered into a settlement of this dispute. As of June 30, 2012, we have included in our Condensed Consolidated Balance Sheets, under accounts payable, a balance due to Suntech America of $989,771.

On June 7, 2012, Barry Cinnamon, the former chief executive officer of the Company, filed a complaint with the U.S. Department of Labor, Occupational Safety and Health Administration, at its office in San Francisco California, alleging that Mr. Cinnamon’s termination of employment on May 8, 2012 constituted a violation of the whistleblower protections of the Sarbanes-Oxley Act of 2002.  In his complaint, Mr. Cinnamon requests that the Secretary of Labor institute an investigation of alleged retaliation against Mr. Cinnamon by us and our board of directors. The complaint also indicates that Mr. Cinnamon has a variety of state law claims, which he intends to pursue in court.  We have not been notified that any other proceedings have been filed by Mr. Cinnamon as of August 10, 2012.  We have responded to the initial complaint, disagreeing with Mr. Cinnamon’s characterization of events.  We believe that the complaint and claims by Mr. Cinnamon are without merit, and we intend to defend ourselves in any proceedings brought by Mr. Cinnamon.

We are also involved in other litigation from time to time in the ordinary course of business. In the opinion of management, the outcome of such proceedings will not materially affect our financial position, results of operations or cash flows.

XML

Note 13 - Earnings Per Share

6 Months Ended

Jun. 30, 2012

Earnings Per Share [Text Block]

13. Earnings Per Share

On January 1, 2009, we adopted ASC 260 (formerly Financial Accounting Standards Board Staff Position (FSP) Emerging Issues Task Force (EITF) 03-6-1) (ASC 260), Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities (the “Staff Position”), which states that unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and shall be included in the computation of net income (loss) per share pursuant to the two-class method described in ASC 260 (formerly Statement of  Financial Accounting Standards (SFAS) No. 128), Earnings Per Share.
 

In accordance with the Staff Position, basic net income (loss) per share is computed by dividing net income (loss), excluding net income (loss) attributable to participating securities, by the weighted average number of shares outstanding less the weighted average unvested restricted shares outstanding. Diluted net income (loss) per share is computed by dividing net income (loss), excluding net income (loss) attributable to participating securities, by the denominator for basic net income (loss) per share and any dilutive effects of stock options, restricted stock, convertible notes and warrants.

On April 6, 2011, we filed a Certificate of Amendment to our Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a reverse split of our common stock at a ratio of 1-for-4. The reverse stock split became effective at the close of business on April 13, 2011. All historical share and per share amounts have been adjusted to reflect this reverse stock split. The par value of our common stock did not change. The following table sets forth the computation of basic and diluted net loss per share (unaudited):

	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
Basic:
Numerator:
Net loss	$	(2,196,814	)	$	(1,327,762	)	$	(5,047,902	)	$	(2,641,251	)
Less: Net loss allocated to participating securities		56,260			24,695			115,380			41,312
Net loss attributable to stockholders		(2,140,554	)		(1,303,067	)		(4,932,522	)		(2,599,939	)
Preferred stock dividend		(21,028	)		—			(42,287	)		—
Preferred deemed dividend		—			—			—			(975,460	)
	$	(2,161,582	)	$	(1,303,067	)	$	(4,974,809	)	$	(3,575,399	)
Denominator:
Weighted-average shares outstanding		18,944,321			11,603,691			17,707,296			11,555,616
Weighted-average unvested restricted shares outstanding		(485,162	)		(215,817	)		(404,735	)		(180,744	)
Denominator for basic net loss per share		18,459,159			11,387,874			17,302,561			11,374,872
Basic net loss per share attributable to common stockholders	$	(0.12	)	$	(0.11	)	$	(0.29	)	$	(0.31	)
Diluted:
Numerator:
Net loss	$	(2,196,814	)	$	(1,327,762	)	$	(5,047,902	)	$	(2,641,251	)
Less: Net loss allocated to participating securities		56,260			24,695			115,380			41,312
Net loss attributable to stockholders		(2,140,554	)		(1,303,067	)		(4,932,522	)		(2,599,939	)
Preferred stock dividend		(21,028	)		—			(42,287	)		—
Preferred deemed dividend		—			—			—			(975,460	)
	$	(2,161,582	)	$	(1,303,067	)	$	(4,974,809	)	$	(3,575,399	)
Denominator:
Denominator for basic calculation		18,459,159			11,387,874			17,302,561			11,374,872
Weighted-average effect of dilutive stock options		—			—			—			—
Denominator for diluted net loss per share		18,459,159			11,387,784			11,302,561			11,374,872
Diluted net loss per share attributable to common stockholders	$	(0.12	)	$	(0.11	)	$	(0.29	)	$	(0.31	)

The following table sets forth potential shares of common stock at the end of each period presented that are not included in the calculation of diluted net loss per share because to do so would be anti-dilutive:

	June 30, 2012		December 31, 2011
Stock options outstanding		704,869		1,077,744
Unvested restricted stock		348,973		289,795
Warrants to purchase common stock		3,633,794		4,106,016
Preferred stock convertible into common stock		3,409,029		3,409,029

XML

Note 9 - Stockholders' Equity

6 Months Ended

Jun. 30, 2012

Stockholders' Equity Note Disclosure [Text Block]

9. Stockholders’ Equity

On February 17, 2011, we entered into a securities purchase agreement with certain institutional accredited investors relating to the sale of 4,000 units at a price of $900 per unit. See Note 10 for a discussion of the sale of units.

On March 25, 2011, we entered into a Supply Agreement (the “Lightway Supply Agreement”) with Light Way Green New Energy Co., Ltd (Lightway). Lightway is a vertically integrated manufacturer of polycrystalline silicon wafers, solar cells and solar modules. Lightway is a supplier for our proprietary Westinghouse solar panels. In consideration of the new contract manufacturing arrangement, we agreed to issue to Lightway shares of our common stock with a market value of $520,000, based on the closing share price of our common stock on the date of the first shipment of products by Lightway. On July 31, 2011, in conjunction with their first shipment, we issued Lightway 361,111 unvested shares of our common stock. The shares will vest ratably on a monthly basis over a one year period beginning August 31, 2011. As of June 30, 2012, 331,019 shares have vested. The unvested shares are subject to forfeiture in the event of termination of the Lightway Supply Agreement by either party.

On August 16, 2011, we entered into a securities purchase agreement with an institutional accredited investor relating to the sale of 990,099 shares of common stock at a price of $1.01 per share, along with the sale of Series L Warrants to purchase up to 643,564 shares of common stock (65% of the number of shares of common stock initially issued) at an exercise price of $1.17 per share. The warrants were not exercisable until six months after issuance and have a term of five years from the date they are first exercisable. The aggregate purchase price for the shares and the warrants was $1,000,000. Under the securities purchase agreement, we agreed to amend the outstanding Series J Warrants, such that the exercise price of the Series J Warrants was reduced from $2.44 per share to $1.17 per share. In addition, each of the Series J Warrants, (i) is not exercisable until the six month anniversary of the closing under the August 16, 2011 securities purchase agreement, and (ii) the expiration date is extended such that the warrant is exercisable for five years from the delayed initial exercise date.

On September 28, 2011, we entered into a securities purchase agreement with an institutional accredited investor relating to the sale of 500,000 shares of common stock at a price of $0.80 per share, along with the sale of Series M Warrants to purchase up to 325,000 shares of common stock (65% of the number of shares of common stock initially issued) at an exercise price of $0.81 per share. The warrants were not exercisable for six months after issuance and have a term of 5.5 years from the date they are first exercisable. The aggregate purchase price for the shares and the warrants was $500,000. Under the securities purchase agreement, we agreed to amend the outstanding Series L Warrants, such that the exercise price of the Series L Warrants is reduced from $1.17 per share to $0.81 per share. In addition, each of the Series L Warrants, (i) was not exercisable for the six month anniversary of the closing under the September 28, 2011 securities purchase agreement, and (ii) the expiration date is extended such that the warrant is exercisable for five years from the delayed initial exercise date. 

On December 30, 2011, we entered into a securities purchase agreement with CBD Energy Limited (“CBD”), an Australian corporation, relating to the sale of 1,666,667 shares of common stock at a price of $0.60 per share. The aggregate purchase price was $1,000,000.

As a result of the December 30, 2011 sale, (i) the conversion price of the Series B Preferred was reduced to $0.60 per share of common stock, and (ii) the exercise price per share of the Series K Warrants was reduced to $0.60 per share of common stock. There are currently 2,273 shares of Series B Preferred that remain outstanding. After adjustment to the conversion price, the outstanding Series B Preferred would be convertible into 3,409,029 shares of common stock. Because we have previously recognized the full amount of proceeds allocated to the preferred stock as a preferred deemed dividend, there was no further accounting implication to this adjustment.

On March 30, 2012, we entered into an amendment to the outstanding Series K warrants which removed the provision for any future price adjustment to the exercise price. See Note 12 for a discussion on the accounting treatment of these warrants.

Pursuant to the Lightway Supply Agreement, on March 30, 2012, we issued 1,900,000 shares of our common stock to Lightway. The shares were issued at $0.55 per share based on the latest closing sale price on the date of issuance. The issuance of the common stock, valued at $1,045,000, increased equity and reduced accounts payable by an equal amount. We filed a registration statement, on May 15, 2012, to register for resale the shares of common stock issued to Lightway. The registration statement was declared effective on May 25, 2012.

XML

Note 15 - Fair Value Measurement (Detail) - Assets and Liabilities Measured at Fair Value on Recurring Basis (USD $)	Jun. 30, 2012
Fair value of common stock warrant liability	$ 10,123
Accrued rent related to office closures	35,182
Total	45,305
Fair Value, Inputs, Level 3 [Member]
Fair value of common stock warrant liability	10,123
Accrued rent related to office closures	35,182
Total	$ 45,305

XML

Note 7 - Accrued Liabilities

6 Months Ended

Jun. 30, 2012

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

7. Accrued Liabilities

Accrued liabilities consist of the following:

	June 30, 2012 (Unaudited)		December 31,  2011
Accrued salaries, wages, benefits and bonus	$	63,494	$	92,692
Accrued accounting and legal fees		167,973		138,233
Allowance for returns		—		20,081
Customer deposit payable		44,345		13,819
Accrued tariff		66,751		—
Royalty payable		292,500		125,000
Accrued interest		36,337
Other accrued liabilities		53,791		38,988
	$	725,191	$	428,813

XML

Note 8 - Credit Facility

6 Months Ended

Jun. 30, 2012

Debt Disclosure [Text Block]

8. Credit Facility

On February 15, 2011, we entered into a Business Financing Agreement (the "2011 Credit Facility") with Bridge Bank, National Association (“Bridge Bank”) to finance our accounts receivables. The 2011 Credit Facility provides for a credit limit of $750,000, representing the maximum amount of advances based on up to 50% of $1.5 million of gross eligible accounts receivables. The 2011 Credit Facility may be terminated at any time by either party and may be renewed under similar terms if acceptable and agreed to by both parties. If any advance is not repaid in full within 90 days from the earlier of (a) invoice date, or (b) the date on which such advance is made, we are obligated to immediately pay the outstanding amount to Bridge Bank. Outstanding loans under the 2011 Credit Facility will accrue interest at the Bridge Bank Prime rate plus 3.0% (annualized) of the daily gross financed amount outstanding. The 2011 Credit Facility is secured by substantially all of our assets. As of June 30, 2012 and December 31, 2011, there was approximately $94,000 and $92,000, respectively, borrowed under the 2011 Credit Facility.

XML

Note 10 - Convertible Redeemable Preferred Stock and Preferred Deemed Dividend

6 Months Ended

Jun. 30, 2012

Convertible Redeemable Preferred Stock And Preferred Deemed Dividend [Text Block]

10. Convertible Redeemable Preferred Stock and Preferred Deemed Dividend

On February 17, 2011, we entered into a securities purchase agreement with certain institutional accredited investors relating to the sale of 4,000 units at a price of $900 per unit (the “Securities Purchase Agreement”). Each unit consists of (i) one share of Series B Preferred Stock (the “Series B Preferred”), with each such share of Series B Preferred initially convertible into 500 shares of common stock at an initial conversion price of $1.80 per share, subject to future adjustment for various events, and (ii) warrants to purchase 425 shares of common stock at an initial exercise price of $2.40 per share, subject to future adjustment for various events, which warrants were not exercisable for six months after issuance and have a term of five years from the date of first exercisability (the “Series K Warrants” and together with the Series B Preferred, the “Securities”). The aggregate purchase price for the Securities was $3,600,000, less $532,000 in issuance costs. As of May 10, 2012, 1,727 shares of preferred stock had been converted into 891,601 shares of common stock.

The Certificate of Designation to create the Series B Preferred includes certain negative covenants regarding indebtedness and other matters, and includes provisions under which the holders of the Series B Preferred are entitled to demand redemption for cash upon specified triggering events. The Series B Preferred bears dividends at the rate 4% per year for the first year, and 8% per year thereafter, payable in stock or in cash at our election, subject to certain restrictions.

In connection with the sale of the Securities under the Securities Purchase Agreement, we entered into a registration rights agreement with the purchasers (the “Registration Rights Agreement”). In accordance with the Registration Rights Agreement, we filed a registration statement, on March 18, 2011, to register for resale the shares of common stock issued and issuable to the purchasers upon conversion of the Series B Preferred and the shares issuable upon exercise of the Series K Warrants. The registration statement was declared effective on June 17, 2011. Under the terms of the Registration Rights Agreement, we are obligated to maintain the effectiveness of the resale registration statement until all securities registered thereunder are sold or otherwise can be sold pursuant to Rule 144, without restriction.

On the date of issuance, we recorded the value of the Series B Preferred of $1.0 million and of the warrants of $2.6 million on our balance sheet. The closing price of our common stock on the date of issuance was used to value the Series B Preferred and we used the Black-Scholes model to value the Series K Warrants. For purposes of calculating the fair value of the warrants, we used a risk free rate of return of 1.4%, an expected life of 4.1 years and a volatility percentage of 103.2%. The intrinsic value of the beneficial conversion feature is considered a preferred deemed dividend totaling $975,000 to the preferred shareholders, and was charged to additional paid-in capital on our condensed consolidated balance sheets and net loss attributable to common stockholders on our condensed consolidated statements of operations.

Effective August 23, 2011, we amended our Certificate of Designation of Preferences, Rights and Limitations of the Series B 4% Convertible Preferred Stock to amend the terms of the outstanding Series B 4% Convertible Preferred Stock. The principal changes included in the Certificate of Amendment are to: (i) add a hard floor price of $0.10 per share of common stock as a limitation to any future conversion price adjustment to the Series B Preferred Stock resulting from future sales of common stock (or common stock equivalents) or at the one year anniversary of the original issuance date (February 18, 2012) if the recent trading price (20 day VWAP) is below the then current conversion price; (ii) reclassify the consequence of certain breaches and triggering events such that the holders of the Series B Preferred Stock would not be entitled to potentially receive cash redemption in such events, but instead would have rights to receive additional shares of common stock (either in the form of increased dividend payments or upon redemption of their Series B Preferred); and (iii) take into account certain adjustment events that have occurred since the Original Filing, including the 1-for-4 reverse stock split of our common stock implemented after the close of business on April 13, 2011. The purpose for adopting the Certificate of Amendment was to implement revisions that caused the balance sheet value associated with the Series B Preferred Stock to be treated as stockholders’ equity, rather than as “mezzanine” equity, for accounting purposes.

As a result of our December 30, 2011 stock sale to CBD, the conversion price of the Series B Preferred was reduced to $0.60 per share of common stock. The maximum intrinsic value of the beneficial conversion feature was previously recorded on the date of issuance for the Series B Preferred and, consequently, no additional preferred deemed dividend was recorded as a result of the reduction in the conversion price of the Series B Preferred.

See Note 12 for a discussion of the accounting treatment of the stock warrant transactions described above.

XML

Note 17 - Commitments and Contingencies (Detail) (USD $)	Jun. 30, 2012
Accounts Payable, Other	$ 989,771

XML

Note 15 - Fair Value Measurement (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

Liabilities	Level 1		Level 2		Level 3		June 30, 2012
Fair value of common stock warrant liability	$	—	$	—	$	10,123	$	10,123
Accrued rent related to office closures		—		—		35,182		35,182
Total	$	—	$	—	$	45,305	$	45,305

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

	Other Liabilities*			Common Stock Warrant Liability			Total Level 3
Beginning balance – January 1, 2012	$	79,888		$	317,490		$	397,378
Total realized and unrealized gains or losses		222			426,640			426,862
Repayments		(44,928	)		—			(44,928	)
Net transfers in and/or (out) of level 3		—			(734,007	)		(734,007	)
Ending balance – June 30, 2012	$	35,182		$	10,123		$	45,305

XML

Note 11 - Stock Option Plan and Stock Incentive Plan (Detail) - Summary of Stock Option Activity (USD $)	6 Months Ended
	Jun. 30, 2012
Outstanding at January 1, 2012	1,077,744
Outstanding at January 1, 2012 (in Dollars per share)	$ 5.47
Granted	25,000
Granted (in Dollars per share)	$ 0.40
Forfeited/cancelled/expired	(397,875)
Forfeited/cancelled/expired (in Dollars per share)	$ 7.82
Outstanding at June 30, 2012	704,869
Outstanding at June 30, 2012 (in Dollars per share)	$ 3.97
Exercisable at June 30, 2012	412,122
Exercisable at June 30, 2012 (in Dollars per share)	$ 5.01

XML

Note 15 - Fair Value Measurement

6 Months Ended

Jun. 30, 2012

Fair Value Disclosures [Text Block]

15. Fair Value Measurement

We use a fair-value approach to value certain assets and liabilities. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. We use a fair value hierarchy, which distinguishes between assumptions based on market data (observable inputs) and an entity’s own assumptions (unobservable inputs). The hierarchy consists of three levels:

• Level one — Quoted market prices in active markets for identical assets or liabilities;

• Level two — Inputs other than level one inputs that are either directly or indirectly observable; and

• Level three — Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use.

Determining which category an asset or liability falls within the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter. Assets and liabilities measured at fair value on a recurring basis are summarized as follows (unaudited):

Liabilities	Level 1		Level 2		Level 3		June 30, 2012
Fair value of common stock warrant liability	$	—	$	—	$	10,123	$	10,123
Accrued rent related to office closures		—		—		35,182		35,182
Total	$	—	$	—	$	45,305	$	45,305

A discussion of the valuation techniques used to measure fair value for the common stock warrants is in Note 13. The accrued rent relates to a non-cash charge for the closure of our Anaheim and San Diego, California locations, calculated by discounting the future lease payments to their present value using a risk-free discount rate from 0.0% to 1.2%. The accrued rent is included within liabilities of discontinued operations and long-term liabilities of discontinued operations in our consolidated balance sheets.

The following table shows the changes in Level 3 liabilities measured at fair value on a recurring basis for the six months ended June 30, 2012:

	Other Liabilities*			Common Stock Warrant Liability			Total Level 3
Beginning balance – January 1, 2012	$	79,888		$	317,490		$	397,378
Total realized and unrealized gains or losses		222			426,640			426,862
Repayments		(44,928	)		—			(44,928	)
Net transfers in and/or (out) of level 3		—			(734,007	)		(734,007	)
Ending balance – June 30, 2012	$	35,182		$	10,123		$	45,305

*           Represents the estimated fair value of the office closures included in accrued and other long-term liabilities.

XML

Note 3 - Discontinued Operations (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]

Assets of discontinued operations:	June 30, 2012 (unaudited)		December 31, 2011
Accounts receivable and other receivables	$	7,383	$	41,762
Prepaid expenses and other current assets		—		34,415
Other assets		9,913		11,278
Total current assets of discontinued operations		17,296		87,455
Security deposits on operating leases		—		9,913
Security deposit – escrow account for installation jobs		200,000		200,000
Total assets of discontinued operations	$	217,296	$	297,368

Liabilities of discontinued operations:	June 30, 2012 (unaudited)		December 31, 2011
Accrued liabilities	$	36,682	$	124,751
Accrued warranty		1,081,317		1,133,549
Deferred revenue		—		50,520
Total current liabilities		1,117,999		1,308,820
Other long-term liabilities		—		10,200
Total discontinued operations liabilities	$	1,117,999	$	1,319,020

XML

Note 11 - Stock Option Plan and Stock Incentive Plan (Detail) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Dec. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)	3,000,000		3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in Shares)	1,843,418		1,843,418
Expiration Rate Per Year of Restriction Period on Restricted Stock Grants	25.00%		25.00%
Term of Options			5 years
Share-based Compensation	$ 145,000	$ 189,000	$ 440,342	$ 606,317
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)			$ 0.24
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures (in Shares)			25,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term			3 years 36 days		3 years 73 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	8,000		333,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	0		0
Restricted Stock [Member]
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	277,000		277,000		465,000
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition			1 year 146 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value			196,000	110,000
Stock Options [Member]
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	$ 110,000		$ 110,000		520,000
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition			11 months

XML

Note 4 - Accounts Receivable (Detail) - Allowance for Doubtful Accounts (USD $)	6 Months Ended		12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Dec. 31, 2011
Balance at Beginning of Period	$ 39,000	$ 5,000	$ 5,000
Provisions, net	102,000	10,000	34,000
Balance at End of Period	$ 141,000		$ 39,000

XML

Condensed Consolidated Statements of Changes in Redeemable Convertible Preferred Stock and Stockholders' Equity (Unaudited) (USD $)	Redeemable Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at January 1, 2012 at Dec. 31, 2011	$ 751,223	$ 16,041	$ 72,683,781	$ (70,451,856)	$ 2,999,189
Balance at January 1, 2012 (in Shares) at Dec. 31, 2011	2,273	16,040,581
Issuance of common stock for supply agreement		2,080	1,130,790		1,132,871
Issuance of common stock for supply agreement (in Shares)		2,080,558
Preferred stock dividends paid in common stock		112	42,175	(42,287)
Preferred stock dividends paid in common stock (in Shares)		111,537
Reclassify fair value of common stock warrant liability upon exercise and modification			734,007		734,007
Exercise of warrants for common stock		472	282,862		283,334
Exercise of warrants for common stock (in Shares)		472,222
Grants of restricted stock, net of forfeitures and repurchases for employee taxes		460	(4,948)		(4,488)
Grants of restricted stock, net of forfeitures and repurchases for employee taxes (in Shares)		460,162
Stock-based compensation expense			440,342		440,342
Placement agent and registration fees and other direct costs			(58,180)		(58,180)
Net loss				(5,047,902)	(5,047,902)
Balance at June 30, 2012 at Jun. 30, 2012	$ 751,223	$ 19,165	$ 75,250,830	$ (75,542,045)	$ 479,173
Balance at June 30, 2012 (in Shares) at Jun. 30, 2012	2,273	19,165,060

XML

Note 4 - Accounts Receivable

6 Months Ended

Jun. 30, 2012

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

4. Accounts Receivable

Accounts receivable consists of the following:

	June 30, 2012 (Unaudited)			December 31,  2011
Trade accounts	$	728,056		$	1,230,895
Less: Allowance for bad debts		(141,000	)		(39,000	)
Less: Allowance for returns		(13,504	)		(95,315	)
	$	573,552		$	1,096,580

The following table summarizes the allowance for doubtful accounts as of June 30, 2012 and December 31, 2011:

	Balance at Beginning of Period		Provisions, net		Write-Off/ Recovery		Balance at End of Period
Six months ended June 30, 2012	$	39,000	$	102,000	$	—	$	141,000
Year ended December 31, 2011	$	5,000	$	34,000	$	—	$	39,000

XML

Note 14 - Concentration of Risk (Detail) - Percentages of Sales to Largest Customers (Sales Revenue, Goods, Net [Member])	3 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2012	Dec. 31, 2011	Dec. 31, 2011
Lennar Corporation [Member]
Percentage of sales		12.60%	21.20%	14.60%
Lennox International Inc. [Member]
Percentage of sales	26.00%	39.20%	25.20%	32.30%
Lowe's Companies, Inc. [Member]
Percentage of sales	13.70%	8.00%	1.80%	1.60%

XML

Note 4 - Accounts Receivable (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

	June 30, 2012 (Unaudited)			December 31,  2011
Trade accounts	$	728,056		$	1,230,895
Less: Allowance for bad debts		(141,000	)		(39,000	)
Less: Allowance for returns		(13,504	)		(95,315	)
	$	573,552		$	1,096,580

Allowance for Credit Losses on Financing Receivables [Table Text Block]

	Balance at Beginning of Period		Provisions, net		Write-Off/ Recovery		Balance at End of Period
Six months ended June 30, 2012	$	39,000	$	102,000	$	—	$	141,000
Year ended December 31, 2011	$	5,000	$	34,000	$	—	$	39,000

XML

Note 3 - Discontinued Operations (Detail) (USD $)	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Dec. 31, 2011
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax	$ 23,000	$ 4,000
Escrow Deposit	200,000
Escrow Deposit Disbursements	40,000
Other Inventory, Net of Reserves	$ 16,000		$ 18,000

XML

Note 14 - Concentration of Risk

6 Months Ended

Jun. 30, 2012

Concentration Risk Disclosure [Text Block]

14. Concentration of Risk

Financial instruments that potentially subject us to credit risk are comprised of cash and cash equivalents, which are maintained at high quality financial institutions. At December 31, 2011, there was approximately $1.1 million in excess of the Federal Deposit Insurance Corporation (FDIC) limit of $250,000. At June 30, 2012, we did not have any deposits in excess of the FDIC limit.

The relative magnitude and the mix of revenue from our largest customers have varied significantly quarter to quarter. During the three and six months ended June 30, 2012 and 2011, three customers have accounted for significant revenues, varying by period, to our company: Lennar Corporation (Lennar), a leading national homebuilder, Lennox International Inc. (Lennox), a global leader in the heating and air conditioning markets, and Lowe’s Companies, Inc. (Lowe’s), a leading residential solar energy installation company/integrator. For the three and six months ended June 30, 2012 and 2011, the percentages of sales to Lennar, Lennox and Lowe’s are as follows:

	Three Months Ended June 30,						Six Months Ended June 30,
	2012			2011			2012			2011
Lennar Corporation		—			21.2	%		12.6	%		14.6	%
Lennox International Inc.		26.0	%		25.2	%		39.2	%		32.3	%
Lowe’s Companies, Inc.		13.7	%		1.8	%		8.0	%		1.6	%

We had no receivable balance from Lennar as of June 30, 2012 or December 31, 2011. Lennox accounted for 23.5% and 23.1% of our gross accounts receivable as of June 30, 2012, and December 31, 2011, respectively. Lowe’s accounted for 10.5% and 13.9% of our gross accounts receivable as of June 30, 2012, and December 31, 2011, respectively.

Over time, as we work to add additional distributors to our network and to grow our distribution business, we anticipate the relative significance to our revenue of any particular customer will decline.

We maintain reserves for potential credit losses and such losses, in the aggregate, have generally not exceeded management’s estimates. Our top three vendors accounted for approximately 46.2% and 58.0% of materials purchased during the six months ended June 30, 2012 and 2011, respectively. At June 30, 2012, accounts payable included amounts owed to these top three vendors of approximately $1.1 million. At December 31, 2011, accounts payable included amounts owed to the top three vendors of approximately $3.3 million.

Historically, we obtained virtually all of our solar panels from Suntech. On March 25, 2011, we entered into a volume supply agreement for a new generation of our solar panel products with Light Way Green New Energy Co., Ltd (Lightway), and in August 2011, we began purchasing solar panels from Lightway. Both Suntech and Lightway manufacture panels for us that are built to our unique specifications. We currently purchase all of the microinverters used in our AC solar panels from Enphase. Although we had an adequate amount of inventory on hand as of June 30, 2012, and although we believe we could find alternative suppliers for solar panels manufactured to our specifications, and alternative suppliers for microinverters, on comparable terms, the sudden loss of any of our current primary component supply relationships could be disruptive to our operations. In recent months, because of our cash position and liquidity constraints, we have been late in making payments to both of our panel suppliers. On March 30, 2012, pursuant to our Supply Agreement with Lightway, we issued 1,900,000 shares of our common stock to Lightway in partial payment of our past due account payable to them. The shares were valued at $1,045,000. On May 1, 2012, Suntech America filed a lawsuit against us for breach of contract, alleging that it delivered products to us and has not received full payment. We currently do not have any unshipped orders for solar panel product pending with Suntech. We have pending and planned orders for additional shipments of product from Lightway. Unless we are able to satisfy our panel suppliers that we will make timely payment for future product orders, our suppliers may delay further shipments to us, which could result in decreased sales and revenue for us, and adversely affect our customer relationships and result in cancelled orders.